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Abstract 
Global shortages in fish oil are forcing the aquaculture feed industry to use 
alternative oil sources. Nevertheless, the complete and successful replacement of fish 
oil by alternative oil, without negatively impacting on the final fatty acid 
composition of the cultured product, has yet to be achieved. Specifically, the failure 
to meet this milestone is largely attributed to the unsolved issues surrounding the 
dilution of omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) when fish 
are fed fish oil deprived diets. Thus, the modulation of fatty acid metabolism and the 
potential of in vivo biosynthesis of n-3 LC-PUFA in cultured fish is the core of an 
intensive global research effort. 
 
Of particular interest within this context are the roles of dietary linoleic acid (LA, 
18:2n-6), α-linolenic acid (ALA, 18:3n-3) and their ratio, as these fatty acids are the 
basic precursors to LC-PUFA and compete for the same bioconverting enzymes.  It 
is envisaged that more efficient fish oil replacement strategies can be achieved 
through a better understanding of the nutritional roles and interactions of these two 
essential fatty acids (EFA), which are generally abundant in alternative oils and have 
major impacts on final fatty acid composition of fish fillets when fish oil is replaced. 
Secondly, of great interest are all potential nutritional factors that may modulate in 
vivo fatty acid metabolism. These include micronutrients that may play a significant 
role in the biochemical reactions involved in the pathway of the de novo LC-PUFA 
biosynthesis. Of these potential micronutrients, evidence from mammalian studies 
suggests that pyridoxine (Vitamin B6) plays an important role in fatty acid 
metabolism as a co-factor/activator of desaturase enzymes, whereas iron, a structural 
component and integral part of the desaturase enzymes, directly impacts the 
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enzymatic activities of the LC-PUFA biosynthetic pathway. Nevertheless, there is 
little information currently available on the optimal dietary ALA/LA ratio or the 
effects of dietary pyridoxine and iron availability on fatty acid metabolism in 
cultured fish when fed fish oil deprived diets. 
 
Following a general introduction of the aforementioned topics (Chapter 1) and a 
general description of the materials and methods required for their investigation 
(Chapter 2), the first research chapter (Chapter 3) of this PhD study describes an 
experiment assessing the effects of varying dietary ALA/LA ratios with a constant 
amount of total C18 PUFA in the freshwater, warmwater species, Murray cod 
(Maccullochella peelii peelii).  This study focused on the growth performance, feed 
utilization efficiency and tissue fatty acid composition of Murray cod at the end of an 
experimental grow-out period in which fish were fed alternative oil based 
(specifically, formulated blends of sunflower oil, linseed oil or/and beef tallow) diets 
containing varying ALA/LA ratios and the subsequent restoration efficiency of fillet 
fatty acid compositions following a fish oil wash-out/finishing period. Overall 
performance and tissue lipid concentrations were unaffected by a varying dietary 
ALA/LA ratio. However, the dietary ALA/LA ratio significantly impacted on the 
final fatty acid make-up and nutritional quality of the fish fillet. In particular, the 
fillets of fish fed with higher ALA/LA ratios (hence receiving more dietary ALA) 
recorded significantly higher concentrations of eicosapentaenoic acid (EPA; 20:5n-3), 
and docosahexaenoic acid (DHA; 22:6n-3, respectively). High dietary LA content 
seemed to have significant negative impacts on the efficiency of a finishing strategy. 
Interestingly, on average, only 10% of the total EPA and DHA provided during the 
finishing period via the fish oil based diet was retained and deposited into the fish 
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fillet. The deposition of EPA and DHA during the finishing period was shown to be 
affected by previous feeding history, with fish previously fed high LA diets 
depositing significantly lower amounts of these fatty acids in comparison to fish 
previously fed a diet rich in ALA. 
 
The second research chapter of this thesis (Chapter 4) was based on the same feeding 
trial presented in Chapter 3, but aimed to gain a better understanding of the metabolic 
response of dietary fatty acids in Murray cod with a special focus on varying dietary 
ALA/LA ratios at a constant level of C18 PUFA (ALA+LA). The whole body fatty 
acid balance method was employed to deduce in vivo fatty acid metabolism. The 
results indicated that dietary ALA was more actively β-oxidized and bioconverted, 
whereas LA appeared to be more efficiently deposited. LA was β-oxidized at a 
constant level (~36 % of net intake), independent of dietary availability, while ALA 
was oxidized proportionally to dietary supply. The in vivo apparent Δ-6 desaturase 
activity acting on n-3 and n-6 PUFA exhibited an increasing and decreasing trend, 
respectively, with the elevated dietary ALA/LA ratio clearly indicating that this 
enzymatic activity is substrate-dependant. However, the maximum Δ-6 desaturase 
activity acting on ALA peaked at the substrate level of 3.2186 (μmol g fish-1 day-1), 
suggesting that additional inclusion of ALA is not only wasteful, but 
counterproductive in terms of n-3 LC-PUFA production. Despite a constant total 
supply of ALA+LA, the recorded total in vivo apparent Δ-6 desaturase activity on 
both substrates (ALA and LA) increased in synchrony with the ALA/LA ratio, 
peaking at 1.54,  Additionally, a 3.2-fold greater Δ-6 desaturase affinity towards 
ALA over LA was recorded in Murray cod during the experimental period. 
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The objective of the third research chapter (Chapter 5) was to evaluate the potential 
regulatory effects of dietary pyridoxine (Vitamin B6) supplementation in fatty acid 
metabolism of the coldwater, freshwater finfish, rainbow trout (Oncorhynchus 
mykiss) which has been recognized among cultured fish as an efficient candidate in 
LC-PUFA bioconversion. A feeding trial was implemented on rainbow trout, in 
which fish were fed one of four experimental diets containing a pyridoxine 
hydrochloride concentration of 2.4, 4.6, 7.8 and 19.0 mg kg-1 diet (all containing the 
same blend of vegetable oils) for 60 days. The polyunsaturated fatty acid (PUFA) 
fraction of the four experimental diets was mainly represented by C18 fatty acids (LA 
and ALA). The whole body fatty acid balance method was used to deduce in vivo 
fatty acid metabolism. The growth performance, feed utilization and total lipid 
content of rainbow trout was not significantly influenced by dietary pyridoxine 
supplementation. n-6 PUFA metabolism was significantly impacted by the dietary 
pyridoxine supplementation in relation to apparent Δ-5 desaturase and elongase 
enzyme activities and was elevated in the groups supplemented with higher dietary 
pyridoxine. Though not significantly different, apparent Δ-5 desaturase activity on n-
3 PUFA (ALA) also seemed to be influenced by the dietary pyridoxine level. No 
significant effects were observed in relation to apparent Δ-6 desaturase activity, fatty 
acid de novo production or β-oxidation for both n-6 and n-3 PUFA. Nevertheless, the 
deposition of LC-PUFA, EPA, DPA, DHA and ARA in particular, were 
comparatively higher in fillets of fish fed higher dietary pyridoxine levels. Dietary 
pyridoxine level was shown to modulate and positively stimulate the activity of the 
fatty acid elongase, Δ-6 and Δ-5 desaturase enzymes. However, this activity was 
insufficient to compensate for a diet lacking in LC-PUFA, but does highlight 
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potential strategies to maximise this activity in cultured fish, especially when fish oil 
is replaced with alternative oil. 
 
The final research chapter (Chapter 6) describes an experiment carried out to 
elucidate the potential roles of dietary iron on the fatty acid metabolism of rainbow 
trout. In this study, graded inclusions of dietary iron were tested in 100% vegetable 
oil based diets with identical fatty acid composition in rainbow trout. The growth 
performance, feed utilization and total lipid content of rainbow trout was not 
significantly influenced by dietary iron supplementation. Promising, but preliminary 
evidence, suggests that dietary iron concentrations can have a positive effect on the 
overall LC-PUFA biosynthesis in fish. In particular, dietary iron level was shown to 
affect the final n-3 LC-PUFA content of fish tissues and likely modulate the activity 
of fatty acid desaturase enzymes. As was the case for dietary pyridoxine, this 
enhanced enzyme activity promoted by dietary iron supplementation was insufficient 
to compensate for a diet lacking in LC-PUFA, although the information generated 
does provide valuable insight for the expansion of knowledge relative to fatty acid 
metabolism in fish and the tentative improvement in the efficiency of in vivo LC-
PUFA biosynthesis in aquaculture species. 
 
In the final chapter (Chapter 7), the major findings obtained from the trials reported 
in this thesis are discussed, attempting to compare the results obtained across the 
different trials, and between the two different studied species, with suggested future 
research directions. Though an efficient strategy to completely replace fish oil in 
aquafeed without detrimental modifications to the fatty acid composition of cultured 
product was not achieved,  this body of work will provide valuable information for 
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the scientific community to progress toward this important goal, ultimately required 
for the future environmental and economic sustainability of the aquaculture sector. 
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regression equation: Y = 368.8X × (0.7560+X)-1, normality of residuals P=0.095; 
20:5n-3, regression equation: Y = 319.2X × (0.9978+X)-1, normality of residuals 
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P>0.1; and 22:5n-3 regression equation: Y = 261.9X × (0.4659+X)-1, normality of 
residuals P>0. B) Elognase acting on n-6 PUFA: 18:3n-6, regression equation: Y = 
0.7697X +24.82, R2 = 0.37, P = 0.0366; 20:4n-6, regression equation: Y = 0.4970X 
+0.0213, R2 = 0.52, P =0.0085................................................................................153 
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CHAPTER 1 
General Introduction 
1.1 Current status of global fisheries and aquaculture  
Seafood, more precisely fish and shellfish is the major source of animal protein  
acquired from capture fisheries in nourishing the global human population. However, 
over the last few decades, the nature of supplying seafood has been gradually 
changing, being transformed into a more farming-dependent food supply, 
transforming the art of aquaculture into more of a science (De Silva et al., 2010). 
According to recent statistics, it is estimated that 50% of the seafood needs are 
currently met by the aquaculture industry (FAO, 2010), which is now recognised as 
the fastest growing and most vibrant food production sector in the world. It is 
therefore forecast that by the year 2030, aquaculture will provide up to 60–70% of 
globally consumed seafood (Subasinghe et al., 2009). 
 
As the global population increases, there has been an unprecedented increase in 
desire for seafood, which are recognised as the prime source of omega-3 long chain 
polyunsaturated fatty acids (n-3 LC-PUFA) and an affordable source of animal 
protein for the human food supply. As such, world per capita seafood consumption 
has increased during the last few decades recording a maximum of 17.0 kg per capita 
in 2008 (FAO, 2010). Nevertheless, since the 1980s, global production of capture 
fisheries has remained static at about 100 million metric tons per annum due to 
declining catches of capture fisheries, and the implementation of sustainable 
management policies (FAO, 2010). Therefore, the gap between demand and supply 
of fish food will have to be borne by the aquaculture industry. 
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Despite the declining capture fisheries, the aquaculture industry, especially intensive 
aquaculture systems where high-valued carnivorous fish are raised, are currently 
utilising large amounts of formulated feeds containing high protein and lipid 
concentrations. Traditionally, the favourite raw materials used by the industry to 
satisfy these requirements have been fish meal and fish oil; being fish meal 
recognised as the best source of protein and essential amino acids, and fish oil the 
best source of lipid and essential fatty acids.  However, the aquaculture industry’s 
continued reliance on already strained capture fisheries and feeding fish to fish.is 
currently at the core of a heated global debate, with major concerns raised relative to 
the sustainability of the industry. Furthermore, ethical issues have also been placed 
on the use of fishery resources for aquafeed manufacture, with suggestions that these 
resources would be better utilised directly for human consumption (FAO, 2007).  In 
realisation of reducing the reliance on marine resources in aquafeed manufacturing, 
alternative lipid and protein resources are needed for the sustainable production of 
aquaculture and the aquafeed industry. 
 
In this context, limited supply and increasing demand appear to be the major reasons 
for ever increasing prices of fishmeal and FO. In accordance with the prevailing 
statistics, the prices of fishmeal and FO have risen 50% and 130%, respectively 
between mid-2005 and mid-2008 (Naylor et al 2009). The pricing of feed ingredients 
plays a significant role in determining the price of the final fish product and thus, it 
directly affects profitability of the farming industry. Therefore, it is of paramount 
importance to explore all possible strategies to replace FO in aquafeed with readily 
available and low cost alternative terrestrial oils for the future growth and 
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sustainability of the aquaculture industry as it is already using roughly 90% of annual 
FO production reaching a 'bottleneck' stage (FAO, 2010). This will effectively 
address the issue of declining capture fisheries production and the escalating demand 
for fish and fishery products by seafood consumers. 
 
1.2 Nutritional roles of fatty acids 
1.2.1 Human Nutrition 
Fatty acids are classified as essential fatty acid (EFA) when they are required to be 
administered via the diet due to the absence of corresponding enzymatic 
processes/enzymes needed for de novo synthesis. Humans, like all other vertebrates, 
demonstrate an absolute dietary requirement for the two basic polyunsaturated fatty 
acids (PUFA); linoleic acid (18:2n-6; LA) and α-linolenic acid (18:3n-3; ALA) due 
to a lack of the Δ-12 and Δ-15 desaturase enzymes which are required for de novo 
synthesis (Holman, 1986; Tinoco, 1982). Of the two essential fatty acids, all 
vertebrates including humans can synthesize more biologically active long chain 
fatty acids such as ARA, EPA and DHA using relevant desaturase and elongase 
enzymes. Of these LC-PUFA, especially n-3 series of fatty acids which are derived 
from ALA, are known to play a significant role in human nutrition preventing 
numerous pathologies (Sargent et al., 2002). DHA is found largely in retina, brain 
and other neural tissues (Uauy et al., 2003) and is a requirement for normal cognitive 
and visual development particularly in foetal and newly born infants (Hornstra et al., 
1995; Lauritzen et al., 2001). In addition, neuro/psychological disorders such as 
Alzheimer’s disease, clinical depression and schizophrenia are associated with 
relatively low levels of n-3 LC-PUFA, particularly DHA, in brain and adipose tissue 
(Conquer and Holub, 1997; Mamalakis et al., 2002). Moreover, consumption of food 
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rich in n-3 LC-PUFA is known to result in the prevention of many inflammatory 
conditions which are prevalent in the Western world, including rheumatoid arthritis, 
atopic illness, psoriasis, multiple sclerosis, bronchial asthma and type I diabetes 
(Leaf and Weber, 1988; Harris, 1989; Kinsella et al., 1990; Simopoulos, 1991; 
Calder, 1997; de Deckere et al. 1998; Connor, 2000). There is also a strong body of 
evidence that consumption of fish rich in high levels of EPA and DHA helps prevent 
coronary heart disease (Dyerberg et al., 1978; Stansby, 1990; Kelly, 1991). Further, 
intake of n-3 LC-PUFA has been speculated to lower the risk of atherosclerotic 
plaque formation, colon and breast cancers (Bougnoux et al., 1994; Caygill and Hill, 
1995). However, from a human nutritional point of view, n-6 PUFA are still of 
physiological importance as a deficiency of LA is known to interfere with growth, 
reproduction and skin function in mammals (Burr, 1942; Holman, 1968; Hansen and 
Jensen, 1995). Moreover, eicosanoids which are derived primarily from the ARA and 
EPA are essentially a family of active fatty acid metabolites which are broadly 
associated with stressful situations (Fischer, 1989; Sargent et al., 2002). Excessive 
production of eicosanoids often occurs in pathological conditions.  In humans, ARA 
is known to be the chief precursor of biologically active eicosanoids generating 2-
series prostanoids and 4-series leucotrienes which mediate inflammatory functions. 
However, EPA competitively interferes with ARA for the same enzymes and is 
converted itself into 3-series prostanoids and 5-series leucotrienes which are 
generally less biologically active to those derived from ARA mediating anti-
inflammatory functions (Sargent et al., 2002). Therefore, the nature of eicosanoid 
action is determined by the ratio of ARA to EPA in cellular membranes which in turn 
being determined by dietary intake of n-6 and n-3 PUFA (Sargent et al, 2002). In this 
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context, it is of paramount importance to ensure the human diet to be balanced with 
the optimal level of n-6 to n-3 ratio. 
 
Despite the above well known health promoting characteristics of n-3 LC-PUFA, 
current Western diets are still reported to have an n-6 to n-3 PUFA ratio ranging 
from 10:1 to 25:1, which is far beyond the expected optimum value of 5:1 
(Simopoulos, 1991). The prevailing data on dietary lipid sources and fatty acids 
intake have been closely linked with the reported health implications and disorders 
commonly observed in the in the Western world (Janus et al., 1996; Okuyama et al., 
1997; Bulliyya, 2000). Therefore, as fish and seafood are the primary-if not the only- 
natural source of n-3 LC-PUFA in the human diet, an increase in fish intake will help 
rebalance the n-6 to n-3 ratio and reduce many of the aforementioned health 
disorders prevalent among humans, especially among the developed nations. 
 
1.2.2 Fish Nutrition 
As with all other vertebrates, lipids and their constituent fatty acids play a vital role 
in fish nutrition as a source of available energy and essential fatty acids where they 
form structural components of biomembranes, carriers of fat-soluble vitamins, 
precursors to eicosanoids, hormones and vitamin D, and as enzyme co-factors (Higgs 
& Dong 2000). Therefore, the dietary lipids in formulated feeds for farmed fish are 
an important source of energy and both essential and non-essential fatty acids for 
regular growth, health, reproduction and basic metabolic functions. If a dietary 
deficiency occurs in essential fatty acids, the growth of the animal and its 
reproduction is impaired and it leads to the development various pathologies, 
eventually causing the death of the animal (Sargent et al., 2002). Fish, as with other 
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vertebrate, have an absolute dietary requirement for both n-6 and n-3 PUFA. Of 
these, the biologically active forms of essential fatty acids are generally the C20 and 
C22 metabolites (LC-PUFA) of LA and ALA (Sargent et al., 2002). However, it has 
been suggested that the only two fatty acids that should be specifically termed as 
EFA are LA and ALA which cannot be synthesized de novo by fish and other 
vertebrates (Turchini et al., 2009).  
 
It is well-known that all fish have the ability of converting the two basic EFA, n-6 
PUFA (LA) and n-3 PUFA (ALA) into corresponding C20 and C22 n-6 and n-3 LC-
PUFA in vivo by an alternating succession of desaturation and elongation (Nakamura 
and Nara, 2004). Nevertheless, many species have lost this ability as a result of 
adaptation to a LC-PUFA rich environment. The inadequacy of marine fish to 
convert C18 PUFA to LC-PUFA is believed to be caused by enzymatic insufficiency 
within the desaturation/elongation pathway, specifically by the impairment of Δ-5 
desaturase and/or C18-20 elongase activities (Owen et al., 1975; Tocher et al., 1989). 
Consequently, the fundamental EFA requirements of fish vary depending on species 
and their habitat. Generally, freshwater fish can survive by converting dietary C18 
PUFA to LC-PUFA, whereas marine fish rely on preformed LC-PUFA through 
dietary sources. Consequently, the C20 and C22 LC-PUFA themselves are considered 
to be the dietary EFA in species that cannot perform these conversions (Sargent et 
al., 2002). In this realisation, it is well accepted that many species have a net 
requirement for the preformed LC-PUFA, mainly ARA, EPA and DHA which are 
considered to be highly bioactive in nature. Additionally, the EFA requirements can 
vary also within a species according to the developmental and physiological stage, 
relative to the trophic level and the environment they evolved, and the EFA 
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requirement may increase with the increasing content of lipid in the diet. Generally, 
it is considered that marine fish and coldwater freshwater finfish have an essential 
requirement for n-3 PUFA while freshwater warmwater fish have requirements for 
both n-3 and n-6 fatty acids (De Silva and Anderson, 1995). It is interesting to state 
that both LA and ALA play no direct functional role in fish and rather serve only as 
precursors of the functionally bioactive LC-PUFA (eg: ARA, EPA and DHA) 
(Tocher, 2003). Of these, ARA together with EPA act as the primary precursors for 
the de novo production of eicosanoids mediating many cellular immune functions in 
fish as can be seen in humans (Fischer, 1989). Further, both n-3 (EPA & DHA) and 
n-6 (ARA) LC-PUFA play a role as structural components of phospholipids (PL) 
contributing to the structural integrity of cell membranes (Sargent et al., 2002). 
Therefore, it is imperative to provide sufficient amounts of the correct EFA to satisfy 
growth and development of fish by drawing attention to the particular species. 
 
1.3 Fatty acid metabolism in fish 
1.3.1 Fatty acid catabolism and energy production (β-oxidation) 
The major source of energy in many species of fish is acquired through fatty acid 
catabolism which occurs in cellular organelles (eg. mitochondria and peroxisomes) 
via a set of enzymes. The particular process is termed as β-oxidation and involves the 
sequential cleavage of two-carbon units, released as acetyl-CoA, through a cyclic 
series of reactions catalyzed by several distinct enzyme activities. Briefly, activated 
fatty acids are transported into the mitochondrion in the form of fatty acylcarnitine 
esters formed through the action of carnitine acyltransferase, and converted back into 
fatty acyl-CoA derivatives, and then undergo a round of dehydrogenation, hydration, 
second hydrogenation, and cleavage steps to produce acetyl-CoA and NADH. The 
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acetyl-CoA can then be metabolized via the tricarboxylic cycle to produce more 
NADH. The NADH produced from the oxidation of fatty acids can then provide 
metabolic energy in the form of ATP through the process of oxidative 
phosphorylation (Tocher, 2003). 
 
Fatty acid oxidation is an important metabolic function occurring in several tissues of 
fish. In addition to liver, heart and red muscles, white muscle has recently been 
reported to play a significant role in overall fatty acid β-oxidation in Atlantic salmon 
(Froyland et al., 1998; Froyland et al., 2000). While white muscle has a low β-
oxidation capacity per gram of tissue, it is reported to be the major site for β-
oxidation given the size of the tissue (Froyland et al., 2000). Nevertheless, the fish’s 
capacity to catabolise fatty acids varies depending on various factors such as fish 
size, life stage and season (Stubhaug et al., 2006).  
 
Generally, the β-oxidation process in fish takes place mainly within the 
mitochondria. In addition, peroxisomes are also found to be another site of β-
oxidation where these organelles are specifically used in the initial chain shortening 
prior to conventional β-oxidation of very long chain unsaturated fatty acids. 
However, the importance of mitochondrial or peroxisomal β-oxidation is dependent 
on the type of tissue. It has been reported that peroxisomal β-oxidation may account 
for up to 30% of total hepatic β-oxidation in fish (Crockett and Sidell, 1993). 
However, the contribution from peroxisomal β-oxidation is reported to be less than 
10% of the total β-oxidation in both white and red muscle in Atlantic salmon but 
known to increase up to 60% in red muscle during parr smolt transformation 
(Stubhaug et al., 2007).  
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The replacement of FO with AO may have significant changes in dietary and tissue 
fatty acid composition and may have influences on the β-oxidation capacity. It has 
been reported that MUFA, mainly 18:1n-9 and 22:1n-11 as well as C18 PUFA (LA 
and ALA), are readily β-oxidised when present at high concentrations in Atlantic 
salmon (Bell et al., 2003a; Torstensen and Stubhaug, 2004). In addition, EPA and 
DHA are also highly β-oxidized in Atlantic salmon tissues when in dietary surplus 
during high growth periods. Therefore, with the alteration of dietary fatty acid 
composition, different fatty acids will be the dominating energy substrate for β-
oxidation with the AO-based diets fed fish retaining more EPA and DHA compared 
to those in FO fed fish (Stubhaug et al., 2007).  
 
1.3.2. Fatty acid anabolism 
1.3.2.1. Fatty acid biosynthesis (Lipogenesis) 
The biosynthetic reaction for the formation of new endogenous lipids is known as 
lipogenesis. The ultimate carbon source for the biosynthesis of new lipids is acetyl-
CoA formed in mitochondria from the oxidative decarboxylation of pyruvate 
(carbohydrate source) or the oxidative degradation of some amino acids (protein 
source). The key pathway in lipogenesis is catalysed by the cytosolic fatty acid 
synthetase (FAS) multi-enzyme complex that has been characterized in fish (Sargent 
et al., 1989). The main biosynthetic products generated are the saturated fatty acids 
16:0 and 18:0, which can be biosynthesized de novo by all known organisms, 
including fish (Sargent et al., 1989). 
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1.3.2.2. Fatty acid bioconversion (desaturation and elongation)  
In addition to the aforementioned biosynthesis of SFA, all organisms, including fish, 
are capable of desaturating both 16:0 and 18:0 to produce 16:1n-7 and 18:1n-9, 
respectively. The ∆-9 desaturase enzyme (Steroyl Co-A desaturase), which is 
responsible for the above bioconversion, has been particularly well characterized and 
its gene has been cloned in several animal species, including common carp (Cyprinus 
carpio) (Tiku et al., 1996) and grass carp (Ctenopharyngodon idellus) (Chang et al., 
2001). 20:1n-11 is also generated by the action of the ∆-9 desaturase on 20:0, and 
20:1n-11 can then be elongated to 22:1n-11. However, the 20:1n-11 and 22:1n-11 
fatty acids, which can be abundant in fish triacylglycerols, are known to derive 
mainly from the corresponding fatty alcohol in the wax esters of zooplankton 
(Sargent and Henderson, 1995). 
 
Desaturation of fatty acids in fish, like all animals, takes place in the endoplasmic 
reticulum of cells of particular tissues via an aerobic process utilizing CoA-linked 
substrates and requiring NADH and O2 (Brenner, 1974 ). These monounsaturated 
products formed (16:1n-7 and 18:1n-9) have markedly lower melting points (phase 
transition temperatures) than their saturated precursors (16:0 and 18:0). Hence, Δ-9 
fatty acid desaturase provides a means of regulating the viscosity of cell membranes 
by altering the phase transition temperatures of the fatty acids in their constituent 
phosphoglycerides (Tocher, 2003).  
 
In addition to MUFA, the enzymatic reactions involved in the PUFA pathway where 
C20 and C22 are biosynthesized from their C18 precursors are particularly important in 
fish as for other vertebrates to satisfy their LC-PUFA requirements. As previously 
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mentioned (section 1.2.2), theoretically, almost all fish possess the innate ability to 
convert ALA into n-3 LC-PUFA (EPA and DHA) and LA into n-6 LC-PUFA (ARA) 
via in vivo LC-PUFA biosynthetic pathway (Sargent et al., 2002; Nakamura and 
Nara, 2004). 
 
The first step of the n-3 LC-PUFA biosynthetic pathway is the production of 18:4n-3 
from ALA catalysed by the Δ-6 desaturase enzyme. This product can then be 
successively elongated by fatty acid elongase and further desaturated by the Δ-5 
desaturase enzyme to produce EPA (Sargent et al., 2002; Nakamura and Nara, 2004). 
The eventual production of DHA requires the combination of a further elongation, a 
Δ-6 desaturation and finally, a chain-shortening reaction (Sprecher et al., 1995). 
Similarly, in the n-6 LC-PUFA biosynthetic pathway, the first step is the production 
of 18:3n-6 from LA which is catalysed by the same Δ-6 desaturase enzyme. This 
product is then be elongated by the same elongase enzymes and subsequently 
desaturated by the same Δ-5 desaturase enzyme to produce ARA (Sargent et al., 
2002; Nakamura and Nara, 2004). 
 
Some of the aforementioned critical enzymes (eg. desaturases and elongases) which 
play a significant role in the LC-PUFA biosynthetic pathway have been cloned from 
a range of freshwater and marine teleosts (Hastings et al., 2001b; Agaba et al., 2004; 
Zheng et al., 2004a).  In a previous nutritional study on Atlantic Salmon, the relevant 
c-DNA for Δ-6 and Δ-5 desaturase enzymes and PUFA elongase enzymes have been 
cloned (Hastings et al., 2004; Zheng et al., 2004a). Moreover, the activity of the 
desaturases and elongases has been found to be considerably high in salmonid 
hepatocytes and enterocytes (Tocher et al., 2003b; Stubhaug et al., 2005b).  
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In addition, replacing dietary FO with AO has been demonstrated to enhance the 
hepatic desaturase and elongase activities of the LC-PUFA biosynthetic pathway in 
Atlantic salmon especially during the sea water stage (Henderson et al., 1994; 
Stubhaug et al., 2005b).  
 
Despite the existing scientific evidences on the capability of some freshwater fish 
species to satisfy their EFA requirements from C18 PUFA (ALA and/or LA) via in 
vivo LC-PUFA biosynthetic pathway, it has been shown that the reduction in dietary 
EPA and DHA in AO-based diets cannot be compensated by in vivo synthesis of 
EPA and DHA from the n-3 precursors in the freshwater coldwater fish Atlantic 
salmon and brown trout (Salmo trutta) (Bell et al., 2001; Tocher et al., 2003b; Zheng 
et al., 2005b). Similar observation have been made in the freshwater warmwater 
carnivorous fish Murray cod (Francis et al., 2007a; Senadheera et al., 2011; Turchini 
et al., 2006b) and freshwater coldwater water rainbow trout (Turchini et al., 2009 and 
Thanongsak et al., 2011a; 2011b) using the whole body fatty acid balance method 
which is used as an efficient tool to quantify fatty acid metabolism. 
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Figure 1.1 Vertebrate Δ-5/Δ-6 desaturation/elongation pathway 
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1.3.3. Nutritional factors with potential effects on the fatty acid bioconversions  
Previous investigations on lipid nutrition have reported that the activities of the 
critical enzymes involved in fatty acid and triacylglycerol biosynthesis are tightly 
controlled by different nutritional, hormonal, and developmental conditions (Sul and 
Wang, 1998). Among the well known regulatory factors, dietary fatty acid 
composition is known to play a significant role directly affecting desaturase enzyme 
activities (Brenner, 1981). In several previous studies conducted using different fish 
species (eg Atlantic salmon, rainbow trout, zebrafish, (Zebra danio), and tilapia, 
(Oreochromis niloticus) it has been shown that the hepatic desaturation of ALA and 
LA was significantly greater in fish fed diets containing vegetable oils compared to 
fish fed diets containing fish oil (Buzzi et al., 1996a; Bell et al., 1997; Tocher et al., 
2000a; Zheng et al., 2005a). However, the fatty acid compositional data indicated 
that despite the increased activity, desaturation of ALA was insufficient to maintain 
tissue proportions of EPA and DHA in fish fed the AO diet at the same level as in 
fish fed the FO diet (Tocher et al., 2002a).  
 
Additionally, it has been speculated that the vitamins such as vitamin B6 
(pyridoxine) may act as cofactors/activators of PUFA biosynthesis (Das, 2007; 
Zamaria, 2004). Previous nutritional studies have demonstrated that an adequate 
availability of vitamin B6 in animals is heavily involved in both protein and lipid 
metabolism (Kirschman and Coniglio, 1961; Cunnane et al., 1984), regulating a large 
number of metabolic processes. In addition, positive correlations of dietary vitamin 
B6 supplementation on LC-PUFA deposition have been reported from previous 
studies using Atlantic salmon and rainbow trout (Albrektsen et al., 1994; Maranesi et 
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al., 2005). Nevertheless, positive effects of vitamin B6 on fatty acid bioconversion 
were not reported in the above two studies. 
 
Moreover, some elements have been found in regulating fatty acid metabolism in 
terms of bioconversions of C18 PUFA to LC-PUFA. Evidence of some nutritional 
studies on rats suggests that zinc (Zn) deficiency may cause an increase in the 
proportion of SFA and MUFA and a marked reduction of PUFA profile of hepatic 
diglycerides together with impaired bioconversion of LA to ARA (Clejan et al., 
1982).  Cunnane (1988) suggested that Zn affects lipid metabolism in two ways, for 
the desaturation and elongation pathway and the lipid incorporation of EFA. 
Furthermore, Mahfouz and Kummerow (1989) investigated the effect of magnesium 
(Mg2+) deficiency on Δ-6 desaturase activity and showed that the fatty acid 
composition of the liver microsomes in the Mg2+ deficient group of rats, had a slower 
rate of conversion of LA to ARA which was consistent with the decrease of Δ-6 
desaturase activity in liver microsomes.  The decrease of Δ-6 desaturase activity was 
attributed to the lower concentration of actual enzyme molecules as a result of the 
decreased rate of protein synthesis in Mg 2+ deficiency. In addition, the regulatory 
effects of iron on the LC-PUFA bioconversion pathway have been reported in 
previous studies conducted using two groups of human subjects having low and 
normal serum iron (Fe) levels and the above study concluded that dietary iron has 
significant positive impacts on LC-PUFA biosynthetic pathway (Krajcovicova-
Kudlackova et al., 2004). In this context, it is of paramount importance to be aware 
of what regulates LC-PUFA biosynthesis in farmed fish, and how it can be optimised 
to enable fish to make effective use of dietary lipid sources especially when the 
dietary FO is replaced with alternative lipid sources. 
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1.3.3.1. Vitamin B6 in fish nutrition and fatty acid metabolism 
Of the essential vitamins, pyridoxine (vitamin B6) is known to play a significant role 
in living animals and is found mainly in three readily inconvertible forms: pyridoxine 
(plants), pyridoxal phosphate and pyridoxamine phosphate (animals). Of these, 
pyridoxal phosphate is known to be the most biologically active form making it a 
crucial and versatile co-factor in most of the metabolic processes in living cells 
regulating the activity of vitamin B6 dependant enzymes (Halver, 2002). In its co-
enzyme forms (pyridoxal phosphate or pyridoxamine phosphate); pyridoxine is 
known to be involved in a large number of physiological processes in particular with 
protein metabolism. In addition, pyridoxine is also known to involve in lipid 
metabolism especially in relation to essential fatty acids. Dietary pyridoxine level has 
been shown to affect the tissue LC-PUFA content in vertebrates (Cunnane et al., 
1984; Bordoni et al., 1998; Bertrandt et al., 2004b)_including fish (Albrektsen et al., 
1994; Maranesi et al., 2005) during previous investigations. 
 
Because of its key involvement in a large number of metabolic reactions, a dietary 
requirement for vitamin B6 has also been demonstrated in a number of fish species. 
In particular, carnivorous fish are known to have stringent requirement for vitamin 
B6 in their diets compared to others as the body stores are rapidly exhausted due to 
its major role as a co-factor in protein metabolism. Specifically, the high growth rate 
of larval stages of fish and their exceptionally high utilization of amino acids in 
energy metabolism suggests a higher requirement for vitamin B6 (Halver, 1989). The 
pyridoxine requirement established by National Research Council (2011) for 
coldwater fish was 10mg kg-1 diet irrespective of dietary protein level or energy 
utilization. Nevertheless, in a later nutritional study, a minimum requirement of 
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vitamin B6 for the growth of young rainbow trout was reported to be 2 mg kg-1 diet 
(Woodward, 1989) and 5 mg kg-1 for Atlantic salmon (Lall and Weerakoon, 1990). 
However, the dietary vitamin B6 requirement for maximum activity of the vitamin 
B6 dependant enzyme aspartate aminotransferase in the muscle of rainbow trout was 
found to be 6 mg kg-1, three times higher than that for maximum growth (Woodward, 
1989) but, the vitamin B6 requirement for the maximum activity of alanine 
aminotransferase in Atlantic salmon was obtained at 5mg kg-1 as for the maximum 
growth response (Lall and Weerakoon, 1990). The vitamin B6 requirement for the 
channel catfish for its maximum growth was found to be approximately 3mg kg-1 diet 
(Andrews and Murai, 1979). Huang et al (2005) showed that the optimal pyridoxine 
levels for grouper, Epinephelus coioides to keep normal survival, and whole blood 
haemoglobin level were approximately 1.75 and 1.87 mg kg-1 respectively. The 
optimum dietary pyridoxine requirement for maximum growth of Heteropneustes 
fossilis under the experimental conditions was found to be 3.21 mg kg diet-1 
(Mohamed, 2001). Lim, et al. (1995 ) concluded that 3mg of vitamin B6 kg diet-1 
was sufficient for maximum growth, feed efficiency and survival and for prevention 
of deficiency signs for red hybrid tilapia grown in sea water. Ogino (1965) reported 
that pyridoxine requirement of common carp was 5.4 mg vitamin B6 kg diet-1. 
However, with semi-purified diets, the dietary pyridoxine requirement of juvenile 
Jian carp (Cyprinus carpio), the first artificial breed Chinese carp, based on percent 
weight gain was found to be 6.07 mg pyridoxine kg-1 diet (He et al., 2009).  Kissil, et 
al (1981) found that, minimum dietary pyridoxine requirement necessary for optimal 
growth in gilthead seabream (Sparus aurata) was 1.97 mg kg-1 diet. In a study using 
semi-purified diets, Wanakowat, et al (1989) demonstrated that 5 mg kg-1 pyridoxine 
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was required for the normal growth of seabass whereas 10 mg kg-1 was required for 
normal lymphocyte levels.  
 
Due to the multiple roles of vitamin B6, in various metabolic processes, a number of 
potential deficiency signs have been identified in vitamin B6-deficient animals 
including fish. The signs of vitamin B6 deficiency symptoms seem to be rather 
unspecific in fish and include anorexia, anemia, dark coloration, degenerative 
changes in tissues, poor appetite and food conversion, hyperirritability coupled with 
erratic swimming behaviour, convulsions and paralysis, growth retardation and high 
mortality (Kissil et al., 1981; Hermen, 1985; Wanakowat et al., 1989; Albrektsen et 
al., 1993; Halver, 2002).Therefore, adequate availability of vitamin B6 is of 
paramount importance to optimize metabolic needs of fish to maintain optimum 
growth, good health and composition of the muscle tissue of the fish in terms of 
enhancing their nutritional value.  
 
1.3.3.2. Iron in fish nutrition and fatty acid metabolism 
Iron is one of the essential trace elements important for many biological processes in 
all living animals including fish (NRC, 2011). Even though, its presence is of 
paramount importance in carrying out numerous vital biological reactions, because of 
its highly reactive nature, iron is extremely toxic if its concentrations are not properly 
regulated intracellularly (Lee et al., 2006). The divalent state of iron makes it highly 
toxic, as it can rapidly react with hydrogen peroxide and molecular oxygen to 
produce free radicals. These free radicals are known to promote lipid peroxidation, 
DNA strand breaks, and modification or degradation of biomolecules, eventually 
leading to cell death. Hence, management of iron is a critical issue for all living cells. 
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Consequently, the cells have evolved a sophisticated mechanism consisting of an 
array of proteins that regulate the amount of free iron in cells by modulating its 
uptake, storage, and export (Cairo and Pietrangelo, 2000; Papanikolaou and 
Pantopoulos, 2005). 
 
The mechanisms of iron absorption from the digestive tract, storage and excretion in 
fish appear similar as for other vertebrates. However, some absorption of iron takes 
place via the gill membranes while the intestinal mucosa is the major site of iron 
absorption. Diet is considered to be the major source of iron for metabolic purposes. 
The absorbed iron is probably transported in the blood by means of transferrin which 
has been found in some fish species. It has been found out that the iron in rainbow 
trout is absorbed from the peritoneal cavity and stored at higher concentrations in the 
liver, spleen and head kidney (Walker and Fromm, 1976). Negligible concentrations 
of iron are known to be lost through urine or faeces (Lall, 2002). 
 
Deficiency of iron may cause microcytic anemia characterised by pale red blood 
cells (Webster and Lim, 2002). Iron deficiency has been observed in brook trout 
(Salvelinus fontinalis) (Kawatsu, 1972) with characteristic microcytic anemia or with 
low haemoglobin levels, in rainbow trout (Desjardins et al., 1987), Atlantic Salmon 
(Andersen et al., 1996), common carp and in red sea bream (Sakamoto and Yone, 
1978b). In most of the cases, iron deficiency did not seem to affect the growth. Iron 
deficiency in channel catfish was found to suppress hemotocrit, haemoglobin and 
plasma iron levels and causes transferrin saturation (Gatlin and Wilson, 1986). Since 
free iron is toxic, the iron molecules are transported along with a protein; two atoms 
of ferric iron are bound to one molecule of transferrin, a beta-globulin protein. If the 
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level of iron exceeds the binding capacity of transferrin, iron toxaemia may occur 
(Webster and Lim, 2002). Reduced growth, poor feed utilization, feed refusal, 
increased mortality and histopathological damage to liver cells were among the 
major effects of toxicity. An excess of iron in the diet is known to bind with 
phosphorous to form an insoluble iron-phosphate complex which could also lead to 
phosphorous deficiency (Webster and Lim, 2002).  
 
Previous studies have established the dietary iron requirement for certain fish 
species. The iron requirement of ~100–250 mg Fe kg–1 d.m. food have been 
suggested for salmonids (Desjardins et al., 1987; Andersen et al., 1996). The dietary 
requirement for Atlantic salmon was determined to be between 60 and 100 mg iron 
kg-I (Andersen et al., 1996). The iron requirement for channel catfish (Gatlin and 
Wilson, 1986) and red seabream (Sakamoto and Yone, 1978b) are 30 and 150 mg per 
kg of diet respectively. 
 
Iron plays an active role in oxidation/reduction reactions and electron transport 
associated with cellular respiration (Webster and Lim, 2002).  It is found in 
complexes bound to proteins such as heme compounds (haemoglobin and 
myoglobin), in heme enzymes (mitochondrial and microsomal cytochromes), non-
heme enzymes such as desaturases forming their active centres and in non-haem 
compounds such as transferrin and ferritin. Iron occurs in the blood as haemoglobin 
in erythrocytes being a carrier of oxygen while transferrin is found in plasma being 
the principal carrier of iron in blood playing an important role in iron metabolism. 
Ferritin and hemosiderin, the storage form of iron protein mainly occur in liver, 
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spleen and bone marrow.  Further, small amount of iron as Ferritin also occurs in the 
serum (Aisen et al., 2001; De Silva et al., 1996; Lall, 2002; Watanabe et al., 1997). 
The presence of iron in cytochromes, catalases, hydroxylases, peroxidases, 
desaturases, lypoxygenase and cyclo-oxygenase indicates the importance of iron in 
various metabolic events related to lipid metabolism. Stearoyl CoA desaturase 
enzyme complex which is responsible for synthesis of monounsaturated fatty acids 
consists of cytochrome b5, cytochrome b5 reductase and terminal desaturase which 
contain non heam iron protein. Furthermore, Δ-6 and Δ-5 desaturases are also 
containing active di-iron centres at their ends and involve in synthesizing LC-PUFA 
from LA and ALA.  
 
Previous experiments with animal models including humans during the past decades 
have revealed strong relationship between dietary iron and lipid metabolism 
especially in relation to LC-PUFA biosynthesis (Cunnane and McAdoo, 1987; Fox et 
al., 1994; Stangle and Kirchgessner, 1998; Krajcovicova-Kudlackova et al., 2004a). 
However, information is scarce on the effect of dietary iron concentration on fatty 
acid metabolism in fish. In this context it would be worthwhile to explore whether 
dietary iron play an important role in fatty acid metabolism specifically on LC-PUFA 
biosynthesis in freshwater farmed fish of aquaculture interest especially when they 
are fed with plant oil based diets containing high amounts of dietary precursors 
(ALA and LA). 
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1.4 Current issues in aquaculture 
1.4.1 Fish oil usage, production, price and future availability  
Despite ever increasing prices, the finfish and crustacean aquaculture sector is still 
highly dependent upon marine capture fisheries to obtain key dietary ingredients, 
mainly FO and fish meal, for the production of aquafeeds, due in part to their 
familiarity with the product and the perception that it is the best lipid source for the 
culture of aquatic species, containing high levels of n-3 LC-PUFA, which is known 
to be essential for the optimal growth and health of the farmed fish (Turchini et al., 
2009). This dependency is particularly known to be strong within compound 
aquafeed meant for farmed carnivorous finfish species and marine crustaceans. 
According to the currently available statistics, aquafeed manufacturers represent the 
major category of FO users (Tacon and Metian, 2008). 
 
The results of a recently conducted global survey concerning the use of FO within 
compound aquafeed has revealed that the aquaculture sector consumed 835,000  
tonnes of FO which accounted for 88.5% of the total reported FO production in 2006 
(Tacon and Metian, 2008). The authors of the above study reported that, despite 
increases in the total global consumption of FO and fish meal by the aquaculture 
sector, the average inclusion levels of FO in compound aquafeeds were steadily 
being curtailed (except for catfish) between the period of 1995-2006. The main 
reason for this global trend in reducing the reported dietary inclusion levels of FO in 
aquafeed has been due to the increasing global FO prices since 2000. FO prices have 
almost doubled from US 894 to US $1700 per tonne between March 2007 and March 
2008 (FAO, 2008). Hence, it is predicted that dietary fish meal and FO inclusion 
levels within compound aquafeed will further decrease in the long term, with fish 
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meal and FO usage mainly being targeted for use as a high value feed ingredient for 
use within higher value starter, finisher and brood-stock feeds (Tacon and Metian, 
2008). Due to the prevailing nature of decreasing global availability coupled with 
highly fluctuating prices of this commodity has currently forced the aquaculture 
industry to explore the possibilities of alternative dietary lipid sources and efficient 
feeding strategies replacing FO in feed formulations with a view to running the 
industry in a sustainable manner (Turchini et al., 2009). 
 
1.4.2 Fish oil replacement in aqua-feed   
1.4.2.1 Effects on growth and fish performance  
Numerous studies have investigated the effects of replacing dietary FO with different 
VO, such as linseed oil (LO) (Tocher et al., 1997), sunflower oil (SFO) (Tocher et 
al., 1997), palm oil (PO) (Torstensen et al., 2000), rapeseed oil (RO) (Bell et al., 
1997; Bell et al., 2001) soybean oil (SBO) (Rosenlund et al., 2001b) and olive oil 
(OO) (Rollin et al., 2003) on the nutritional performances in different life stages of 
Atlantic salmon (Salmo salar) and in rainbow trout juveniles replacing FO by linseed 
and sunflower oil (Thanuthong et al.,2011b. 2011c). Even at complete replacement 
with a VO mix , no significant negative effects were noted on growth performance in 
Atlantic salmon (Torstensen et al., 2005) and rainbow trout (Thanuthong et 
al.,2011b. 2011c) . However, in each of the above feeding experiments, either partial 
replacement of FO or the inclusion of dietary fish meal was provided with n-3 LC-
PUFA (EPA and DHA) at a minimum of 1.6 % of total dietary fatty acids (Turchini 
et al., 2009). On contrary, few other studies on Atlantic salmon that utilized defatted 
fish meal completely replacing FO with CO & echium oil have shown no significant 
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impacts on growth performances compared to FO-fed fish (Miller et al.,2008; 
Codabaccus et al.,2011;) 
 
Despite the above positive observations, several studies have reported negative 
impacts on growth performance of farmed fish following VO inclusion. Freshwater 
fish species including Murray cod (Maccullochella peelii peelii) (Francis, 2007) 
surubim (Psedoplatystoma coruscans) (Martino et al., 2002) channel catfish 
(Ictalurus punctatus) (Stickney and Andrews, 1972) barramundi (Lates calcarifer) 
(Raso and Anderson, 2003) and air-breathing catfish (Clarius batrachus) 
(Mukhopadhyay and Mishra, 1998) have responded relatively poorly to dietary VO 
inclusion with impaired growth. Moreover, some salt water species such as red 
seabream (Pagrus auratus) (Glencross et al., 2003), European seabass 
(Dicentrarchus labrax) (Montero et al., 2005) and red drum (Sciaenops ocellatus) 
(Tucker et al., 1997) have exhibited similar growth depressions. 
 
Additionally, the digestibility of fatty acids has been found to be affected by dietary 
fatty acid composition. The quantity of dietary saturated fatty acids (SFA) has been 
found to influence negatively for the digestibility of lipids, particularly at low water 
temperatures (Caballero et al., 2002; Torstensen et al., 2005). Consequently the 
replacement of FO with rapeseed or canola oils (RO or CO) resulted in less SFA and 
an increase in monounsaturated fatty acids (MUFA), increasing the lipid digestibility 
at low water temperatures in both rainbow trout (Oncorhynchus mykiss) and Atlantic 
salmon (Caballero et al., 2002; Karalazos et al., 2007). Furthermore, prolonged 
dietary inclusion of VO may affect immune response and overall resistance to 
environmental stressors. It has been demonstrated that the inclusion of VO can lead 
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to inadequate ratios of n-3 and n-6 fatty acids which can cause alterations to the 
synthesis of eicosanoids which possess a wide range of physiological actions such as 
blood clotting, inflammatory response, cardiovascular tone, neural function and 
reproduction (Tocher, 2003). 
 
With regard to fish performance, it is considered that if the EFA requirements are 
satisfied by the diet, a significant portion (60 to 75 %) of dietary FO can be 
substituted with alternative lipid sources without having significant effects on growth 
performance, feed efficiency and feed intake in almost all finfish species studied to 
date. However, as different species respond in different ways to FO replacement in 
their diets, the above generalisation needs to be addressed carefully before making 
recommendations for feed formulations (Turchini et al., 2009).  
 
1.4.2.2 Effects on final quality of farmed fish  
At present, the inclusion of VO in aquafeed as a replacement to FO is showing an 
increasing trend in the aquaculture industry. In contrast to FO, AO (alternative oils; 
i.e. VO and terrestrial animal fats) are lacking in n-3 LC-PUFA, such as EPA and 
DHA, and are characterised by a very high n-6/n-3 ratio. A number of studies have 
shown that the complete or partial replacement of FO with a VO or VO blend for all 
or part of production cycle of Atlantic salmon affects the final fatty acid composition 
of the edible portion (Rosenlund et al., 2001; Bell et al., 2003b; Regost et al., 2004 ; 
Torstensen et al., 2005). In addition, the dietary fatty acid composition is also 
mirrored in the fish’s organs and lipid stores (Caballero et al., 2002; Bell et al., 
2003b; Stubhaug et al., 2007; Tocher et al., 2003b; Torstensen et al., 2005). Similar 
effects have been reported in almost all finfish species studied to date fed with AO 
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(Martino et al., 2002; Glencross et al., 2003; Luzzana et al., 2003; Turchini et al., 
2003, Francis et al., 2006, Turchini et al., 2006a; 2006b; Francis et al., 2007a; 2007b; 
Turchini et al., 2007a; 2007b; Thanongsak et al., 2011c) 
 
The distinct undesirable feature of FO replacement in aquafeed is the resultant 
modification of fish fillet fatty acid composition and the consequent loss of the 
particular health promoting characteristics expected by the consumption of fish and 
seafood. These modifications not only affect sensory qualities of fish fillets but also 
to the consumers’ perception of farm raised finfish and shellfish. Although numerous 
studies reported that dietary lipid sources can have negative impacts on some of the 
principal characteristics of the final eating quality of farmed fish, such as sensory and 
other organoleptic characteristics (eg. texture, flavour), pigmentation, storage 
stability and shelf life of the edible product, the results often seemed contradictory 
and not yet fully understood (Turchini et al., 2009). 
 
However, the health beneficial properties of farmed raised fish need to be 
maintained, since fish and seafood is believed to be the major contributor of 
biologically active LC-PUFA; particularly EPA and DHA in the human diet, 
(Pickova and Mørkøre, 2007) playing a significant role in preventing various 
pathologies in humans. 
 
1.5 Finishing strategies   
To address this undesirable modification of final eating quality of the final product, 
there has been great interest in adopting potential strategies to restore the original 
FO-like fatty acid make-up of the farmed fish fillets. The most common approach 
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has been the implementation of a subsequent finishing period on a FO-based diet 
(wash-out diet), at the end of grow out period fed with AO-based diets. Based on 
these preliminary observations, a simple, but effective, dilution model was proposed 
by Robin et al (2003) to describe the fatty acid deposition into fish tissues, providing 
a tool to predict the final fatty acid make-up of a fillet of fish fed a given diet. The 
model is based on two assumptions: (i) that fatty acids are incorporated into different 
tissues without any mobilisation or turnover; and (ii) that the same species of fish 
under similar culture conditions, would incorporate dietary fatty acid in the similar 
manner, despite the initial fatty acid composition of the fish tissues. However, the 
initial fat content in fish tissue at the end of grow out period fed with AO-based diets 
is known to affect directly to the time required for the restoration of FO like fatty 
acid profile in the tissue in question to be influenced by a dietary change (Palmeri et 
al., 2009, Thanuthong et al., 2011d). 
 
The positive aspects as well as the limits of the proposed dilution model have been 
shown and the principal observation was that the model is not applicable for all fish 
species in particular for ‘lean’ fish that store only a small amount of fat in the fillet in 
which the lipids are primarily represented by structural, cell membrane PL (Jobling, 
2003). Despite the reported limitations, the dilution model (Robin et al., 2003) can be 
generally considered a useful tool to plan appropriate finishing strategies to obtain a 
final product with a desired fatty acid make-up. 
 
However, it should be emphasised that although finishing diets can partially restore 
the initial fatty acid make-up of fish, they should not be considered as an ideal 
solution to the problem of FO replacement in aquafeed since the final optimal fatty 
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acid make-up of the edible product cannot be completely restored without a 
considerable amount of FO (Turchini et al., 2009). 
 
1.6 Research objectives   
The effects of total C18 PUFA on growth performance and fatty acid metabolism of 
the freshwater, warmwater, Murray cod have been reported in a previous nutritional 
study conducted using 100 % fish oil deprived diets (Francis et al., 2009). However, 
the effects of the ratio of n-3: n-6 fatty acids (ALA/LA) on growth performance and 
fatty acid metabolism in Murray cod are still unknown. Therefore, the first main 
objectives of this PhD study are to investigate the effects of the dietary ALA/LA 
ratio on growth, fillet fatty acid composition, fatty acid restoration efficiency during 
finishing period and fatty acid metabolism of Murray cod. This investigation will 
place a special focus on the rate of LC-PUFA biosynthesis while gaining more 
understanding of the fatty acid metabolism in the context of fish oil replacement 
and/or substitution with alternative oil sources in the diets in order to achieve a 
desirable level of n-3 LC-PUFA content in the final fish product for human 
consumption.  
 
Previous studies have indicated that the innate ability of fish for the production of 
LC-PUFA (eg. EPA, DHA and ARA) from dietary precursors (ALA and LA) is 
influenced by numerous nutritional factors such as micronutrients, dietary fatty acid 
composition, dietary carbohydrate levels and starvation (Kirschman and Coniglio, 
1961; Rao et al., 1984; Bautista and Cruz, 1988; Sul and Wang, 1998; Kersten, 2001; 
Krajcovicova-Kudlackova et al., 2004; Nakamura and Nara, 2004). Therefore, in 
addition to the investigation of the effects of the ratio of the two dietary precursors 
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(ALA and LA), the subsequent step of the present PhD study was to evaluate the 
influence of two selected micronutrients; pyridoxine (vitamin B6) which has been 
speculated to act as cofactor/activator and iron (Fe) a structural component of 
desaturase enzyme that are directly involved in the bioconversion of ALA and LA 
into EPA, DHA and ARA. For this purpose, current PhD study selected the 
freshwater coldwater species rainbow trout, which has been recognized as an ideal 
candidate capable of bioconverting C18 PUFA into LC-PUFA more efficiently at the 
expense of FO deprived diets compared to other freshwater species. Though there are 
evidences on the dietary pyridoxine supplementation on growth and deposition of 
LC-PUFA in rainbow trout in a previous study employing fish oil based diets 
(Maranesi et al., 2005), no scientific data is available on the effects of dietary 
pyridoxine supplementation on in vivo fatty acid metabolism especially in terms of 
LC-PUFA bioconversion in rainbow trout when the diets are totally comprised of 
AO sources containing an abundance of dietary precursors. Similarly, there is no 
scientific research conducted so far on the effects of dietary iron supplementation on 
in vivo fatty acid metabolism of fish, specifically on LC-PUFA bioconversion, even 
though there is some information on the influence of iron on the fatty acid 
metabolism of humans (Krajcovicova-Kudlackova et al., 2004).  
 
1.7 Thesis orientation 
The present chapter (Chapter 1) is a general introduction including literature review 
of lipids and fatty acids in aquaculture, fatty acid metabolism in farmed finfish and 
related cofactors regulating fatty acid bioconversion. Chapter 2 addresses all the 
common methodologies related to each experimental trial including animal 
husbandry, feed formulations, chemical analysis, calculation of fatty acid metabolism 
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using in vivo whole body fatty acid balance method and statistical analyses. The 
specific aims and methodologies of each experiment in this PhD study are included, 
in detail, in the introduction and materials and methods sections of each research 
chapter (Chapter 3 to Chapter 6). 
 
The aims of the experiment 1-Part a : grow out & finishing (Chapter 3) are to 
investigate fish oil replacement in diets, in particular to determine how the dietary 
ratio of ALA:LA affects growth performance, feed efficiency, fat deposition, fatty 
acid profiles and the efficiency of a finishing strategy of farmed fish with special 
attention to the freshwater warmwater, Murray cod for which the effect of total C18 
PUPA (ALA+LA) had been elucidated in a previous nutritional study (Francis et al, 
2009). The experiments were addressed by implementing two specific feeding trials 
which consisted of a grow-out phase (74 days) using diets formulated with a blend of 
linseed oil, sunflower oil and beef tallow containing different levels of ALA:LA 
ratios while maintaining a constant amount of total C18 PUFA and a subsequent 
finishing phase (42 days) with a FO-based wash-out (finishing) diet.  
 
The aims of the experiment 1-Part b: fatty acid metabolism (Chapter 4) are to 
investigate how the dietary ALA:LA ratio affects fatty acid metabolism and 
specifically to in vivo fatty acid bioconversions in Murray cod. The whole body fatty 
acid balance method was employed to quantify the amount of β-oxidation and 
elongase and desaturase activities in the LC-PUFA bioconversion pathways. 
  
The aims of Chapter 5 and Chapter 6 were to evaluate the effects of two potential 
regulatory factors; dietary pyridoxine (vitamin B6) and iron supplementation on 
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growth performance, feed efficiency, fatty acid metabolism in particular, fatty acid 
bioconversions with special focus on freshwater coldwater fish; rainbow trout. The 
two specific hypothesis were tested by implementing two separate feeding 
experiments employing VO-based (Canola and linseed oil) experimental diets 
supplemented with graded concentrations of pyridoxine (pyridoxine hydrochloride) 
and iron (Ferrous sulphate) respectively using juveniles of rainbow trout for 60 day 
and 58 day experimental period respectively. 
 
 
Chapters 3 and 4 of this PhD thesis have been published in Aquaculture (309: 222–
230) journal and in the Journal of Agricultural and Food Chemistry (59: 1020–1030) 
respectively. Additionally, Chapters 3 and 4 were presented as a combined paper at 
the International Symposium of Fish Nutrition and Feeding, 31st May - 4th June, 
2010, Qingdao, China. Chapters 5 and 6 have been published in the Journal of 
Agricultural and Food Chemistry (60, 2343-2353) and Aquaculture (342-343, 80-88) 
respectively whereas Chapters 5 and 6 were also presented at the UK Aquaculture 
Conference - 2012 held on 23rd-24th May, 2012, Aveimore, Scotland, UK and at the 
International Symposium on Fish Nutrition and Feeding on 4th-7th June, 2012, 
Molde, Norway, respectively.  
 
Lastly, Chapter 7 generally discusses the importance of this PhD study and the 
principal findings of all research chapters in relation to the effects of FO replacement 
in diets of freshwater farmed fish (Murray cod and rainbow trout), with a major focus 
on the role of dietary ALA/LA ratio and dietary pyridoxine and iron supplementation 
on de novo LC-PUFA bioconversions. The major findings obtained by the trials 
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reported in this PhD thesis are discussed attempting also to compare results obtained 
during the different trials and by the two different studied species, and suggesting 
future research directions. 
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CHAPTER 2 
 
General Materials and Methods 
 
In the present chapter, all the common materials and methods used for the four 
experimentations (Chapters 3-6) are reported, whilst specific methodologies for each 
experiment are then reported in the respective experimental chapters. 
 
2.1. Experimental animals and husbandry 
Juvenile Murray cod (Maccullochella peelii peelii) (Figure 2.1) and rainbow trout 
(Oncorhynchus mykiss) (Figure 2.2) belonging to the 2008 and 2010 year classes 
respectively, were used for the four experimentations conducted under the present 
study. The captive bred Murray cod juveniles used for the first two experiments 
(Feeding trial 1-Part a: Grow-out & finishing and Feeding trial 1-Part b: fatty acid 
metabolism) were sourced from the resident stock maintained within the 
recirculating aquaculture system (RAS) located at the Aquaculture Research Facility 
(ARF) (Deakin University, Warrnambool campus, VIC, Australia). Rainbow trout 
juveniles were obtained from the salmonid hatchery of the Department of Primary 
Industries, Victoria (Snob’s Creek, VIC, Australia) and transported to the ARF 
(Deakin University, Warrnambool campus) to be used for the second two 
experiments (Feeding trial 2 and Feeding trial 3). Prior to commencement of each of 
the experiments, both fish stocks were maintained within the RAS located in two 
separate thermostatically controlled rooms in the ARF and were fed on a commercial 
diet (SS classic, Skretting, Cambridge, Tasmania, Australia) and acclimatized to the 
experimental conditions for two weeks.  
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Figure 2.1: Juveniles of Murray cod (Maccullochella peelii peelii) used for  
the feeding trail 1 (Part a & Part b) 
 
 
 
Figure 2.2: Juveniles of Rainbow trout (Oncorhynchus mykiss) used for  
the feeding trials 2 & 3 
 
The culture system, used for the first two feeding experiments (Feeding trial 1-Part a 
and Feeding trial 1-Part b; Chapter 3 and Chapter 4, respectively) with Murray cod 
65 
 
juveniles consisted of a RAS of 36 tanks of 160-L capacity (Figure 2.3), whereas the 
system used for the last two trials (Feeding trial 2-vitamin B6, and Feeding trial 3-
iron; Chapter 5 and Chapter 6, respectively) with rainbow trout comprised of a RAS 
of 18 tanks of 1000-L capacity (Figure 2.4). Both systems were equipped with an in-
line oxygen generator along with a physical and biological treatment plant, and were 
maintained on a 12 h light–12 h dark cycle. Fish in each treatment were fed the 
experimental diets to apparent satiation, twice daily (09.00 and 16.00 h) and feed 
consumption was recorded weekly. A careful record was kept of all behavioural and 
morphological changes observed during experimentation and dead fish were 
removed as soon as possible and mortalities were recorded. All the procedures 
implemented in the present study were approved by the Deakin University Animal 
Ethic Committee. 
 
2.2. Disease prevention and water quality management 
To prevent the possible transmission of pathogens, rainbow trout juveniles were 
treated with a 100 mg L-1 formalin bath for one hour upon arrival. Throughout the 
feeding trial, chlorinated foot baths were placed at the entrance of experimental 
rooms to prevent possible introductions of harmful pathogens. As a precautionary 
measure, salt was added into the system with Murray cod throughout the feeding trial 
to maintain salinity at 5 g L-1 to reduce the stress in the fish and thereby avoid the 
likelihood of outbreaks. 
 
Optimal water quality conditions were maintained throughout feeding trial with level 
of pH between 8.00-8.60, dissolved oxygen concentration between 8.4-8.7 mg L-1 
and water temperature between 20.0-22.0°C (Murray cod) and 14.0-15.2°C (rainbow 
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trout) and these parameters were measured every day using Aquamerk colorimetric 
test kits (pH) and an automatic temperature-compensated Oxy Guard gamma probe 
(Oxy Guard International, Birkerod (oxygen and temperature). The levels of 
ammonia and nitrite in water were measured weekly using Aquamerck test kits 
(Merck, Darmstadt, Germany) and the levels of ammonia and nitrite were below 0.20 
and 0.25 mg L−1, respectively throughout the feeding trial, for all feeding trials.  
 
                                                
 
 
Figure 2.3: Culture system used for the 1st feeding trial (Part a & Part b) with Murray cod 
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Figure 2.4: Culture system used for the 2nd & 3rd feeding trials with rainbow trout 
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2.3 Diet formulation and preparation 
2.3.1 Murray cod diets  
The two feeding experiments on Murray cod (Feeding trial 1-Part a; grow-out & 
finishing - Chapter 3 and Feeding trial 1-Part b; fatty acid metabolism - Chapter 4) 
were based on commercial-like experimental diets in terms of ingredients used for 
the formulation. Prior to the preparation of diets, the raw ingredients used for the 
experimental diets were analysed for moisture, protein, lipid and ash. Iso-energetic, 
iso-lipidic and iso-nitrogenous diets were then formulated using the values obtained 
from these analyses. The amounts of ingredients used for all the experimental diets 
used for the 1st feeding trial (Part a & Part b)  were identical except for the type of 
added lipid sources. Dry ingredients were sieved and ground to a fine, homogenous 
powder and mixed thoroughly using a bench top mixer/grinder (Kitchen Aid Inc., 
St.Joseph, MI, USA). The dietary lipid and hot water (80 0C) were added separately 
and mixed until all ingredients were finely bound and the consistency of soft dough 
had been achieved. The warm dough was then pelleted into long strands using a 
partially modified commercial meat grinder (Tasin TS – 108, Ta Shing Food 
Machinery, Taichung, Taiwan) with a 4 mm die. Pelleted strands were placed onto 
trays and fan dried (30 ˚C) until firm to the touch (~ 24 hrs.). The dry pellets were 
then stored in sealed plastic bags and stored at ambient temperature until required. 
 
2.3.2 Rainbow trout diets  
The two feeding trials on rainbow trout (Feeding trial 3; vitamin B6 - Chapter 5 and 
Feeding trial 4; iron trial - Chapter 6) were based on semi-purified experimental 
diets. Purified (eg: gelatin, dextrin) and non-purified ingredients (eg. fish meal) were 
used for the formulation of semi-purified diets for 2nd and 3th feeding trials with 
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varying inclusion levels of vitamin B6 (pyridoxine hydrochloride) and iron (ferrous 
sulphate), respectively. The amounts of ingredients used on the basis of g per kg of 
diet for all the experimental diets used for the 3rd and 4th feeding trials were identical 
except for the amount of vitamin B6 or iron added to each of the diet. A sample of 
100 g from each diet was kept separately in sealed plastic containers for subsequent 
chemical analyses.  
 
Prior to the preparation of diets, vitamin and mineral mixtures were prepared 
separately. Complete vitamin and mineral mixtures were prepared with the exclusion 
of vitamin B6 and iron, for the two experiments, respectively. Vitamin B6 and iron 
were then added separately as described below. During the preparation of diets, all 
the dry ingredients were finely ground separately using a porcelain motor and pestle, 
sieved and mixed thoroughly using a bench top mixer/grinder (Kitchen Aid Inc., St. 
Joseph, MI, USA). During the preparation of vitamin B6 diets, the required amount 
of vitamin B6 was firstly mixed with dextrin and then added to dry ingredients 
mixture and homogenized properly. When preparing the iron-containing diets, the 
required amount of iron was first dissolved in deionized water and added to the 
homogenized dry ingredients mixture. For both trials, cellulose was used as the filler 
to compensate for different vitamin or mineral inclusion. The dietary lipids/oils along 
with tochopherol was then added to the homogenized mixture and mixed properly 
until all ingredients were finely bound and the consistency of soft dough had been 
achieved.  
 
Finally, the required amounts of slightly warm tap water were added to the mixture 
until warm dough is formed. Using a partially modified commercial meat grinder 
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(Tasin TS – 108, Ta Shing Food Machinery, Taichung, Taiwan) with a 4 mm die, the 
dough was pelleted into long strands and the strands were placed onto trays and fan 
dried (30 ˚C) until firm to the touch (~ 24 hrs.). The dry pellets were then ground to a 
suitable size and stored in 1kg batches at -20 ˚C until required. A sample of 100 g 
from each diet was kept separately in sealed plastic containers for subsequent 
chemical analyses. 
 
2.4. Chemical analysis 
2.4.1. Proximate analysis 
Proximate analysis of diets, whole body and muscle samples of fish mentioned in 
this thesis were determined employing standard methods (AOAC, 1990, codes 
930.15; 942.05; 955.04). Briefly, moisture was determined by drying samples in an 
oven at 80 0C to a constant weight. Protein (N×6.25) content was determined using 
an automated Kjeltech 2300 (Foss Tecator, Geneva, Switzerland). Lipid content was 
determined gravimetrically following chloroform:methanol (2:1) extraction 
according to Folch et al.(1957) as modified by Ways and Hanahan (1964). The ash 
content was determined by incinerating samples (approximately 0.5 g) in a muffle 
furnace (Wit, C & L Tetlow, Melbourne, Australia) at 550 οC for 18 h. Nitrogen-free 
extract (NFE) was calculated by the difference; % NFE = 100 -  (% Crude Protein + 
%Total Lipid + %ash). For the purpose of the chemical composition analyses, the left 
fillets of the fish were utilised. All analyses on fish samples and experimental diets 
were performed in duplicate. 
 
71 
 
2.4.2. Fatty acid analysis 
Fatty acid analysis was performed in duplicate for each of the added dietary oils, 
experimental diets, and on three pooled fish samples (whole body and fillet) and 
faecal samples from each of the triplicates under each treatment. 
 
2.4.2.1. Acid catalysed methylation method 
Following the lipid extraction (see section 2.4.1), fatty acids were esterified into 
methyl esters using the acid catalysed methylation method (Christie, 2003). The 
method was performed according to the methods used in Deakin University’s fish 
nutrition laboratory. Approximately, 20 mg of lipid was transferred to a Pyrex vial 
and 500 μl of 23:0 (1.5 mg ml-1, Sigma-Aldrich, Inc., St. Louis, Mo, USA) as an 
internal standard. The CHCl3/Methanol (2:1) solvent was then evaporated from the 
sample using a nitrogen evaporator (N-EVAP III, Organomation Associates, Inc.MA, 
USA) and 2 ml of freshly prepared Acetyl Chloride/Methanol (1:10) was added as 
the methylation catalyst. The vials containing the samples were then sealed and 
shaken and placed in an oven at 100 οC for 1 hour. Upon removal, samples were 
allowed to cool inside ice slurry and 2 ml of K2CO3 (1M) was added to neutralize the 
acidity of the Acetyl Chloride /Methanol mix. Subsequently, 3 ml of hexane was 
added to the vial, mixed using a vortex and then centrifuged. A sample from the 
supernatant (hexane layer) was placed in a gas chromatography (GC) vial for GC 
injection.      
 
2.4.2.2. Gas chromatography 
Fatty acid methyl esters were isolated and identified using a Shimadzu GC 17A 
(Shimadzu, Chiyoda-ku, Tokyo, Japan) (Figure 2.5) equipped with an Omegawax 
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250 capillary column (30m x 0.25 mm internal diameter, 25 μm film thickness, 
Supelco, Bellefonte. PA, USA), a flame ionisation detector (FID), a Shimadzu AOC 
- 20i auto injector, and a split injection system spilt ration 50:1). The temperature 
programme was 150 οC to 180 οC at 3 0C min-1, then from 180 οC to 250 οC at 2.5 οC 
min-1 and held at 250 οC for 10 min. The carrier gas was helium at 1.0ml min-1, at a 
constant flow. Each of the fatty acids was identified relative to known external 
standards. The resulting peak areas were then corrected by theoretical relative FID 
response factors (Ackman, 2002) and quantified relative to the internal standard. 
 
 
 
 
Figure 2.5.Fatty acid analysis by Gas Chromatography  
 
2.5 Growth parameters 
The following formulae were used to assess growth and feed utilization parameters: 
Percent Weight Gain 
Gain% = (final weight – initial weight) x (initial weight)-1 x 100 
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Specific growth rate:  
SGR (%  day-1) = [Ln (final weight) - Ln (initial weight)] x (number of days)-1 x 100 
Fat Deposition Rate:  
FDR (%  day-1) = [Ln (final lipid)–Ln (initial lipid)] x (number of days)-1 x 100 
Feed Conversion Ratio:  
FCR = (dry feed consumed by fish) x (wet weight gain)-1 
Protein Efficiency Ratio:   
PER = (final weight – initial weight) x (mass of protein consumed)-1 
 
2.6 Biometric parameters 
The main biometric parameters measured in each experiment included total length, 
total weight, gutted/somatic weight, liver weight and fillet weight. All weights were 
obtained in grams (g) and lengths in centimetres (cm). Using the main parameters, 
following biometric parameters were computed. 
 
Hepatosomatic index: HSI%= (weight of liver) x (total fish weight)-1 x 100 
Dress-out percentage: DP%= (gutted fish weight) x (total fish weight)-1 x 100 
Fillet yield percentage: FY% = (fillet weight x body weight -1) x 100 
 
 
2.5. Chromium oxide analysis & digestibility calculations 
Faeces samples were collected from each experimental tank during the last week of 
each grow-out/feeding experiment as previously described by Francis et.al, (2007c). 
 
Chromic oxide in the diets and faeces were estimated according to the method of 
(Furukawa and Tsukahara, 1996). Estimates of apparent digestibility coefficient 
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(ADC fatty acid) of individual fatty acids were calculated using standard formulae (De 
Silva and Anderson, 1995). The individual fatty acid digestibility values were used to 
deduce fatty acid metabolism via whole body fatty acid balance method (section : 
2.6). 
 
ADC of nutrients =100 - [100 (%Cr2O3 in diet) ÷ (%Cr2O3 in faeces)] x [(% nutrient 
in faeces) ÷ (% nutrients in diet)]                                                                           
 
2.6. Fatty acid metabolism 
The estimation of the apparent in vivo fatty acid metabolism (fatty acid de novo 
production, β-oxidation, elongation and desaturation) was calculated via the 
implementation of the whole body fatty acid balance method, as initially proposed 
and fully described by Turchini et al. (2007b) with subsequent developments 
(Turchini et al., 2008; Turchini and Francis, 2009). Briefly, the method involves the 
computation of the net appearance/disappearance of each individual fatty acid by 
means of a mass balance, which is determined by the difference between total fatty 
acid gain (=final fatty acid content - initial fatty acid content) and the net fatty acid 
intake (=total fatty acid intake × fatty acid digestibility). Data are then transformed 
from mg to mmol (μmol or nmol) of appeared/disappeared fatty acids per gram of 
body weight per day. The subsequent step involves a series of backwards 
computations along all the known fatty acid bioconversion pathways (n-3 PUFA, n-6 
PUFA, SFA and MUFA) so that the fate of each individual fatty acid towards 
bioconversion, β-oxidation or deposition, can be determined. Data are then reported 
as apparent in vivo enzyme activity and expressed as μmol (or nmol) of enzyme 
product produced per gram of body weight per day (μmol g-1 day-1). 
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2.7. Statistical Analysis 
All data were reported as means ± standard error of mean (SEM). Comparisons were 
made amongst treatments by one-way analysis of variance (ANOVA) at a 
significance level of 0.05 following confirmation of normality and homogeneity of 
variance. Where significant differences were detected by ANOVA, data were 
subjected to a Student-Newman-Keuls post-hoc test for individuating homogeneous 
subsets. Statistical analyses were computed using SPSS v17.0 (SPSS Inc., Chicago, 
IL, USA).  
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CHAPTER 3 
 
Effects of dietary α-linolenic acid (18:3n-3) / linoleic acid (18:2n-6) ratio on 
growth performance, fillet fatty acid profile and finishing efficiency in  
Murray cod 
 
A peer reviewed publication has resulted from this chapter:     
 
Senadheera, S.P.S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2010. Effects 
of dietary alpha-linolenic acid (18:3n-3)/linoleic acid (18:2n-6) ratio on growth 
performance, fillet fatty acid profile and finishing efficiency in Murray cod. 
Aquaculture. 309, 222-230. 
 
 
3.1 Introduction 
As introduced and discussed in Chapter 1, the role of dietary LA and ALA is of 
particular interest for fish nutritionists, as these fatty acids can be bioconverted to 
longer, more unsaturated and more biologically active LC-PUFA (Sargent et al., 
2002). Thus, it is envisaged that more efficient FO replacement strategies can be 
achieved through a better understanding of the nutritional roles and interactions of 
these two EFA, which are generally abundant in AO and have major impacts on final 
fatty acid composition of fish fillets when FO is replaced. 
 
A recent study on the Australian native freshwater fish, Murray cod, focused on 
different inclusion levels of total C18 PUFA with a constant ratio of ALA/LA (1:1), 
demonstrating that the total concentration of C18 PUFA plays a vital role in fatty acid 
metabolism of this species (Francis et al., 2009). The logical subsequent step from 
this study was to evaluate the effect of the ratio of ALA/LA on growth performance 
and final fillet fatty acid composition in Murray cod, a yet scarcely addressed issue in 
most of the cultured aquatic species. Hence, the objective of the present study was to 
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evaluate the effect of different ALA to LA ratios (at constant ALA+LA content), 
while employing 100% FO deprived diets, on growth performance and flesh fatty 
acid composition of juvenile Murray cod and the influence of the ALA/LA ratio on 
the progressive evolution of flesh fatty acid profiles when fish were reverted to a FO 
diet during a final finishing period. 
 
3.2 Materials and Methods 
Animals and husbandry methodologies used for this experimentation were described 
in Chapter 2. 
 
3.2.1 Experimental diets 
Six iso-proteic, iso-lipidic experimental diets, varying only in the dietary lipid source 
were formulated to contain ~15% of lipid and ~47% of protein.  Three different lipid 
sources; sunflower oil, linseed oil and beef tallow, were utilised to formulate the AO-
based diets with varying ratios of 18:3n-3 (ALA)/18:2n-6(LA), maintaining a 
constant level of total C18 PUFA (Table 3.1). The five experimental diets were 
designated from MC-0.3 through MC-2.9 and their ALA/LA ratios were 0.3, 0.6, 1, 
1.6, and 2.9, respectively, with a total C18 PUFA content of ~51%. Fish oil was used 
for the sixth / control diet (MC-FO). Diets were prepared and stored as previously 
reported in details (Chapter 2). 
 
3.2.2 Experimental design 
Following the acclimation period, 840 juvenile specimens of Murray cod were 
individually weighed and randomly allocated in quadruplicate groups into 24 tanks 
(35 fish per tank; 4 tanks per treatment). At the commencement of the experiment, a 
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sample of 15 fish was taken and euthanized in excess anaesthetic for subsequent 
analysis.  As described in Chapter 2, fish were fed with one of the six formulated 
diets for a 74-day grow-out period. At the termination of the grow out experiment, 
fish were anaesthetized, individually weighed, and 3 fish from each experimental 
tank (12 fish per treatment) were randomly selected, euthanized and stored at -20°C 
for subsequent analysis. The remaining fish were returned to their original 
experimental tanks and all fish groups were subjected to a dietary shift to the fish oil 
diet (MC-FO) for a further 42 days of wash-out/finishing. At the termination of the 
finishing period, all fish were individually weighed and 3 fish from each tank were 
culled for whole body testing and stored at -20°C for further analysis.  
 
3.2.3 Chemical analyses  
The samples subjected to chemical analysis included six experimental diets initial 
cod fillets (10 fish), cod fillets at the end of 74 day grow-out phase with AO-based 
experimental diets (3 fish per tank; 12 fish per treatment) and cod fillets at the end 42 
day fishing period (3 fish per tank; 12 fish per treatment). Proximate analyses and 
fatty acid analysis were carried out according to the procedures described in Chapter 
2 of this PhD thesis. 
 
3.2.4 Calculation of growth, biometric and feed utilization parameters 
Growth, biometric and feed utilization parameters were determined using the 
formulae described in Chapter 2. 
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3.2.5 Computation of fillet EPA and DHA retention efficiency  
The retention of dietary EPA and DHA in the fillets of fish during the finishing 
period was computed to assess the efficiency of the process. This computation can be 
described by following 5 steps. In step 1, the average fillet weight of fish receiving 
each of the dietary treatments was estimated using biometric data (% fillet yield) and 
the mean final body weight, at both the end of grow-out and finishing period.  In step 
2, the amount of EPA+DHA per average fish fillet in each dietary treatment was 
calculated using fatty acid data (mg g lipid-1) and % lipid values in fillets for both the 
grow-out and finishing phase. In step 3, the actual accumulation of EPA+DHA in 
fish fillets during the finishing period was estimated by subtracting the value 
(EPA+DHA) at the end of grow-out from the value at the end of finishing. In step 4, 
the amount of EPA+DHA administered through the diet during finishing was 
calculated using the diet fatty acid data (mg g lipid-1) and the average feed 
consumption values for each dietary group. Lastly, in step 5, the retention/deposition 
efficiency of EPA+DHA was determined by computing EPA+DHA accumulation in 
average fish fillets as a percentage of total EPA+DHA supplied by the diet during 
finishing. 
 
3.2.6 Computation of coefficient of distance 
For comparison of the whole fatty acid profile of the fillets of fish under the five AO-
based experimental treatments (MC-0.3 to MC-2.9 ; “test fish”) relative to that of the 
control/reference fish (MC-FO; “reference fish”), the coefficient of distance D 
(McIntire et al., 1969) was computed using the equation:  
 
 
    »¼º«¬ª ¦  ni ihij PPDjh 1 2
2/1
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where, Djh is the degree of difference (coefficient of distance) between samples j 
“reference fish” and h “test fish”, Pij and Pih are percentage of fatty acid i in sample j 
and h, for each i fatty acid. Fish continuously fed the FO diet were the “reference 
fish”, while fish under the different treatments were the “test fish”. The coefficient of 
distance D was computed at the end of 74 day grow-out period and the end of 42 day 
finishing period. 
 
3.2.7 Computations of predicted fatty acid profile by dilution model 
The dilution model proposed by Robin et al. (2003) is considered one of the most 
reliable models to predict the fatty acid composition of fish tissues, after a dietary 
shift, as in the case of a finishing strategy. This model is applicable to fish previously 
fed a specific diet (“test” fish), such as vegetable oil- based diets, in comparison with 
fish continuously fed a reference diet (“reference fish”), usually a fish oil - based 
diet.  
 
The dilution model is expressed mathematically as:  
 
it
ri
rt QQ
PPPP  
 
 
where, Pt is the percentage of fatty acid in the tissues of the “test” fish at time t, Pi is 
the initial percentage of fatty acid in the tissues of the “test” fish and Pr is the 
percentage of the fatty acid in the tissues of the “reference” fish at time t. Qi is the 
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initial total amount of fatty acids (or total fat) present and Qt is the amount present at 
time t in the tissues of the “test” fish. 
 
The observed tissue fatty acid values at the end of the finishing period in the present 
study were compared with the expected values estimated by computing the dilution 
model (Robin et al., 2003).  
 
3.2.8 Statistical analysis 
Statistical analyses were performed as described in Chapter 2. 
 
3.3 Results 
3.3.1 Experimental diets 
The proximate compositions of the diets were similar across all treatments and the 
total lipid contents ranged from 149.7 to 153.3 g/kg (Table 3.1). Fatty acid analysis 
of the different experimental diets reflected the objective of the formulations (Table 
3.2). MC-FO, formulated with FO was characterised by a comparatively high content 
of n-3 LC-PUFA, mainly represented by EPA (13.8%) and DHA (11.7%) with the 
highest n-3/n-6 ratio (4.7). The n-3/n-6 ratios of the five experimental diets were 0.5, 
0.8, 1.2, 1.9 and 3.3 for MC-0.3, MC-0.6, MC-1.0, MC-1.6 and MC-2.9, 
respectively. The percentages of EPA ranged from 2.2 to 2.4% and DHA ranged 
from 4.2 to 4.4% of total fatty acids, clearly derived from the lipid content of the fish 
meal included in the formulation. The specific ALA/LA ratios in the five 
experimental diets were 0.3, 0.6, 1.0, 1.6 and 2.9 in diets MC-0.3 to MC-2.9, 
respectively and the total sum of ALA+LA was constant at ~51% for all five diets 
(Table 3.2). In general, concentrations of saturated fatty acid (SFA), 
82 
 
monounsaturated fatty acids (MUFA), PUFA and LC-PUFA were similar in all five 
experimental diets (MC-0.3 to MC-2.9), with the only variation in the actual ALA 
and LA content. 
 
3.3.2 Growth performance, feed utilisation and proximate composition 
All experimental diets were well-accepted and subsequently no significant 
differences were noted in feed intake (mean feed consumption) (Table 3.3). In the 
initial grow-out period of 74 days, fish increased their weight by over 400% in all 
treatments, and there were no significant differences in final mean weights which 
ranged from 83.3±3.48 to 106±9.5 g, respectively (Table 3.3) among fish fed the six 
dietary treatments. The SGR varied from 2.2 to 2.5, while FCR and PER ranged from 
1.1 to 1.3 and 1.6 to 1.8, respectively, with no significant differences among the 
dietary treatments. However, there was a tendency (though not significant, P>0.05) 
of higher final mean weights and SGR recorded in fish fed the FO diet (MC-FO). 
The overall mortality was low and did not seem to be affected by the dietary 
treatment. There were no significant differences among dietary treatments with 
respect to other biometric parameters over the 74-day grow-out period (Table 3.3). 
 
In the subsequent finishing trial of 42 days, fish grew a further ~75%, relative to the 
commencing weights with the finishing diet (Table 4). The final mean weights varied 
from 136.7±5.66 g (MC-0.3) to 172.4±15.71 g (MC-FO) with no significant 
differences among treatments. Though not significantly different (P>0.05), higher 
gain percentage values (Gain%) were observed in fish groups previously fed the AO 
experimental diets compared to the FO fed group (MC-FO), with values tending to 
increase with increasing ALA/LA ratios in the respective diets. The highest Gain% 
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of 85.4% was recorded in fish receiving the MC-2.9 diet while the MC-FO group 
recorded the lowest gain of 70.3%. The SGR values of finishing groups ranged from 
1.3 to 1.5 while FCR and PER varied from 1.0 to 1.3 and 1.6 to 2.0, respectively 
(Table 3.4). However, no significant differences were observed in relation to any of 
the above parameters among the six dietary treatments. 
 
No significant differences were detected among dietary treatments for moisture, ash, 
protein or total lipid content in Murray cod fillets during both the grow-out and 
finishing phases (Table 3.5). 
 
3.3.3 Fillet fatty acid composition 
At the end of grow-out phase, fillet fatty acid compositions mirrored that of the 
dietary treatments (Table 3.6). The degree of differences tended to decrease 
following transfer to the wash-out diet (Table 3.7).  
 
At the end of the grow-out phase, the overall fatty acid composition of fillets of fish 
fed the five experimental diets were similar in terms of SFA (~21%), MUFA (~23%) 
and PUFA (~55%), with the exception of the MC-FO treatment (Table 3.6). Within 
the PUFA class, the content of ALA and LA clearly reflected that of diets and the 
ALA/LA ratios were 0.3, 0.4, 0.7, 1.1 and 1.9 for MC-0.3 to MC-2.9, respectively. 
Clear trends manifested in the fillet content of LC-PUFA. n-6 LC-PUFA 
concentrations were significantly higher (P<0.05) in MC-0.3 compared to MC-2.9, 
and conversely, n-3 LC-PUFA concentrations were greatly enhanced by moving 
from MC-0.3 to MC-2.9, with recorded values varying from 12.1% in MC-0.3 to 
15.7% in MC-2.9. In particular, observing the fatty acids involved in the n-3 PUFA 
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bioconversion pathway (from ALA to DHA), an evident trend was recorded. Despite 
the fact that the five AO-based diets contained almost identical amounts of these 
fatty acids (namely 18:4n-3, 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3), moving along 
from MC-0.3 to MC-2.9, and thus from low ALA/LA ratio to high ALA/LA ratio, 
the resultant fillet concentrations of these fatty acids increased significantly (P<0.05), 
as depicted in Figure 3.1.  
 
The coefficient of distance (D), computed comparing the fillets of fish fed the five 
experimental diets and the MC-FO group, was significantly higher (P<0.05) in MC-
0.3 (31.9) compared to all other treatments (varying from 26.5 to 28.8). During the 
finishing period, the overall fatty acid composition of fish fillets was modified and 
was in general more similar to that of fish constantly fed the control FO-based diet 
(Table 3.7). These modifications were clearly summarised by the D value which was 
significantly reduced when compared to that recorded at the end of the grow-out 
period. Interestingly, even after the finishing period, the fillets of MC-0.3 fed fish 
showed the highest D value (P<0.05), compared to all others. 
 
During the finishing period, the final accumulation of n-3 LC-PUFA did not seem to 
be affected by the previous dietary ALA/LA ratio within the five experimental 
groups (Table 3.7). However, when values are reported in mg of fatty acid per 100g 
fillet, the retention of EPA and DHA during finishing was significantly higher 
(P<0.05) in MC-2.9 (161.6±6.20 and 419.8±22.4 mg FA/100 g fillet respectively) 
compared to MC-0.3 (129.5±5.84 and 333.8±15.37 mg FA/100 g fillet, respectively) 
MC-0.6 (136.6±5.54 and 351.2±16.18 mg FA/100 g fillet, respectively) and MC-1.0 
(125.68 ± 5.07 and 354.4 ±15.28, respectively) (Figure 3.2). 
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3.3.4 Fillet EPA+DHA retention efficiency 
The total EPA+DHA retention efficiency in average fillets of Murray cod, expressed 
as a percentage of total EPA+DHA fed during the finishing period is shown in Table 
8. Significantly higher (P<0.05) contents of EPA+DHA in fish fillets was recorded in 
the fish group continuously fed FO diet compared to those on AO- based dietary 
treatments, both at the end of grow-out and finishing period (267.6±5.7 and 
512.0±12.5 mg per fillet, respectively). Significant differences were also detected in 
fillet EPA+DHA contents among the AO-fed groups during the grow-out period, 
with fillets of the MC-1.6 treatment recording higher EPA+DHA contents (96.7±2.7 
mg fatty acids per fillet) compared to all other AO-fed fish, which varied from 
79.8±1.0 in MC-2.9 to 85.8±2.1 in MC-1.0. The retention of EPA+DHA in fillets at 
the end of the finishing period was significantly higher in MC-1.6 (348.2±10.6 mg 
FA fillet-1) and MC-2.9 (361.7±17.5 mg FA fillet-1) compared to MC-0.3 
(256.3±10.9mg FA/fillet), demonstrating an increasing trend of accumulation during 
finishing from the fish groups previously fed with AO-based diets containing higher 
ALA/LA ratios.  EPA+DHA fed during the finishing period had a better retention 
rate in fish previously fed MC-1.0, MC-1.6 and MC-2.9 diets compared to MC-0.3 
and MC-0.6 as a result of higher feed consumption levels. However, the levels of 
EPA+DHA fed were not significantly different among the dietary treatments 
indicating that the levels of EPA+DHA were roughly similar across each of the 
experimental groups. The retention efficiency of EPA+DHA in fillets (deposition as 
a % of total administered level by FO diet) ranged from 7.8% (MC-0.3) to 11.0% 
(MC-2.9) denoting an increasing trend of retention efficiency by the groups 
previously fed on diets with high ALA/LA ratios. The retention efficiency for the 
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reference group continuously fed on FO diet was 10.7%, denoting a similar retention 
level to the groups previously fed with higher ALA/LA ratios (MC-1.6 and MC-2.9). 
 
3.3.5 Dilution model  
Following the dilution model equation, the predicted percentages of fatty acids were 
computed for fish groups previously fed the AO-based diets. The observed percent 
values of the same fatty acids were obtained from the fatty acid data of fillets at the 
end of the finishing phase. The relationship between the predicted percentages of all 
fatty acids and major fatty acid classes (Y) and those observed (X) in fish fillets of 
each test group is shown in figure 3A and 3B.  Linear regression was performed (Y= 
0.9967X-0.0117; R2 = 0.9975) to determine the relationship between observed and 
predicted percentages of all individual fatty acids in fillets for all treatment groups. 
The resulting line was found to be relatively close to the line of equity (a regression 
that has a slope of 1 and passes through the origin; Y = X). The expected and actual 
percentages of all major fatty acid classes were also close to the line of equity further 
supporting the dilution theory. 
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Table 3.1 Ingredients and proximate composition of the experimental diets (g kg -1  
dry diet) used for the 1st feeding trial with Murray cod 
 
 Dietary treatments1 
MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
Ingredients       
Fish meal2 525 525 525 525 525 525 
Defatted soybean meal2 280 280 280 230 230 230 
CMC3 20 20 20 20 20 20 
Wheat flour4 63 63 63 63 63 63 
Vitamin+mineral premix2 3 3 3 3 3 3 
Choline5 2 2 2 2 2 2 
Cr2O35 2 2 2 2 2 2 
Fish oil2 (FO) 105 - - - - - 
Beeftallow2 (BT) - 2.6 6.6 10.5 14.4 18.4 
Linseed oil6 (LO) - 28.2 43.0 57.8 72.2 86.6 
Sunflower oil6 (SO) - 74.2 55.5 36.8 18.4 - 
Proximate composition  (mg g-
1
      
Moisture 67.7 78.9 60.1 57.1 55.3 54.5 
Crude protein 465.9 467.5 473.3 485.1 474.7 462.4 
Crude lipid 152.0 151.3 151.7 153.3 150.0 149.7 
Ash 103.5 100.7 105.2 103.0 103.9 102.3 
NFE7 210.9 201.6 209.8 201.6 216.2 231.1 
1 Diet abbreviations – MC-FO: (Control diet ; 100% FO); MC-0.3: (0.3 ALA/LA ratio in 100%  AO  
diet with SO, LO & BT), MC-0.6 : (0.6 ALA/LA ratio in 100% AO diet with SO, LO & BT), MC-1.0: 
1.0 ALA/LA ratio in 100% AO diet with SO, LO & BT), MC-1.6: 1.6 ALA/LA ratio in 100% AO diet 
with SO, LO & BT), MC-2.9: (2.9 ALA/LA ratio in 100% AO diet with SO & LO) 
2 Ridley AgriProducts, Narangba, Queensland, Australia 
3 Carboxymethyl cellulose (CMC) - BDH Laboratory Supplies, Poole, United Kingdom 
4 Black and Gold, Tooronga, Victoria, Australia 
5 Sigma-Aldrich, Inc. St. Louis, MO, USA 
6 Sceney Chemical PTY., LTD. Sunshine, VIC., Australia  
7 NFE (Nitrogen Free Extract): Calculated by difference 
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Table 3.2 Fatty acid composition (% w/w relative to total fatty acids) of Murray cod 
diets used for the 1st feeding trial for 74 days 
      Dietary  treatments1     
Fatty acids MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 8.0 1.2 1.3 1.3 1.5 1.6 
16:0 22.4 10.7 11.2 11.6 12.1 12.5 
18:0 4.9 4.3 4.7 5.0 5.4 5.7 
16:1n-7         9.5 1.5 1.5 1.6 1.6 1.7 
18:1n-9         10.7 19.1 18.3 17.5 16.5 15.6 
18:1n-7         3.1 1.4 1.5 1.5 1.6 1.7 
20:12 1.3 0.5 0.5 0.5 0.5 0.5 
22:13 0.8 0.3 0.3 0.3 0.3 0.3 
18:2n-6         4.3 39.3 32.7 26.3 19.8 13.2 
18:3n-6         0.4 0.1 0.1 0.1 0.1 0.1 
20:2n-6         0.2 0.1 0.1 0.1 0.1 0.1 
20:3n-6         0.2 n.d. n.d. n.d. n.d. n.d. 
20:4n-6         1.5 0.5 0.5 0.5 0.5 0.5 
22:2n-6         n.d. n.d. n.d. n.d. n.d. n.d. 
22:4n-6         0.2 0.1 0.1 0.1 0.1 0.1 
18:3n-3         1.2 12.4 18.8 25.4 31.6 37.8 
18:4n-3         1.9 0.3 0.3 0.3 0.3 0.3 
20:3n-3         0.1 n.d. 0.1 0.1 0.1 0.1 
20:4n-3         0.9 0.1 0.1 0.1 0.1 0.1 
20:5n-3         13.8 2.3 2.3 2.2 2.3 2.4 
22:5n-3         2.3 0.5 0.5 0.5 0.5 0.5 
22:6n-3         11.7 4.4 4.3 4.2 4.4 4.5 
SFA 35.9 17.0 17.9 18.4 19.4 20.2 
MUFA 25.4 22.9 22.2 21.5 20.6 19.9 
PUFA 38.7 60.1 60.0 60.0 60.0 59.9 
n-6 PUFA 6.8 40.1 33.5 27.1 20.6 14.0 
n-6 LCPUFA 2.1 0.7 0.7 0.7 0.7 0.7 
n-3 PUFA 31.9 20 26.5 32.9 39.4 45.8 
n-3 LCPUFA 28.8 7.4 7.3 7.2 7.4 7.7 
ALA+LA4  5.5 51.7 51.5 51.7 51.4 51.0 
n3/n65 4.7 0.5 0.8 1.2 1.9 3.3 
ALA/LA6 0.3 0.3 0.6 1.0 1.6 2.9 
 
1 See Table 3.1 for diet abbreviations 
2Represents the sum of all 20:1 isomers 
3Represents the sum of all 22:1 isomers 
4Sum of ALA (α-linolenic acid, 18:3n-3) and LA (linoleic acid, 18:2n-6) 
5Ratio of total Omega 3 fatty acids to Omega 6 fatty acids  
6Ratio of ALA (ά-linolenic acid, 18:3n-3) to LA (linoleic acid, 18:2n-6) 
 n.d. = not detected 
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Table 3.3 Mean (± SEM) growth, feed utilisation and other body parameters of 
Murray cod reared on the experimental diets over the 74-day grow-out period2 
                                               Dietary treatments1 
 MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
Initial weight. 16.8±0.33 16.4±0.59 16.3±0.81 16.5±0.72 16.4±0.40 16.8±0.26 
Final weight 106.4±9.51 83.3±3.48 91.3±8.58 91.1±4.33 98.1±10.25 88.8±4.34 
Feed consumption (g/fish) 105.0±7.97 91.5±3.73 93.5±4.62 95.5±2.83 97.2±6.51 93.8±5.12 
Gain % 536.4±62.49 407.5±19.14 464.1±60.24 453.3±12.13 493.2±50.86 429.8±29.91 
SGR (% day)3 2.5±0.14 2.2±0.05 2.3±0.15 2.3±0.03 2.4±0.12 2.2±0.08 
FCR4 1.1±0.07 1.3±0.02 1.2±0.10 1.2±0.06 1.2±0.08 1.3±0.13 
PER (% day)5 1.8±0.11 1.6±0.03 1.7±0.14 1.6±0.07 1.7±0.11 1.7±0.19 
FDR (% day)6 2.7±0.19 2.4±0.09 2.6±0.16 2.5±0.06 2.5±0.15 2.4±0.17 
DP%7 89.3±0.40 89.5±0.07 89.1±1.61 90.8±0.41 89.0±0.49 90.8±0.52 
FY%8 41.5±1.99 40.8±1.03 40.4±1.21 41.9±1.60 41.6±1.77 40.2±1.86 
HSI%9 1.6±0.15 1.3±0.11 1.4±0.13 1.3±0.05 1.7±0.07 1.4±0.09 
       
 
1 See Table 3.1 for diet abbreviations 
 2Values in the same row with different superscripts are significantly different (P < 0.05; ANOVA and Student– Newman–Keuls  
post hoc test, n = 4; N=24) 
3SGR; Specific Growth Rate = [Ln (final weight) - Ln (initial weight)] x (number of days)-1 x 100 
4FCR; Food Conversion Ratio = (dry food fed) x (wet weight gain)-1 
5PER; Protein Efficiency Ratio:  = (final weight - initial weight) x (mass of protein consumed)-1 
6FDR; Fat Deposition Rate: =[Ln (final lipid) - Ln(initial lipid)] x (number of days)-1x 100 
7DP; Dress-out Percentage = (carcass weight x total body weight-1) x 100 
8Fillet Yield = (fillet weight x total body weight-1) x 100 
9HSI; Hepatosomatic Index = (liver weight x total body weight-1) x 100 
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Table 3.4 Mean (± SEM) growth, feed utilisation and other body parameters of 
Murray cod during the 42-day finishing period2 
                                                          Dietary treatments1 
 MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
Initial weight. 101.5±9.6
4
78.8±4.35 85.5±7.74 87.1±3.81 92.2±11.11 84.5±4.87 
Final weight. 172.4±15.
71
136.7±5.66 149.3±12.52 155.1±6.32 166.4±21.25 156.4±7.89 
Feed intake (g/fish) 77.6±4.82 75.1±3.17 80.4±6.14 90.4±1.95 83.2±5.69 86.1±1.32 
Gain % 70.3±5.69 74.0±4.18 75.0±1.35 78.2±0.97 80.0±1.54 85.4±4.38 
SGR (% day)3 1.3±0.08 1.3±0.06 1.3±0.02 1.4±0.01 1.4±0.02 1.5±0.06 
FCR3 1.0±0.07 1.2±0.04 1.2±0.03 1.3±0.05 1.1±0.10 1.1±0.06 
PER (% day)3 2.0±0.12 1.7±0.06 1.7±0.04 1.6±0.06 1.9±0.17 1.8±0.10 
FDR (% day)3 1.4±0.16a
b
1.2±0.15a 1.0±0.08ab 1.4±0.05ab 1.4±0.10ab 1.7±0.25b 
DP %3 89.7±0.63 90.0±0.72 89.8±0.46 90.8±0.60 90.2±0.47 89.4±0.40 
FY %3 40.4±2.43 40.2±1.63 42.5±2.23 36.5±0.94 40.2±1.79 39.6±1.24 
HSI %3 1.6±0.07 1.6±0.08 1.5±0.11 1.6±0.12 1.7±0.12 1.5±0.06 
       
 
1 See Table 3.1 for diet abbreviations 
 2Values in the same row with different superscripts are significantly different (P < 0.05; ANOVA and 
Student–    Newman–Keuls post hoc test, n = 4; N=24) 
3 See Table 3 for parameters description and formulae 
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Table 3.5 Fillet proximate compositions (mean ± SE; % wet weight) of Murray cod 
at the end of grow-out period and at the end of finishing period2 
                              Dietary treatments1       
  Initial  MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
Grow-out phase       
        
Moisture 78.3±0.14 76.7±0.36 77.4±0.74 78.2±0.16 78.4±0.54 78.4±0.82 77.5±0.52 
Ash 1.2±0.00 1.1±0.02 1.1±0.02 1.1±0.02 1.0±0.05 1.0±0.05 1.4±0.26 
Protein 17.6±0.19 18.8±0.18 18.2±0.42 18.1±0.14 18.0±0.60 17.8±0.80 18.6±0.25 
Lipid 2.9±0.04 3.4±0.29 3.3±0.46 2.6±0.10 2.6±0.13 2.8±0.42 2.5±0.17 
Finishing phase       
        
Moisture  76.6±0.13 77.7±0.25 76.6±0.65 77.5±0.42 77.0±0.84 78.3±1.12 
Ash  1.2±0.02 1.2±0.02 1.1±0.01 1.1±0.02 1.2±0.08 1.0±0.09 
Protein  18.5±0.10 17.8±0.27 18.5±0.24 18.2±0.12 18.1±0.31 17.0±0.98 
Lipid  3.7±0.24 3.3±0.38 3.7±0.52 3.1±0.54 3.7±0.56 3.7±0.59 
                
 
1 See Table 3.1 for diet abbreviations.  
2 Data are reported as the mean ± SEM (n = 4). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test, n=4; N=24)
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Table 3.6  Fatty acid composition (% w/w of total fatty acids) of Murray cod fillets at 
the end of the experimental diet grow out period2  
             Dietary treatments1       
  MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 6.1±0.06b 1.5±0.05a 1.4±0.07a 1.5±0.05a 1.6±0.06a 1.7±0.05a 
16:0 21.8±0.24b 13.9±0.29a 14.0±0.22a 14.6±0.22a 14.2±0.18a 14.7±0.34a 
18:0 5.2±0.10a 5.2±0.14a 5.5±0.13ab 5.7±0.12b 5.4±0.10ab 5.8±0.06b 
16:1n-7 8.4±0.14b 2.0±0.07a 1.9±0.07a 2.0±0.04a 2.1±0.04a 2.2±0.06a 
18:1n-9 13.1±0.02a 19.8±0.20e 18.8±0.20d 18.1±0.12c 18.1±0.12c 17.2±0.05b 
18:1n-7 3.5±0.02c 1.9±0.03a 1.9±0.03a 2.0±0.01a 2.0±0.02ab 2.0±0.02b 
20:13 1.0±0.03b 0.6±0.02a 0.6±0.03a 0.6±0.03a 0.6±0.04a 0.6±0.04a 
22:14 0.4±0.04b 0.1±0.03a 0.1±0.03a 0.1±0.04a 0.1±0.01a 0.1±0.02a 
18:2n-6 5.3±0.14a 31.6±0.57f 26.9±0.40e 21.6±0.19d 18.0±0.07c 12.5±0.18b 
18:3n-6 0.4±0.01b 0.1±0.02a 0.1±0.01a 0.1±0.02a 0.1±0.01a 0.1±0.02a 
20:2n-6 0.2±0.01a 0.5±0.01f 0.4±0.00e 0.4±0.01d 0.3±0.00c 0.3±0.00b 
20:3n-6 0.2±0.01a 0.5±0.02d 0.4±0.01c 0.3±0.02b 0.2±0.01a 0.2±0.01a 
20:4n-6 1.9±0.04d 0.9±0.04a 1.0±0.04abc 1.1±0.05bc 0.9±0.02ab 1.1±0.04c 
22:2n-6 n.d. n.d. n.d. n.d. n.d. n.d. 
22:4n-6 0.3±0.00b 0.1±0.00a 0.2±0.01a 0.1±0.00a 0.1±0.01a 0.1±0.00a 
18:3n-3 1.3±0.09a 8.0±0.13b 11.8±0.35c 15.7±0.37d 20.6±0.42e 23.9±0.76f 
18:4n-3 1.3±0.04c 0.7±0.03a 0.9±0.03b 1.2±0.06c 1.5±0.05d 1.6±0.06e 
20:3n-3 0.1±0.00a 0.5±0.01b 0.7±0.01c 0.8±0.01d 1.0±0.02e 1.1±0.02f 
20:4n-3 1.0±0.01 0.6±0.01a 0.7±0.01b 0.9±0.04c 1.0±0.01d 1.1±0.03e 
20:5n-3 8.0±0.10c 1.6±0.10a 1.7±0.07a 1.9±0.12ab 1.9±0.12ab 2.2±0.05b 
22:5n-3 5.1±0.05c 1.6±0.04a 1.7±0.05ab 1.8±0.07ab 1.7±0.06ab 1.9±0.06b 
22:6n-3 14.9±0.18c 7.7±0.31a 8.6±0.25ab 9.1±0.22b 8.4±0.15ab 9.4±0.45b 
SFA 33.3±0.33b 20.9±0.41a 21.3±0.38a 22.1±0.37a 21.4±0.21a 22.4±0.45a 
MUFA 26.5±0.19d 24.5±0.33c 23.4±0.31b 22.8±0.16ab 22.8±0.21ab 22.1±0.14a 
PUFA 40.2±0.44a 54.6±0.53b 55.2±0.49b 55.1±0.39b 55.8±0.30b 55.5±0.58b 
n-6 PUFA 8.4±0.19a 33.8±0.55f 29.0±0.36e 23.6±0.15d 19.7±0.12c 14.3±0.17b 
n-6 LC-PUFA 2.7±0.06c 2.1±0.06b 2.0±0.05b 1.9±0.07b 1.6±0.04a 1.7±0.04ac 
n-3 PUFA 31.7±0.25c 20.8±0.27a 26.2±0.24b 31.5±0.28c 36.0±0.40d 41.2±0.43e 
n-3 LC-PUFA 29.1±0.20d 12.1±0.34a 13.5±0.32b 14.5±0.40b 14.0±0.25b 15.7±0.51c 
n3/n6 3.8±0.05f 0.6±0.02a 0.9±0.01b 1.3±0.01c 1.8±0.03d 2.9±0.02e 
ALA/LA 0.2±0.01a 0.3±0.00a 0.4±0.01b 0.7±0.01c 1.1±0.03d 1.9±0.05e 
D value5 - 31.9±0.63b 28.8±0.55a 26.5±0.41a 27.8±0.28a 27.6±0.83a 
 
1 See Table 3.1 for diet abbreviations 
2 Data are reported as the mean ± SEM (n = 4). Values in the same row with the same letter are not 
significantly different (P > 0.05; ANOVA and Student–Newman–Keuls post hoc test, n=4; N=24) 
3Represents the sum of all 20:1 isomers 
4Represents the sum of all 22:1 isomers 
   5 Coefficient of Distance 
   n.d.= not detected 
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Table 3.7 Fatty acid composition (% w/w of total fatty acids) of Murray cod fillets at the end 
of the finishing period2  
    Dietary treatments1     
  MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 5.7±0.17b 3.5±0.12a 3.6±0.16a 3.3±0.18a  3.7±0.11a 3.5±0.11a 
16:0 20.6±0.40c 16.8±0.36a 17.3±0.31ab 18.4±0.40b 18.0±0.16ab 18.1±0.46ab 
18:0 4.9±0.08a 4.8±0.13a 5.0±0.17a 5.6±0.13b 5.2±0.13ab 5.2±0.14ab 
16:1n-7 8.0±0.13b 4.8±0.14a 5.0±0.19a 4.8±0.29a 5.2±0.24a 5.2±0.18a 
18:1n-9 13.8±0.06a 17.5±0.18d 16.8±0.34 15.4±0.19b  16.1±0.27bc  15.5±0.31b 
18:1n-7 3.6±0.04b 2.8±0.02a 2.9±0.05a 2.9±0.12a 2.9±0.07a 2.8±0.12a 
20:13 1.6±0.04b 1.4±0.02a 1.5±0.03a 1.4±0.01a 1.4±0.05a 1.4±0.05a 
22:14 0.8±0.03 0.7±0.03 0.7±0.05 0.7±0.04 0.7±0.03 0.7±0.05 
18:2n-6 5.6±0.10a 17.6±1.12e 15.1±0.30d 12.2±0.20c 10.7±0.14c 8.5±0.16b 
18:3n-6 0.4±0.01b 0.3±0.01a 0.3±0.01a 0.3±0.01a 0.3±0.00a 0.3±0.01a 
20:2n-6 0.2±0.00a 0.4±0.01e 0.4±0.01d 0.3±0.01c 0.3±0.01b 0.3±0.00ab 
20:3n-6 0.2±0.00b 0.3±0.01d 0.3±0.01c 0.3±0.01c 0.2±0.01ab 0.2±0.01a 
20:4n-6 1.7±0.01b 1.3±0.07a 1.2±0.10a 1.5±0.09ab 1.3±0.07a 1.3±0.11a 
22:2n-6 n.d. n.d. n.d. n.d. n.d. n.d. 
22:4n-6 0.3±0.01c 0.2±0.01ab 0.1±0.04a 0.2±0.03ab 0.2±0.04a 0.2±0.03a 
18:3n-3 1.2±0.05a 4.5±0.29b 6.3±0.21c 7.5±0.11d 9.7±0.25e 12.1±0.47f 
18:4n-3 1.5±0.04b 1.2±0.05a 1.3±0.06a 1.3±0.04a 1.5±0.01b 1.6±0.05b 
20:3n-3 0.2±0.01a 0.3±0.01b 0.4±0.01c 0.5±0.01d 0.5±0.02e 0.6±0.02f 
20:4n-3 1.0±0.02c 0.9±0.02a 0.9±0.02b 0.9±0.02b 1.0±0.01c 1.1±0.01d 
20:5n-3 7.6±0.10b 4.8±0.12a 4.7±0.07a 5.0±0.12a 4.9±0.08a 4.9±0.13a 
22:5n-3 5.2±0.07b 3.4±0.09a 3.5±0.10a 3.5±0.06a 3.5±0.02a 3.6±0.06a 
22:6n-3 15.5±0.12b 12.3±0.51a 12.2±0.69a 14.0±0.44ab 12.5±0.41a 12.8±0.62a 
SFA 31.6±0.30c 25.5±0.50a 26.3±0.31ab 27.5±0.45b  27.2±0.08b 27.0±0.53b 
MUFA 27.8±0.14b 27.1±0.32ab 27.0±0.52ab 25.1±0.30a  26.3±0.67ab  25.6±0.60a 
PUFA 40.6±0.20a 47.4±0.76b 46.7±0.53b 47.6±0.75b 46.7±0.76b 47.4±0.66b 
n-6 PUFA 8.5±0.08a 20.1±1.06f 17.4±0.24e 14.8±0.27d 12.9±0.23c 10.7±0.11b 
n-6 LC-PUFA 2.5±0.01b 2.2±0.09ab 2.0±0.10a 2.3±0.11ab 1.9±0.11a 2.0±0.12a 
n-3 PUFA 32.1±0.26c 27.3±0.33a 29.4±0.57b 32.9±0.54c 33.7±0.53c 36.7±0.61d 
n-3 LC-PUFA 29.4±0.22b 21.6±0.63a 21.8±0.79a 24.0±0.49a 22.5±0.38a 23.0±0.79a 
n3/n6 3.8±0.06f 1.4±0.09a 1.7±0.05b 2.2±0.03c 2.6±0.01d 3.4±0.05e 
ALA/LA 0.2±0.01a 0.3±0.00a 0.4±0.01b 0.6±0.00c 0.9±0.01d 1.4±0.03e 
D value5 - 14.9±1.14b 13.1±0.46ab 11.1±0.33a 11.9±0.21a 13.0±0.61ab 
 
1 See Table 3.1 for diet abbreviations 
2 Data are reported as the mean ± SEM (n = 4). Values in the same row with the same letter are not 
significantly different (P > 0.05; ANOVA and Student–Newman–Keuls post hoc test, n=4; N=24) 
3Represents the sum of all 20:1 isomers 
4Represents the sum of all 22:1 isomers 
5Coefficient of Distance 
n.d. = not detected
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Figure 3.1 The percentage values of fatty acids involved in the n-3 PUFA 
bioconversion pathway in the fillets of Murray cod at the end of the grow-out phase 
fed with the five different experimental diets charaterised by different ALA/LA 
ratios. 
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Figure 3.2 The fillet EPA and DHA content (mg 100 g-1 of fillet) in Murray cod at 
the end of the finishing period. 
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Figure 3.3 The relationship between observed and predicted fatty acid percentages in 
the fillet of Murray cod at the end of the finishing period (predicted values computed 
by dilution model): (A) all individual fatty acids; (B) major fatty acid classes. In both 
plots, each data point represents the average percent value of the four replicates. 
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3.4 Discussion 
The present study was designed to determine the effects of the dietary n-3/n-6 PUFA 
ratio, specifically underlining the effect of ALA and LA, on the growth performance 
and fillet fatty acid profiles of juvenile Murray cod and the FO-like fatty acid 
restoration success during a subsequent finishing period. From a fish performance 
viewpoint, the feeding experiment revealed that a varying ALA/LA ratio in diets 
void of FO did not appear to compromise the growth performance of juvenile Murray 
cod. This is partially in contrast to previous findings on the same species where 
significant impairment of growth was recorded following 100% dietary fish oil 
replacement (Francis et al., 2006; Francis et al., 2007a; Francis et al., 2007b; Francis 
et al., 2009). However, the above studies were all conducted using semi-purified 
diets with very limited fish meal content (10%) compared to the present study which 
employed a more practical diet with a relatively high content of fishmeal (50% of the 
protein source). Thus, in previous trials, experimental diets contained ~1.5% of 
EPA+DHA (% of total fatty acids), while in the present trial, a relatively large 
amount of dietary n-3 LC-PUFA was derived by the fish meal fraction (~6.5% of 
EPA+DHA, % of total fatty acids). This clearly suggests that n-3 LC-PUFA, and in 
particular EPA and DHA, plays a direct and important role in the overall growth 
performance of Murray cod. 
 
In agreement with the present study, Blanchard, et al.(2008) reported no significant 
effect of the ALA/LA ratio or partial substitution of fish oil by safflower and linseed 
oil on the growth performance of Eurasian perch (Perca fluviatilis). A previous 
study, conducted by the authors on Murray cod, evaluating the effect of graded 
inclusions of total dietary C18 PUFA content with a constant ALA/LA ratio of 1/1 
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and constant dietary level of n-3 LC-PUFA (Francis et al., 2009), reported no effects 
on fish growth. In contrast, Tan, et al (2009) found that the growth of juvenile yellow 
catfish (Pelteobragus fulvidraco) was affected by the ALA/LA ratio. The best 
growth performance was achieved at ratios of 1.17 and 2.12 while fish receiving 
lower (0.35), or higher (4.18, 7.11 and 14.64) ratios, recorded significantly reduced 
performance. Similarly, in a study investigating the graded replacement of soybean 
oil with linseed oil (thus a sliding n-3/n-6 ratio) in the freshwater fish tench (Tinca 
tinca), growth retardation was recorded for the fish receiving the lowest ALA/LA 
dietary ratio (Turchini et al., 2007c). 
 
In the present study, during the finishing period, no effects on fish performance 
relative to previous dietary treatments were recorded. Interestingly, fish previously 
fed with a higher ALA/LA ratio recorded a significantly higher fat deposition rate 
(FDR) during the finishing period, but while it seems to be important to highlight this 
phenomenon, it is also difficult to find a logical and substantiated explanation. 
Moreover, the total lipid content of fish muscle was not significantly influenced by 
the dietary treatment during both phases, indicating that the dietary ALA/LA ratio 
has no major effect on Murray cod lipid deposition in fillet. This is in agreement with 
previous studies evaluating the effects of dietary ALA/LA ratio (Turchini et al., 
2007c ; Blanchard et al., 2008). 
 
Irrespective of the AO treatment, different patterns of accumulation of certain fatty 
acids were noted in fish fillets at the end of the grow-out period. The rates of 
deposition of LA appeared higher than that of ALA proportionate to their dietary 
inclusion levels which was also apparent by the decreased ALA/LA ratios in fish 
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fillets than in the respective diets. On average, fillet LA and ALA percent values 
were equivalent to 82% and 64% of dietary percentage values, respectively. This 
supported the apparent preferential utilisation detected between ALA vs. LA, where 
ALA appeared to be more catabolised or bioconverted (Francis et al., 2009) and LA 
tended to be directly deposited in the fish tissues (Trushenski et al., 2008; Francis et 
al., 2009). The final n-3 LC-PUFA content of fish fillets was higher than the 
concentrations in corresponding diets. However, and as expected, feeding Murray 
cod with AO-based diets reduced the final fillet contents of n-3 LC-PUFA compared 
to FO fed group (MC-FO). However, an interesting and significant trend towards 
increased n-3 LC-PUFA content in fish receiving higher dietary ALA/LA ratios was 
recorded, clearly indicating that Murray cod were actively elongating and 
desaturating dietary ALA, and that higher levels of dietary LA, a substrate 
competitor for the same elongase and desaturase enzymes, can negatively impact on 
this metabolism and the final n-3 LC-PUFA content of fish fillets (Sargent et al., 
2002; Turchini et al., 2009). 
 
Following the reversion to the fish oil finishing diet most of the differences in the 
fatty acid profiles of fish groups previously fed AO diets tended to diminish, as 
reported in previous studies (Turchini et al., 2006b, 2007a; Palmeri et al., 2009). 
During the finishing period, the levels of ALA were, on average, reduced by 50% 
from those at the commencement of the wash-out period whilst the levels of LA in 
fillets were still relatively high and only reduced by an average of 40% from the 
starting concentrations. Thus, it is evident that not only LA is preferentially 
deposited into fish fillets, but also preferentially retained during a finishing/wash-out 
period, as previously suggested (Turchini et al., 2009). 
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Re-feeding with a FO finishing diet for 42 days effectively increased the EPA and 
DHA contents in fillets of fish previously fed AO diets enhancing the nutritional 
value of Murray cod fillets from a human nutritional point of view. Interestingly, 
significantly higher retention levels of both EPA and DHA (per 100 g of fillet) were 
observed in fish groups previously fed AO-based diets with a higher ALA/LA ratio. 
Regardless of their dietary levels in the finishing diet, the levels of DHA in fillets 
tended to be retained in higher levels compared to EPA in all fish groups, denoting 
the high utilisation of EPA for metabolic activities by the fish. However, the retained 
levels of both EPA and DHA were still significantly lower (P<0.05) in finishing 
groups previously fed AO-based diets than that in the reference group continuously 
fed with the FO diet, denoting that the 42-day finishing period was not sufficient 
enough to achieve a 100% recovery of these health promoting and biologically active 
n-3 LC-PUFA. Similar observations were noted in previous studies conducted on 
Murray cod (Turchini et al., 2006b; Palmeri et al., 2009) and other species (Regost et 
al., 2003; Bell et al., 2004; Fountoulaki et al., 2009 ; Trushenski and Boesenberg, 
2009) which employed a finishing strategy following a grow-out phase with plant oil 
based diets. 
 
As a result of slightly higher feed consumption rates (though not statistically 
significant), fish receiving treatments MC-1.0 - MC-2.9 received greater amounts of 
EPA+DHA during the finishing period. However, the administered levels of total 
EPA+DHA are considered similar to all other treatments as the levels were not 
significantly different from each other. Percentage deposition/retention values of 
EPA+DHA, which ranged from 7.8 – 11.0%, indicate that Murray cod are relatively 
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inefficient in depositing EPA+ DHA in the fillet. Roughly 90% of dietary EPA and 
DHA was catabolised or deposited in the non-edible portions of the fish, such as 
head, pervisceral or subcutaneous fat, liver and other organs. Fish groups previously 
receiving diets of higher ALA/LA (MC-1.6 and MC-2.9) appeared to be more 
efficient in depositing EPA+DHA, than other treatments.  However, MC-1.6 and 
MC-2.9 recorded the same deposition efficiency of fish previously fed the FO diet. 
This observation reveals that fish previously fed with high LA (MC-0.3, MC-0.6 and 
MC-1.0) were actually depositing less EPA+DHA. Therefore, it is reasonable to 
speculate that a high level of LA in the diet may affect the overall efficiency of the 
finishing strategy. 
 
In the present study, the dilution model proposed by Robin et al., (2003) was 
employed to predict the fatty acid composition after the dietary shift to a FO diet. 
The predicted and observed percentage values of fatty acids in fillets conformed well 
to the dilution model (when plotted for all fatty acids in the profile) irrespective of 
the dietary treatments, confirming the results obtained for Murray cod in a previous 
study (Turchini et al., 2006b). This was further supported by the predicted and actual 
percentages of major fatty acid classes which fell close to the line of equity denoting 
the suitability of the model theory to the fillets of Murray cod. 
 
The high n6-PUFA retention, mainly, LA, in all AO fed fish seemed to be the main 
cause for the modified n-3/n-6 ratios. However, the differences of the ratio between 
reference and finishing test groups at the beginning and end of finishing phase 
diminished with the wash-out diet as reported in previous studies (Turchini et al., 
2006b, 2007a; Palmeri et al., 2009). The low coefficient of distance values at the end 
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of finishing trial further confirmed that the fatty acid profiles of re-fed AO groups 
(except MC-0.3) returned to normal variability within 42 days, when referring to the 
specific threshold value of normal fatty acid variability in Murray cod of 13.5 
reported by Turchini, et al. (2006b). MC-1.0, which obtained the lowest D value 
(11.1) along with the highest percentage recoveries of EPA and DHA, performed 
well during the finishing period, attaining a beneficial fatty acid profile desired for 
human consumption. However, a finishing period of 42 days does not appear to be 
sufficient to achieve a FO-like fatty acid profile by any AO group under the present 
study when compared with the threshold value of normal fatty acid variability of 7.7 
reported by Bottino (1974). 
 
The present study highlights that an increased ratio of ALA/LA in diets or complete 
replacement of fish oil by alternative oils does not impair growth performance or 
tissue lipid content of juvenile Murray cod. However, dietary the ALA/LA ratio 
significantly impacts on final fatty acid make-up and nutritional quality of fish fillets. 
The results of the present study suggest that high dietary LA contents may have 
significant negative impacts on the efficiency of a finishing strategy, and in general, 
that alternative oils rich in LA should be used cautiously when replacing fish oil. 
104 
 
CHAPTER 4 
 
Effects of dietary α-linolenic acid (18:3n-3) / linoleic acid (18:2n-6) ratio on fatty 
acid metabolism in Murray cod (Maccullochella peelii peelii) 
 
A peer reviewed publication has resulted from this chapter: 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of 
Dietary alpha-Linolenic Acid (18:3n-3)/Linoleic Acid (18:2n-6) Ratio on Fatty Acid 
Metabolism in Murray Cod (Maccullochella peelii peelii). Journal of Agricultural 
and Food Chemistry. 59, 1020-1030. 
 
4.1 Introduction 
Previous studies have revealed that Murray cod can bioconvert C18 PUFA to LC-
PUFA when dietary fish oil is substituted with vegetable oil sources (Turchini et al., 
2006b Francis et al., 2007a). A recent study on this species evaluated the effects of 
total dietary C18 PUFA (ALA+LA, at a constant ALA/LA ratio of 1/1) on the LC-
PUFA bioconversion pathway, revealing that the absolute quantitative production of 
Δ-6 desaturated fatty acids was proportional to substrate availability, but the maximal 
efficiency of the Δ-6 desaturase enzyme was reached at an average substrate 
availability (Francis et al., 2009). In line with the above study, the present study was 
specifically designed to gain a better understanding of the role of dietary ALA and 
LA on LC-PUFA bioconversion metabolism in Murray cod. Specifically, the present 
study aimed to evaluate the effects of different ALA to LA ratios, while maintaining 
a constant level of C18 PUFA (ALA+LA). This information is envisaged to further 
expand knowledge relative to the existing relationships between dietary fatty acids 
and the resultant in vivo fatty acid metabolism, ultimately providing new insights into 
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more efficient fish oil replacement strategies for implementation in aquaculture 
nutrition. 
 
4.2 Materials & Methods 
Animals and husbandry methodologies used for this experimentation were described 
in Chapter 2. 
 
4.2.1 Experimental diets 
The formulation of experimental diets, preparation and storage for this particular 
experiment (feeding trail 1-Part b) were the same as for the feeding trial 1-Part a 
described in details in the preceding chapter (Chapter 3-section 3.2.1). 
 
Briefly, the five AO-based experimental diets were formulated to obtain increasing 
ratios of ALA/LA, with a constant level of total C18 PUFA (~51%)  (Table 3.1) and 
they were designated as MC-0.3, MC-0.6, MC-1.0, MC-1.6 and MC-2.9 representing 
their corresponding ALA/LA ratios. The sixth / control diet (MC-FO) was 
formulated using FO as the sole dietary lipid source. 
 
4.2.2 Experimental Design 
The experimental design and the data collected immediately before, during and at the 
end of feeding trial using AO-based diets were the same of the feeding experiment  
(feeding trial 1-Part a) in Chapter 3. However, in this study, only the initial grow-out 
trial was assessed and the subsequent finishing period was not considered. Feaces 
samples from each experimental tank were collected during the last week of the 74- 
day grow-out period.  
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4.2.2 Chemical analyses 
The samples subjected to chemical analysis included six experimental diets, whole 
bodies (3 fish per tank; 12 fish per treatment) and faeces (3 samples per treatment) of 
Murray cod obtained at the end of feeding trial with AO-based experimental diets.   
Proximate analysis, Fatty acid analysis and Chromic acid analysis and subsequent 
calculations of digestibility for each individual fatty acid were carried out according 
to the procedures and formulae mentioned in General Materials and Method (Chapter 
2). 
 
4.2.3 Calculation of growth, biometric and feed utilization parameters  
Growth, biometric and feed utilization parameters and fatty acid digestibility were 
determined using the formulae described in Chapter 2. 
 
4.2.4 Determination of in vivo β-oxidation, desaturase and elongase activity 
The estimation of the apparent in vivo fatty acid metabolism (fatty acid de novo 
production, β-oxidation, elongation and desaturation) was calculated via the 
implementation of the whole body fatty acid balance method briefly explained in 
Chapter 2 of this thesis and initially proposed and fully described by Turchini et al. 
(2007b) with subsequent developments (Turchini et al., 2008; Turchini and Francis, 
2009).  
 
4.2.5 Statistical analysis 
Statistical analyses were performed as described in Chapter 2. In addition, data were 
analyzed further by linear or non-linear regression where appropriate, and computed 
using GraphPad Prism version 5.02 for Windows (GraphPad Software, San Diego, 
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CA, USA). After analysis of the residual plots, the simplest model able to efficiently 
describe the trend was selected and reported. In all instances, the full equation and 
the 95% confidence band of the regression line is reported. For linear regression 
analyses, the R2 value and P value describing the slope of deviation from zero were 
computed. Only linear regressions with a significant slope of deviation from zero 
(P<0.05) were reported. For curvilinear regression analyses, R2 values and the P 
values relative to the D’Agostino-Pearson test of normality of residuals were 
computed. Only curvilinear regression analyses with normally distributed residuals 
(P>0.1) were reported. 
 
4.3 Results 
The six experimental diets were iso-proteic and iso-lipidic and the main differences 
between them were relative to their fatty acid composition (Table 4.1). Fatty acid 
analysis of different experimental diets (MC-0.3 to MC-2.9) clearly showed that the 
formulated composition was achieved with specific ALA/LA ratios of 0.3, 0.6, 1.0, 
1.6 and 2.9 in diets MC-0.3 to MC-2.9, respectively and a constant total amount of 
C18 PUFA (ALA+LA) at ~51% (Table 4.1). The levels of SFA, MUFA, PUFA and 
LC-PUFA were close to identical across all five experimental diets (MC-0.3 to MC-
2.9). In these diets, the amounts of EPA ranged from 20 to 21 mg g lipid-1 (2.2 to 
2.4% of total fatty acids) and DHA from 37 to 40 mg g lipid -1 (4.2 to 4.4% of total 
fatty acids). This LC-PUFA was derived from the lipid content of the fishmeal 
included in the formulation. The control diet (MC-FO), which was formulated with 
the inclusion of fish oil, was characterized by a high content of n-3 LC-PUFA, 
consisting mainly of EPA (106 mg g lipid -1, 13.8%) and DHA (90 mg g lipid-1, 
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11.7%). The MC-FO also contained a notably higher concentration of SFA and lower 
concentrations of PUFA in comparison to treatments MC-0.3-MC-2.9. 
 
During the 74-day experimental period, the overall mortality was low and not 
influenced by the dietary treatment. All experimental diets were well accepted by all 
treatment groups, and subsequently, no significant differences (P>0.05) were noted 
in feed intake which ranged from 91.5 to 105.0 g of diet per fish. There was a four-
fold increase in fish weights across the six dietary treatments with no significant 
differences (P>0.05) recorded for growth performance or feed efficiency parameters. 
Briefly, Murray cod achieved a SGR ranging from 2.2 to 2.5 (% day-1), with FCR 
and PER values ranging from 1.1 to 1.3 and 1.6 to 1.8, respectively.  Detailed 
information on growth results, feed efficiency and fillet chemical and fatty acid 
modification have been reported in a separate previous report (Senadheera et al., 
2010). 
 
The total lipid content of fish whole bodies showed no significant differences 
amongst treatments, whilst the dietary fatty acid make-up was clearly mirrored in the 
fish body (Table 4.2). In general, and as expected, fish fed the MC-FO diet had the 
highest levels of LC-PUFA in comparison to the five experimental groups. The 
overall fatty acid classes of whole bodies of fish fed the five experimental diets (MC-
0.3 to MC-2.9) were close in terms of SFA (~185 mg g lipid-1) and PUFA (~485 mg 
g lipid-1) concentrations. Within the PUFA class, the content of ALA and LA clearly 
reflected the composition of the experimental diets and the ALA/LA ratios of whole 
bodies tended to increase, recording 0.3, 0.5, 0.7, 1.2 and 2.0 in MC-0.3 through 
MC-2.9, respectively. Comparatively lower ALA/LA ratios in fish tissue in contrast 
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to that of the experimental diets were recorded, with this trend tending to amplify as 
the treatments progressed from MC-0.3 through MC-2.9. Irrespective of their 
identical dietary levels, clear trends manifested in the whole body content of n-3 and 
n-6 LC-PUFA among the treatment groups (MC-0.3-MC-2.9). In particular, 
significantly higher levels (P<0.05) of all fatty acids along the n-3 desaturation and 
elongation pathway (namely, 18:4n-3, 20:3n-3 and 20:4n-3) were found in fish 
receiving diets with higher ALA/LA ratios (Table 2). However, no statistically 
significant differences were noted in the concentrations of EPA, docosapentaenoic 
acid (22:5n-3, DPA) and DHA, even though the same numerical trend was present. 
Despite the corresponding dietary levels, the whole bodies contained higher levels of 
DHA compared to EPA in all dietary groups. 
 
The results of the first step of the whole body balance method, reporting the 
individual fatty acid appearance/disappearance (mg of fatty acid per fish) during the 
experimental period are reported in Table 4.3. The highest disappearance of fatty 
acids in the MC-FO group was recorded for EPA followed by 16:0, 16:1n-7 and 
14:0, while in the five experimental treatments, the highest disappearance was 
recorded for LA (MC-0.3 and MC-0.6) and ALA (MC-1.0, MC-1.6 and MC-2.9 
groups). Fish receiving MC-0.3 recorded a greater appearance of fatty acids along 
the n-6 desaturation and elongation pathway, whereas fish receiving the MC-2.9 diet 
had the highest appearance of fatty acids along the n-3 desaturation and elongation 
pathway. In the MC-FO group, a significant appearance of DPA was noted (P<0.05). 
 
The apparent in vivo fatty acid β-oxidation (μmol g-1 day-1) of major fatty acid 
classes is shown in Figure 4.1(A-D). Fish fed a higher ratio of ALA/LA exhibited a 
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numerically higher (though not significant, P>0.05) oxidation of SFA and MUFA 
(Fig 1A). n-6 PUFA were oxidized at significantly higher level (P<0.05) in 
treatments with higher LA (Figure 4.1B), and higher n-3 PUFA oxidation was 
observed in treatments fed with higher ALA (Figure 4.1C). Total fatty acid 
oxidation, though not significantly different (P>0.05), was higher in groups fed the 
five experimental diets in comparison to fish receiving the MC-FO treatment, and, 
amongst the five experimental treatments, an increasing trend was evident with the 
increasing ALA/LA ratio (Figure 4.1D). 
 
The apparent in vivo β-oxidation of individual major fatty acids, reported as a 
percentage of net intake is reported in Table 4.4. The only statistically significant 
difference was a lower level of LA β-oxidation in the MC-FO treatment in 
comparison to all other treatments. Among the five experimental treatments, LA was 
oxidized at ~36%, with no clear trend amongst treatments, while ALA was oxidized 
in the range of 40 to 48%, with a noticeable increasing trend towards the higher 
dietary inclusion levels of ALA. In general, the β-oxidation of oleic acid (OA, 18:1n-
9) (as % of net intake) was lower than that of LA and ALA and followed the order of 
ALA>LA>OA. Moreover, though no statistically significant differences were noted, 
a trend towards increased SFA and MUFA oxidation in higher ALA diets was 
observed, with, for example, 16:0 varying from 22.5% to 38.2% and OA from 27.1% 
to 33.3% in MC-0.3 and MC-2.9, respectively. Amongst LC-PUFA, EPA was highly 
oxidized (>65%), whilst the oxidation of DHA was significantly lower (~27%). 
 
Total neogenesis of fatty acids was minimal and only detected in MC-0.3 and MC-
0.6 (0.028±0.028 and 0.004±0.004 μmol g-1 fish day-1, respectively). The apparent in 
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vivo elongase activity is reported in Figure 4.2. In general, the large variability of 
data resulted in a lack of statistically significant differences, even if clear trends were 
evident. Independent of the dietary treatments, higher elongase activity was recorded 
on n-3 PUFA, followed by n-6 PUFA, with minimal elongase activity recorded on 
SFA and MUFA. The fatty acid elongase activity on n-6 PUFA and n-3 PUFA 
decreased and increased, respectively with the elevated dietary ALA/LA ratios, 
resulting from the provision of more or less substrate. High in vivo apparent elongase 
activity acting on n-3 PUFA (mainly ascribable to EPA being elongated to DPA) was 
observed in the MC-FO treatment, while the activity acting on n-6 fatty acids was 
negligible. 
 
No apparent in vivo desaturase (Δ-9, Δ-6 nor Δ-5) activity was detected in fish fed 
the MC-FO treatment and no Δ-5 desaturase activity was observed in any of the 
experimental treatments (Figure 4.3). On the other hand, Δ-6 desaturase activity on 
n-6 and n-3 fatty acids was apparent and tended to decrease and increase, 
respectively from MC-0.3 to MC-2.9, in synchrony with the increasing dietary 
ALA/LA ratio. Interestingly, the highest apparent Δ-6 desaturase activity acting on 
ALA (0.1320 μmol g-1 day-1) was recorded not in fish receiving the highest ALA 
supply (MC-2.9), but in fish receiving MC-1.6, while the highest activity acting on 
LA (0.0960 μmol g-1 day-1) was detected in fish receiving the highest concentration 
of this fatty acid (MC-0.3). 
 
The relationships between in vivo apparent Δ-6 desaturase activity acting on LA and 
ALA against their respective net dietary inclusion, expressed as μmol g-1 day-1 or 
percentage of net intake, are shown in Figures 4.4 and 4.5, respectively. In the case 
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of LA, a positive linear regression described the relationship between dietary content 
(substrate availability) and enzyme activity when expressed as μmol g-1 day-1. 
However, when expressed as a percentage of net intake, the trend was better 
described by a second order polynomial equation (Figure 4.4). Similarly, the 
relationship between apparent Δ-6 desaturase activity acting on ALA (as μmol g-1 
day-1) and its net intake level could also be described by a second order polynomial 
equation, which showed that the rate of increase was proportionally reduced with the 
increase of substrate availability following a peak at the net intake of 3.2186 μmol g-1 
day-1(Figure 4.5). The relative apparent Δ-6 activity acting on ALA (as a percentage 
net intake), described by a negative second order polynomial equation showed that 
the actual efficiency of the enzyme was reduced by an increase in substrate 
availability. The total apparent in vivo Δ-6 desaturase activity (on ALA and LA) 
expressed as both, percentage of net intake and as μmol g fish-1 day-1, in relation to 
the dietary ALA/LA ratio is shown in Figure 4.6. Both relationships were described 
by second order polynomial equations, with the activity tending to increase with the 
increasing dietary ALA/LA ratio. This activity peaked at a ratio of 1.60 and 1.47 for 
percentage of net intake and μmol g fish-1 day-1, respectively, and then tended to 
decrease as the dietary ALA/LA ratio elevated. The maximum activity was detected 
in MC-1.6, therefore indicating that an ALA/LA ratio of 1.54 (the mean value of the 
two peaks computed on the two regression lines) is the most efficient ratio for 
maximal fatty acid Δ-6 desaturase activity in juvenile Murray cod. 
 
The relationship between the percentages of total apparent in vivo Δ-6 desaturase 
activity acting on ALA or LA against the in vivo available substrate ratio (dietary 
ALA/LA ratio) is reported in Figure 4.7. Essentially, the greater the amount of ALA, 
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the greater the rate of desaturation and vice versa for the amount of dietary LA. 
Additionally, by plotting these equations, it is noted that the theoretical maximum 
percentage activity on ALA was 91.89% and the minimum percentage activity acting 
on LA was 8.11% independent of the ALA/LA ratio in the diets. 
 
Figure 4.8 describes the relationship between the dietary ALA/LA ratio and the ratio 
of Δ-6 desaturase activity on the two substrates (activity on ALA / activity on LA 
ratio). A linear regression equation (with a slope of 3.2) best described this 
relationship. Thus, it was clearly shown that the Δ-6 desaturase activity acting on 
ALA, across either experimental treatment (MC-0.3-MC-2.9), was higher than the 
activity on LA (evident if compared to the line of equity), clearly indicating that the 
affinity of the Δ-6 desaturase was 3.2 fold higher for ALA in comparison to LA. 
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Table 4.1 Fatty acid composition of the Murray cod experimental diets used for the 
1st feeding trial for 74 days 
  Dietary treatments1 
  MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
Fatty acids (mg g lipid-1, % in parenthesis)  
14:0 61.8(8.0) 10.1(1.2) 11.8(1.3) 11.5(1.3) 13.0(1.5) 13.4(1.6) 
16:0 171.8(22.4) 92.4(10.7) 103.7(11.2) 101.7(11.6) 107.5(12.1) 107.7(12.5) 
18:0 38.0(4.9) 37.1(4.3) 43.3(4.7) 43.9(5.0) 48.3(5.4) 49.3(5.7) 
20:0 2.1(0.3) 2.2(0.3) 2.0(0.2) 1.7(0.2) 1.7(0.2) 1.5(0.2) 
22:0 1.4(0.2) 3.7(0.4) 3.3(0.4) 2.5(0.3) 1.9(0.2) 1.3(0.1) 
24:0 0.6(0.1) 1.0(0.1) 1.7(0.2) 0.2(0.0) 0.2(0.0) 0.2(0.0) 
16:1n-7              72.8(9.5) 12.7(1.5) 14.1(1.5) 13.7(1.6) 14.5(1.6) 14.6(1.7) 
18:1n-9              82.3(10.7) 164.5(19.1) 169.4(18.3) 153.2(17.5) 146.4(16.5) 133.9(15.6) 
18:1n-7              24.1(3.1) 12.0(1.4) 13.5(1.5) 13.1(1.5) 13.9(1.6) 14.3(1.7) 
20:1n-11 1.2(0.2) 0.7(0.1) 0.8(0.1) 0.7(0.1) 1.01.0(0.1) 1.1(0.1) 
20:1n-9 8.4(1.1) 3.8(0.4) 4.1(0.4) 3.9(0.4) 3.9(0.4) 3.7(0.4) 
22:1n-11 4.8(0.6) 1.5(0.2) 1.5(0.2) 1.4(0.2) 1.4(0.2) 1.4(0.2) 
22:1n-9 1.6(0.2) 0.8(0.1) 0.8(0.1) 0.8(0.1) 0.7(0.1) 0.7(0.1) 
24:1n-9  0.2(0.0) 1.0(0.1) 1.3(0.1) 1.7(0.2) 1.9(0.2) 2.2(0.3) 
18:2n-6  33.0(4.3) 338.3(39.3) 303.5(32.7) 230.4(26.3) 175.8(19.8) 113.6(13.2) 
18:3n-6   3.2(0.4) 0.7(0.1) 0.8(0.1) 0.8(0.1) 1.0(0.1) 1.0(0.1) 
20:2n-6              1.4(0.2) 0.7(0.1) 0.6(0.1) 0.8(0.1) 0.7(0.1) 0.8(0.1) 
20:3n-6              1.5(0.2) 0.4(0.0) 0.4(0.0) 0.4(0.0) 0.3(0.0) 0.4(0.0) 
20:4n-6              11.5(1.5) 4.4(0.5) 4.7(0.5) 4.5(0.5) 4.7(0.5) 4.1(0.5) 
22:2n-6              n.d. n.d. 0.2(0.0) n.d. 0.3(0.0) 0.3(0.0) 
22:4n-6              1.7(0.2) 0.6(0.1) 0.6(0.1) 0.6(0.1) 0.6(0.1) 0.7(0.1) 
18:3n-3              9.4(1.2) 106.5(12.4) 174.6(18.8) 222.4(25.4) 281.4(31.6) 325.7(37.8) 
18:4n-3              14.6(1.9) 2.4(0.3) 3.0(0.3) 2.8(0.3) 2.9(0.3) 3.0(0.3) 
20:3n-3              0.9(0.1) 0.4(0.0) 0.5(0.1) 0.6(0.1) 0.6(0.1) 0.5(0.1) 
20:4n-3              6.5(0.9) 1.2(0.1) 1.2(0.1) 1.1(0.1) 1.2(0.1) 1.1(0.1) 
20:5n-3              106.1(13.8) 19.9(2.3) 21.2(2.3) 19.6(2.2) 20.7(2.3) 20.9(2.4) 
22:5n-3              17.9(2.3) 4.5(0.5) 4.7(0.5) 4.5(0.5) 4.6(0.5) 4.6(0.5) 
22:6n-3              89.5(11.7) 37.5(4.4) 40.3(4.3) 37.2(4.2) 38.7(4.4) 39.0(4.5) 
SFA 275.7(35.9) 146.5(17.0) 165.8(17.9) 161.5(18.4) 172.5(19.4) 173.5(20.2) 
MUFA 195.5(25.4) 196.9(22.9) 205.5(22.2) 188.6(21.5) 183.6(20.6) 171.7(19.9) 
PUFA 297.1(38.7) 517.4(60.1) 556.3(60.0) 525.6(60.0) 533.5(60.0) 515.7(59.9) 
n-6 PUFA 52.2(6.8) 345.1(40.1) 310.9(33.5) 237.5(27.1) 183.3(20.6) 121.0(14.0) 
n-6 LCPUFA 16.0(2.1) 6.0(0.7) 6.4(0.7) 6.2(0.7) 6.3(0.7) 6.0(0.7) 
n-3 PUFA 244.9(31.9) 172.3(20.0) 245.4(26.5) 288.1(32.9) 350.1(39.4) 394.7(45.8) 
n-3 LCPUFA 220.9(28.8) 63.4(7.4) 67.9(7.3) 62.9(7.2) 65.8(7.4) 66.1(7.7) 
ALA+LA2  42.4(5.5) 444.8(51.7) 478.1(51.5) 452.8(51.7) 457.2(51.4) 439.3(51.0) 
n3/n63 4.7 0.5 0.8 1.2 1.9 3.3 
ALA/LA4 0.3 0.3 0.6 1 1.6 2.9 
 
1 See Table 3.1 for diet abbreviations  
2Sum of ALA (α-linolenic acid, 18:3n-3) and LA (linoleic acid, 18:2n-6) 
3Ratio of total Omega 3 fatty acids to Omega 6 fatty acids  
4Ratio of ALA (ά-linolenic acid, 18:3n-3) to LA (linoleic acid, 18:2n-6) 
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 Table 4.2 Fatty acid composition (mg g of lipid-1) of Murray cod whole bodies at 
the commencement and end of the feeding trial2 
        Dietary Treatments1     
Fatty acids Initial MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 47.2 59.2±1.2b 17.4±0.6a 18.0±1.4a 17.3±0.2a 18.1±0.2a 18.5±0.5a 
16:0 171.2 181.5±1.4b 122.5±2.1a 128.8±2.4a 121.8±1.8a 126.1±3.2a 124.0±3.3a 
18:0 38.6 37.8±0.6a 39.8±0.6ab 42.2±0.9b 41.1±0.6b 42.3±1.0b 42.1±0.9b 
20:0 1.3 1.4±0.0b 1.3±0.0b 1.3±0.1b 1.1±0.0a 1.1±0.1a 1.0±0.0a 
22:0 0.9 1.0±0.0b 1.8±0.0e 1.5±0.0d 1.2±0.1c 1.0±0.0b 0.8±0.0a 
24:0 0.5 0.2±0.0 0.1±0.0 0.1±0.0 0.1±0.1 0.4±0.2 0.2±0.1 
16:1n-7 64.4 78.8±1.3b 23.3±0.7a 24.3±0.8a 23.0±0.6a 24.3±0.6a 24.5±0.5a 
18:1n-9 187.8 123.7±4.9a 195.5±2.7d 191.0±1.2d 179.7±3.4c 175.8±1.6c 164.9±0.4b 
18:1n-7 32.5 31.5±0.2b 18.3±0.3a 18.9±0.2a 18.3±0.2a 19.1±0.1a 19.3±0.3a 
24:1n-9 0.1 0.1±0.0a 0.2±0.1ab 0.4±0.1bc 0.7±0.1cd 0.7±0.1cd 0.9±0.1d 
20:1n-11 1.6 1.1±0.1b 0.7±0.1a 0.7±0.1a 0.7±0.1a 0.8±0.1a 0.8±0.1a 
20:1n-9 15.3 9.3±0.5b 6.6±0.2a 6.6±0.4a 6.1±0.2a 6.0±0.2a 6.0±0.4a 
22:1n-11 5.1 3.1±0.1b 1.4±0.1a 1.4±0.2a 1.3±0.1a 1.3±0.1a 1.4±0.1a 
22:1n-9 1.9 1.3±0.1b 0.9±0.0a 1.0±0.1a 0.8±0.0a 0.8±0.0a 0.9±0.1a 
18:2n-6 55.7 50.1±1.4a 294.7±4.3f 246.6±3.4e 203.2±4.4d 161.1±2.9c 109.9±2.1b 
18:3n-6 3.9 3.2±0.3a 10.0±0.3e 8.3±0.3d 7.0±0.2c 5.5±0.1b 3.6±0.1a 
20:2n-6 1.4 1.8±0.16a 4.2±0.1e 3.4±0.0d 2.8±0.1c 2.3±0.1b 1.9±0.0a 
20:3n-6 1.5 2.0±0.1c 3.3±0.1e 2.6±0.1d 2.0±0.0c 1.6±0.0b 1.2±0.0a 
20:4n-6 11.1 13.2±0.3b 5.7±0.2a 5.6±0.3a 5.7±0.1a 5.9±0.2a 6.1±0.3a 
22:2n-6 0.1 0.0±0.0a 0.4±0.0d 0.4±0.0cd 0.3±0.0bc 0.3±0.1b 0.3±0.0b 
22:4n-6 1.8 2.5±0.1b 1.2±0.1a 1.1±0.1a 1.1±0.0a 1.1±0.0a 1.1±0.0a 
18:3n-3 8.6 10.3±0.2a 76.7±1.4b 114.1±2.9c 152.2±2.0d 188.9±2.8e 220.8±12.1f 
18:4n-3 12.6 13.3±0.2c 8.4±0.3a 10.5±0.3b 12.7±0.1c 15.7±0.4d 15.8±0.2d 
20:3n-3 0.8 1.1±0.0a 4.1±0.1b 5.4±0.1c 6.8±0.2d 7.9±0.1e 9.0±0.5f 
20:4n-3 7.3 9.0±0.2d 5.8±0.2a 7.1±0.2b 8.2±0.1c 9.6±0.0d 9.8±0.2d 
20:5n-3 81.8 71.0±1.5b 18.5±0.7a 18.7±2.5a 18.8±0.5a 19.9±1.3a 21.4±2.1a 
22:5n-3 41.5 46.7±1.3b 15.8±0.6a 15.7±1.2a 15.6±0.4a 16.2±0.6a 17.1±1.1a 
22:6n-3 85.0 109.1±2.3b 49.7±0.6a 50.6±2.0a 51.1±1.0a 52.1±1.4a 54.1±2.1a 
SFA 259.6 281.0±2.1b 182.9±2.9a 192.0±2.0a 182.7±2.7a 188.9±3.8a 186.6±4.0a 
MUFA 308.7 248.9±4.9c 247.0±3.6c 244.4±0.9c 230.7±4.4b 228.8±2.1b 218.6±1.0a 
PUFA 313.0 333.4±6.7a 498.6±5.5b 490.3±2.2b 487.5±8.1b 487.9±3.1b 472.0±9.7b 
n-6 PUFA 75.5 72.7±1.6a 319.6±4.5f 268.1±3.2e 222.1±4.8d 177.8±2.8c 124.0±1.8b 
n-6 LC-PUFA 15.9 19.4±0.4e 14.9±0.5d 13.2±0.3c 11.9±0.2b 11.2±0.2ab 10.5±0.4a 
n-3 PUFA 237.5 260.6±5.4c 179.0±1.7a 222.2±3.4b 265.4±3.5c 310.1±0.8d 348.0±8.0e 
n-3 LC-PUFA 216.3 237.0±5.1c 93.9±2.0a 97.5±5.7ab 100.5±1.9ab 105.5±3.1ab 111.4±4.9b 
ALA+LA3 64.3 60.4±1.5a 371.4±5.7c 360.7±6.4c 355.3±5.8bc 350.0±3.2bc 330.6±14.1b 
n3/n64 3.1 3.6±0.1f 0.6±0.0a 0.8±0.0b 1.2±0.0c 1.7±0.0d 2.8±0.0e 
ALA/LA5 0.2 0.2±0.0a 0.3±0.0a 0.5±0.0b 0.7±0.0c 1.2±0.0d 20±0.1e 
 
1See Table 3.1 for diet abbreviations  
2Data are reported as the mean ± S.E.M (N = 4). Values in the same row with the same letter are not significantly different  
(P < 0.05; ANOVA and Student–Newman–Keuls post hoc test, n = 4); initial sample was not included in the statistical 
analysis 
3Sum of ALA (α-linolenic acid, 18:3n-3) and LA (linoleic acid, 18:2n-6) 
4Ratio of total Omega 3 fatty acids to Omega 6 fatty acids  
5Ratio of ALA (α-linolenic acid, 18:3n-3) to LA (linoleic acid, 18:2n-6)  
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Table 4.3 Individual fatty acid appearance/disappearance (mg fish-1)2  
 
 Dietary treatments1 
Fatty acids MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 -329.5±44.3a -35.6±10.1b -37.2±10.3b -55.6±11.6b -67.1±12.4b -83.9±21.5b 
16:0 -715.6±123.0 -235.9±104.3 -202.9±131.2 -401.8±81.7 -424.1±125.7 -552.6±170.9 
18:0 -164.2±20.9ab -110.7±32.6b -128.1±43.0b -204.2±28.5ab -249.5±31.7ab -298.1±62.5a 
20:0 -16.0±1.2 -14.5±1.5 -11.8±1.5 -12.5±1.0 -13.1±0.8 -12.3±1.6 
22:0 -10.3±0.7d -26.4±2.3a -24.5±1.9ab -20.1±1.3bc -16.4±0.8c -10.2±1.3d 
24:0 -7.2±0.6c -9.8±0.4b -18.3±0.9a -1.9±0.4d 0.2±1.2d -1.6±0.5d 
16:1n-7 -330.2±59.0a -36.2±17.4b -22.9±16.3b -52.7±15.8b -50.5±23.7b -72.9±25.7b 
18:1n-9 -149.5±53.5 -574.8±142.8 -523.2±163.8 -635.9±121.2 -568.3±134.1 -623.3±205.6 
18:1n-7 -56.1±21.3 -30.4±13.7 -28.8±15.2 -50.5±11.6 -53.2±15.1 -74.0±21.8 
20:1n-11 -8.3±0.7a -4.5±0.7b -5.7±0.2ab -6.9±1.1ab -7.8±0.5ab -8.9±1.5a 
20:1n-9 -45.1±4.2a -10.6±3.8b -7.9±3.7b -16.6±2.8b -17.8±2.4b -21.7±5.1b 
22:1n-11 -44.6±2.6a -12.3±1.4b -12.5±1.5b -13.5±0.9b -14.4±0.6b -13.6±1.6b 
22:1n-9 -9.9±0.7a -3.5±0.6b -2.5±1.2b -4.0±0.5b -3.9±0.6b -3.5±0.8b 
24:1n-9 -1.8±0.3e -10.2±1.0d -12.3±1.0cd -15.3±1.3bc -17.7±0.9ab -20.0±2.3a 
18:2n-6 -30.0±23.2d -1,705.5±257.4a -1,520.3±238.0ab -1,266.9±159.9ab -918.2±102.9bc -620.8±153.1c 
18:3n-6 -18.3±3.4a 76.7±2.8d 70.4±10.4d 51.3±4.4c 36.5±7.6c 14.1±3.2b 
20:2n-6 -3.1±1.1a 27.0±1.2c 24.8±3.7cd 14.6±2.3b 11.5±2.3b 3.4±2.0a 
20:3n-6 -1.4±1.5a 23.6±1.1c 20.3±3.4c 12.7±1.5b 9.7±1.7b 3.9±1.1a 
20:4n-6 -44.9±8.3a -16.7±2.5b -17.0±3.1b -18.9±3.6b -19.5±1.8b -15.7±5.6b 
22:2n-6 -0.1±0.0b 3.9±0.2c 0.8±0.6b 3.0±0.3c -1.8±0.6a -2.2±0.4a 
22:4n-6 -1.6±2.0 0.9±0.5 1.0±1.0 0.4±0.8 -0.4±0.9 -1.5±1.2 
18:3n-3 -40.7±6.1e -599.9±77.0d -1,022.4±121.9cd -1,471.7±130.4bc -1,898.0±116.7ab -2,273.8±389.6a 
18:4n-3 -99.3±9.3a 26.4±4.0b 49.5±8.3bc 65.9±8.0bcd 94.7±16.6d 81.6±14.6cd 
20:3n-3 -2.7±0.8a 30.1±1.4b 47.8±6.5bc 56.8±5.6c 67.7±10.3c 73.1±11.2c 
20:4n-3 -11.3±6.8a 27.3±1.8b 46.0±5.9bc 52.9±5.4bc 67.6±11.5c 61.8±9.0c 
20:5n-3 -993.2±62.8a -206.8±17.7b -214.1±18.5b -208.0±13.8b -217.0±11.4b -220.3±19.7b 
22:5n-3 179.3±40.6b 26.0±6.8a 37.0±7.1a 29.8±10.3a 34.0±10.6a 27.2±10.2a 
22:6n-3 -281.9±74.7 -132.2±32.5 -118.8±36.2 -124.0±34.2 -136.7±21.2 -161.6±49.8 
 
1 Data are reported as the mean ± S.E.M, (N = 4). Values in the same row with the same letter are not 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test, N = 4)  
2 See Table 3.1 for diet abbreviations 
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Table 4.4 Individual apparent in vivo fatty acid β-oxidation (expressed as % of net 
intake) of selected fatty acids (Mean ± S.E.M; N = 4)2 
 
   Dietary treatments1   
 MC-FO MC-0.3 MC-0.6 MC-1.0 MC-1.6 MC-2.9 
14:0 36.5±5.99 26.7±9.06 21.2±8.84 36.2±7.27 39.6±8.17 46.4±10.88 
16:0 29.6±6.47 22.5±7.55 17.2±9.95 30.3±6.05 30.9±9.78 38.2±11.42 
18:0 31.9±5.17 25.8±7.46 25.7±8.68 37.4±5.02 41.8±6.69 47.4±8.80 
18:1n-9 13.0±5.38 27.1±6.41 24.1±7.56 30.3±5.72 29.1±7.19 33.3±10.58 
18:2n-6 6.9±5.53a 36.2±5.17b 35.6±6.37b 37.6±5.08b 36.2±5.10b 38.4±9.44b 
20:4n-6 25.8±5.92 30.3±4.74 27.3±5.80 31.5±6.67 32.4±5.21 28.3±9.92 
18:3n-3 29.3±5.64 40.0±5.45 40.7±6.38 44.4±4.44 45.4±4.95 47.8±8.60 
20:5n-3 50.6±5.24 71.8±7.09 64.2±5.54 67.4±8.06 65.6±5.12 68.7±6.93 
22:6n-3 21.2±6.46 28.3±6.61 23.4±6.76 25.1±6.79 27.2±5.18 30.7±8.88 
 
1See Table 3.1 for diet abbreviations  
2Data are reported as the mean±S.E.M (n = 4). Values in the same row with the same letter are not significantly different (P 
< 0.05; ANOVA and Student–Newman–Keuls post hoc test, n = 4; N=24) 
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Figure 4.2 Apparent in vivo total elongase activity (μmol g fish-1 day-1).
 
 
120 
 
f
b
b
e
bc
b
d
cd
b
c
d
b
b
d
b
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
SF
A+
M
UF
A 
   
   
  
(Δ
-9
 d
es
at
ur
as
e)
n-
6 
PU
FA
   
   
   
  
(Δ
-6
 d
es
at
ur
as
e)
n-
3 
PU
FA
   
   
   
  
(Δ
-6
 d
es
at
ur
as
e)
TO
TA
L 
 P
UF
A 
   
   
(Δ
-6
 d
es
at
ur
as
e)
μm
ol
 g
 fi
sh
-1
da
y-
1
MC-FO
MC-0.3
MC-0.6
MC-1.0
MC-1.6
MC-2.9
a aa
 
 
 
 Figure 4.3 Apparent in vivo total desaturase (Δ-9 and Δ-6) activity (μmol g fish-1 day-1) 
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Figure 4.4 Apparent in vivo Δ-6 desaturase activity on 18:2n-6 expressed as A) % of net 
intake and as B) μmol g of fish-1 day-1, in relationship to the18:2n-6 net intake (μmol g 
of fish-1 day-1). Error bars represent SEM and dotted lines represent 95% confidence 
band of the regression lines. Regression equations: A) Y = - 0.1542X2 + 1.230X - 
0.1705; R2=0.96; test of normality of residuals D’Agostino-Pearson P=0.97. B) 
Y=0.02851X – 0.02327; R2=0.99; slope deviation from zero P<0.0001. 
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Figure 4.5 Apparent in vivo Δ-6 desaturase activity on 18:3n-3 expressed as A) % of net 
intake and as B) μmol g of fish-1 day-1, in relationship to the18:3n-3 net intake (μmol g 
of fish-1 day-1). Error bars represent SEM and dotted lines represent 95% confidence 
band of the regression lines. Regression equations: A) Y = - 0.2097X2 + 0.8483X + 
3.321; R2=0.81; test of normality of residuals D’Agostino-Pearson P=0.77. B) Y= - 
0.009417X2 + 0.07916X + 0.03560; R2=0.96; test of normality of residuals D’Agostino-
Pearson P=0.10. 
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Figure 4.6 Total apparent in vivo Δ-6 desaturase activity (on 18:3n-3 and 18:2n-6) 
expressed as A) % of net intake and as B) μmol g of fish-1 day-1, in relationship to the 
dietary18:3n-3/18:2n-6 ratio. Error bars represent SEM and dotted lines represent 95% 
confidence band of the regression lines. Regression equations: A) Y = - 0.2636X2 + 
0.8440X + 2.484; R2=0.87; test of normality of residuals D’Agostino-Pearson P=0.87. 
B) Y = - 0.0141X2 + 0.04157X + 0.1373; R2=0.90; test of normality of residuals 
D’Agostino-Pearson P=0.84.
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Figure 4.7 Percentage of total apparent in vivo Δ-6 desaturase activity acting on A) 
18:3n-3 and B) 18:2n-6 plotted against the in vivo available substrate ratio (dietary 
18:3n-3/18:2n-6 ratio). Error bars represent SEM and dotted lines represent 95% 
confidence band of the regression lines. Regression equations: A) Y = - 80.78 e-1.160X + 
91.89; R2=0.99; test of normality of residuals D’Agostino-Pearson P=0.81. B) Y = 80.78 
e-1.160X + 8.107; R2=0.99; test of normality of residuals D’Agostino-Pearson P=0.81. 
 
 
125 
 
0 2 4 6 8 10
0
2
4
6
8
10
Line of Equity (Y=X)
Dietary 18:3n-3/18:2n-6 ratio
R
at
io
 o
f '
-6
 d
es
at
ur
as
e 
ac
tiv
ity
 o
n 
th
e 
tw
o 
su
bs
tr
at
es
 (a
ct
iv
ity
 o
n 
18
:3
n-
3/
 a
ct
iv
ity
 o
n 
18
:2
n-
6 
 r
at
io
)
 
 
Figure 4.8 Relationship between the dietary 18:3n-3/18:2n-6 ratio and the ratio of Δ-6 
desaturase activity on the two substrates (activity on 18:3n-3 / activity on 18:2n-6 ratio). 
Error bars represent SEM and dotted lines represent 95% confidence band of the 
regression line. Regression equation: Y=3.275X – 0.09183; R2=0.88; slope deviation 
from zero P<0.0001. The line of equity (Y=X) has also been reported for visual 
reference. 
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4.4 Discussion 
The major focus of the present study was to evaluate the in vivo fatty acid metabolism of 
juvenile Murray cod fed with varying ALA/LA ratios at a constant level of total C18 
PUFA. For more specific details on growth performance, feed utilization and fillet fatty 
acid composition it is suggested to refer to Senadheera et al. (2010) (Chapter 3). 

As expected, across each of the six treatments, there was a clear reflection of the dietary 
fatty acid composition in the whole bodies of Murray cod; an observation consistent 
with previous studies on the same species (Francis et al., 2007a; Francis et al., 2007b; 
Turchini et al., 2006b; Francis et al., 2009 ) and many other species (Bell et al., 1997; 
Blanchard et al., 2008; Turchini et al., 2009). The levels of LC-PUFA particularly EPA 
and DHA were severely affected by diets devoid of fish oil, as previously reported in 
numerous studies (Bell et al., 1997; Bell et al., 2001; Grant et al., 2008; Trushenski and 
Boesenberg, 2009; Rosenlund et al., 2010; Torstensen and Tocher, 2010). However, 
irrespective of the identical levels of total C18 PUFA (ALA+LA) in the five 
experimental diets, it was interesting to note that the corresponding levels in fish whole 
bodies decreased significantly with the increasing dietary ALA/LA ratio, indicating a 
pronounced higher rate of deposition of total C18 PUFA (LA + ALA) in treatments fed 
with high LA diets. In addition, the relatively lower ALA/LA ratios detected in whole 
bodies in comparison to those found in corresponding diets, further supports the 
observation of apparent preferential utilization observed between ALA and LA, where 
ALA tended to be utilized more readily (β-oxidized or bioconverted), whilst LA 
appeared to be more efficiently and directly deposited in the fish tissues (Trushenski et 
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al., 2008; Francis et al., 2009; Turchini et al., 2009). Despite the major and direct 
influences caused by dietary fatty acid composition, other factors such as digestibility 
(Sigurgisladottir et al., 1992; Torstensen et al., 2000), transport and uptake, desaturation 
and elongation processes (Bell et al., 2001; Bell et al., 2002), and β-oxidation of fatty 
acids (Frøyland et al., 2000; Torstensen et al., 2000) are also known to have impacts on 
the overall membrane and depot fatty acid compositions. 
 
Numerous studies suggest that dietary fatty acids can remarkably affect overall lipid 
metabolism (Bell et al., 1997; Francis et al., 2007b; Turchini and Francis, 2009; 
Torstensen and Tocher, 2010). However, little information is available on the direct 
effects of the dietary ALA/LA ratio on overall fatty acid metabolism. The results of this 
study indicate that the majority of consumed LA, ALA and OA were accumulated in the 
fish body, whilst significantly lower proportions were β-oxidized for energy production, 
or bioconverted. Specifically, Murray cod displayed a preferential order of accumulation 
(as a percentage of net intake) of OA, followed by LA and ALA, and an inverse order of 
preference in β-oxidizing ALA over LA and OA. These results are consistent with the 
observations of previous studies on Murray cod using both fish oil- based experimental 
diets (De Silva et al., 2004) and vegetable oil based diets (Turchini et al., 2006b; Francis 
et al., 2007b). However, this observation is in contrast with previous results for other 
fish species where n-6 and n-9 fatty acids were reported to be more actively β-oxidized 
in comparison with n-3 fatty acids (Stubhaug et al., 2005a). This further validates the 
hypothesis that, when compared to other cultured finfish, n-6 fatty acids play a different 
role in the general fatty acid metabolism of Murray cod, as previously suggested (De 
Silva et al., 2004; Turchini et al., 2006b; Francis et al., 2009). 
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Generally, it is recognized that β-oxidation of specific fatty acids is proportional to their 
dietary availability (Stubhaug  et al., 2005a; Stubhaug et al., 2006; Stubhaug et al., 
2007). In the present study, n-6 PUFA and n-3 PUFA were β-oxidized to a greater extent 
in treatments with high LA and high ALA, respectively.  However, observing the results 
of β-oxidation, expressed as a percentage of net intake (Table 4.4), it was interesting to 
note that LA was β-oxidized at a constant level independently from dietary availability 
(~36 % of net intake), while ALA was proportionally oxidized at a greater rate, if 
provided in surplus, as would normally be expected (Stubhaug et al., 2007). 
Additionally, ALA was found to be β-oxidized to a greater extent than LA irrespective 
of the dietary level, as previously recorded for Murray cod (Turchini et al., 2006b; 
Francis et al., 2007b). 

Currently available information on fatty acid β-oxidation in fish suggests the existence 
of a substrate preference for SFA and MUFA over PUFA (Kiessling and Kiessling, 
1993;Henderson, 1996). A previous study on Atlantic salmon (Salmo salar) fed a diet 
with low n-3 LC-PUFA showed that these fatty acids were selectively retained in fish 
tissues. Specifically, the fish fed a fish oil-based diet stored approximately 20% EPA 
and 30% DHA, whereas vegetable oil-fed fish stored 70% EPA and 80% DHA during 
the fast growth period in sea water (Stubhaug et al., 2007), suggesting a switch in fatty 
acid substrate used for β-oxidation when dietary levels are low. On the contrary, the 
present study observed a higher level of β-oxidation and lower retention levels of EPA 
and DHA in fish fed the five experimental diets containing low n-3 LC-PUFA, 
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compared to those fed the fish oil-based diet. This may be ascribable to differences in 
the overall fatty acid metabolism between the two species. This result is not surprising 
especially in consideration that Atlantic salmon are coldwater anadromous species, 
whilst Murray cod inhabit warmwater and are a strictly freshwater species. In general, in 
the present study, EPA was highly oxidized, whilst DHA seemed to be spared from this 
fate. This finding is in agreement with previous observations (Turchini and Francis, 
2009), and likely relative to the fact that DHA is less easily oxidized as it requires an 
additional step to remove the Δ-4 double bond, prior to β-oxidization for energy 
production (Sargent et al., 2002). 
 
In agreement with similar studies in which fish oil was replaced with alternative sources 
(Stubhaug et al., 2005a; Stubhaug et al., 2006, 2007), only marginal effects on β-
oxidation were recorded in the present study. Nonetheless, during the parr–smolt 
transformation, vegetable oil-fed Atlantic salmon had significantly decreased β-
oxidation capacity in comparison to fish fed fish oil- based diets (Stubhaug et al., 2007). 
Additionally, in vitro studies using Atlantic salmon hepatocytes have indicated that n-3 
LC-PUFA stimulated total β-oxidation activity, but through increased uptake of fatty 
acids into the cells, rather than by stimulating the actual β-oxidation system (Torstensen 
and Stubhaug, 2004). 
 
Freshwater fish fed diets containing alternative lipid sources lacking in n-3 LC-PUFA 
generally have increased rates of enzyme activity and elevated transcription rates in 
comparison to those fed n-3 LC-PUFA-rich fish oil- based diets (Buzzi et al., 1996b; 
Tocher et al., 2000b; Sargent et al., 2002; Tocher et al., 2002b; Tocher, 2003; Zheng et 
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al., 2004b; Zheng et al., 2005b; Stubhaug et al., 2005a; Turchini et al., 2009a; 
Torstensen and Tocher, 2010). However, this metabolic effort is reported to be 
inadequate to compensate for the decreased n-3 LC-PUFA intake, resulting in a 
significant reduction in the n-3 LC-PUFA content in fish tissue, and adversely affecting 
the nutritional quality of farmed fish). (Turchini et al., 2009; Rosenlund et al., 2010). 
This was also the case in the present study where a significant increase in desaturase and 
elongase activity was evident in the five experimental treatments in comparison to the 
control group. Despite an identical intake of LC-PUFA in the five experimental diets, 
the levels of LC-PUFA in Murray cod whole bodies were significantly affected by the 
dietary ALA/LA ratio, manifestly showing modified fatty acid bioconversion. 
Accordingly, similar results were observed in yellow catfish (Pelteobagrus fulvidraco) 
fed diets containing different ALA/LA ratios (Tan et al., 2009). 
 
In general, the elongase activity recorded in the present study was manifestly substrate 
dependant, as previously reported for the same species (Francis et al., 2009). The 
relatively high elongase activity acting on n-3 PUFA recorded in fish receiving the MC-
FO treatment was attributable to an elongation of EPA to DPA and then DHA. These 
results are in agreement with similar observations made for rainbow trout fed on a FO-
based experimental diet (Turchini and Francis, 2009). 
 
Murray cod have been shown to exhibit Δ-5 desaturase activity (Turchini et al., 2006a). 
However, in the present study, no apparent Δ-5 activity was recorded in any of the 
treatments. As previously reported (Francis et al., 2009), an absence of apparent Δ-5 
desaturase activity does not indicate a lack of Δ-5 desaturase capability, but may be 
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attributable to a combination of minimal activity of this enzyme and a masking effect 
resulting from the presence of the enzyme product in the experimental diets and initial 
fish tissues. Similarly, a previous study investigating differing dietary ALA/LA ratios 
with partial fish oil substitution observed lack of Δ-5 desaturase activity compared to Δ-
6 desaturase activity in Eurasian perch (Perca fluviatilis) along the n-6 bioconversion 
pathway (Blanchard et al., 2008). As per the elongase activity, the in vivo apparent Δ-6 
desaturase activity acting on n-3 and n-6 PUFA both increased and decreased with the 
elevation of the dietary ALA/LA ratio, clearly indicating that this enzymatic activity is 
substrate dependant. However, the specific kinetics of Δ-6 desaturase activity acting on 
the two possible substrates (LA or ALA) was quite different. The apparent in vivo Δ-6 
desaturase activity acting on LA (μmol g of fish-1 day-1) showed an increasing trend in 
relation to the substrate availability (LA net intake), as previously reported (Francis et 
al., 2009). However, when this activity was expressed as a percentage of net intake, thus 
indicating the efficiency of this enzyme, the Δ-6 desaturase activity acting on LA 
initially increased, then peaked at the substrate level of 4.1512 (μmol g of fish-1 day-1) 
and subsequently remained constant, indicating that any further increase of substrate 
availability is inefficient in terms of n-6 LC PUFA production. On the other hand, the 
apparent in vivo Δ-6 desaturase activity on ALA was observed to increase with the 
increased substrate availability (ALA net intake), but reached its maximum at an average 
substrate level. The trend of Δ-6 desaturase activity (as a percentage of net intake) on 
ALA appears similar to previous findings (Francis et al., 2009), suggesting that the 
amount of ALA desaturated is proportionally reduced by an increasing dietary substrate 
level. Interestingly, the maximum Δ-6 desaturase activity acting on ALA peaked at the 
substrate level of 3.2186 (μ mol g fish-1 day-1) (MC-1.6), suggesting that any additional 
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amount of ALA is not only wasteful, but counterproductive in terms of n-3 LC-PUFA 
bioconversion. A similar trend was noted for both absolute (μ mol per g fish day-1) and 
relative (as a percentage of net intake) in vivo total apparent desaturase activity in 
relation to the dietary ALA/LA ratio, peaking at an ALA/LA ratio of 1.54, suggesting 
that this could be considered the optimal dietary ALA/LA ratio for Murray cod. In a 
previous study on Eurasian perch, it was concluded that fish fed a linseed-oil based diet, 
with an ALA/LA ratio of 3, was the optimal for maximal n-3 LC-PUFA biosynthesis, 
which is a ratio comparatively higher than what observed in Murray cod during the 
present investigation. However, in this study the actual total substrate availability (ALA 
+ LA) was not balanced, and it is likely that the increased n-3 LC-PUFA biosynthesis 
recorded in fish fed the linseed oil-based diet was primarily derived from the total higher 
substrate availability. In human hepatocytes, the optimal ALA/LA ratio for maximal 
DHA production has been suggested to be 1/1, but higher EPA production was recorded 
in cells fed ALA alone (ALA/LA ratio 1/0) (Harnack et al., 2009). The LC-PUFA 
biosynthesis pathway has most commonly been assayed in vitro by investigating, for 
example, the conversion of radio labelled [1-14C] ALA in isolated cell preparations, and 
mainly in salmonids (Buzzi et al., 1996; Tocher et al., 2003a). The desaturation of radio 
labelled [1-14C] ALA and LA in hepatocytes of Atlantic salmon fed vegetable oil- 
compared to fish fed fish oil-based diets was significantly increased in salmon parr (Bell 
et al., 1997) and smolts (Tocher et al., 1997). These studies observed that the overall 
level of LC-PUFA synthesis from LA was less than half of that from ALA, irrespective 
of the diet. Accordingly, the present study detected a comparatively higher overall 
bioconversion of ALA compared to that of LA regardless of the dietary inclusion level. 
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Specifically, a 3.2-fold greater Δ-6 desaturase affinity towards ALA over LA was 
recorded in Murray cod.  
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CHAPTER 5 
 
Effects of dietary vitamin B6 supplementation on fillet fatty acid composition and 
fatty acid metabolism of rainbow trout fed vegetable oil based diets. 
A peer reviewed publication has resulted from this chapter. 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of 
dietary vitamin B6 supplementation on fillet fatty acid composition and fatty acid 
metabolism of rainbow trout fed vegetable oil based diets, Journal of Agricultural & 
Food Chemistry 60, 2343-2353.  
 
5.1 Introduction 
The activity of desaturase and elongase enzymes is known to be regulated by several 
nutritional and non-nutritional factors (Nakamura and Nara, 2004). Among the 
nutritional factors, vitamin B6 (pyridoxine), in addition to its main role in protein 
metabolism, has been speculated to play an important role as a co-factor or activator in 
the LC-PUFA biosynthetic pathway (Das, 2007; Tsuge et al., 2000; Zamaria, 2004) and 
in general fatty acid metabolism (Kirschman and Coniglio, 1961; Cunnane et al., 1984; 
Webster and Lim, 2002). Therefore, it is feasible to suggest that the adequate provision 
of dietary pyridoxine plays an important role in both lipid and protein metabolism, 
corresponding to optimal growth and health, and importantly, the maintenance of human 
health beneficial nutrients in edible tissues. 
 
As described in Chapter 1, it is clear that pyridoxine is a key micronutrient that can 
affect in vivo fatty acid metabolism, but its mechanisms of action and potential roles in 
improving LC-PUFA biosynthesis and deposition have not yet been fully elucidated. 
Moreover, given the promising results of increased n-3 LC-PUFA in the fillets of trout 
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fed fish oil-based diets fortified with pyridoxine (Maranesi et al., 2005), and the known 
reduction of n-3 LC-PUFA in fish fed vegetable oil-base diet (Turchini et al., 2009), it 
would seem timely and pertinent to evaluate if dietary pyridoxine fortification can 
minimise this detrimental effect of fish oil replacement in aquafeeds.  
 
The aim of the present study was therefore to explore the potential effects of dietary 
pyridoxine levels on fatty acid metabolism in fish fed a fish oil (i.e. LC-PUFA) deprived 
diet. Specifically, the main objective of this study was to verify if dietary pyridoxine 
fortification could positively stimulate LC-PUFA biosynthesis and/or retention and 
deposition in rainbow trout when fed plant oil based diets containing an abundance of 
the fatty acid precursors, LA and ALA, and limited concentrations of LC-PUFA 
 
5.2 Materials and methods 
Animals and husbandry methodologies used for this experimentation were described in 
Chapter 2. 
 
5.2.1 Experimental diets 
Four iso-proteic, iso-lipidic semi-purified experimental diets varying only in their 
pyridoxine (vitamin B6) content were formulated to contain ~20% of lipid and ~40% of 
protein. Fishmeal was included in the formulation to guarantee good palatability of the 
diet, but at very low concentration (12% of protein source), to minimise the inclusion of 
n-3 LC-PUFA derived from its residual oil. The added lipid source was a blend of 
canola (rapeseed) and linseed oils (70/30) (Table 5.1). The vitamin and mineral mix was 
purposely formulated, as described earlier (Francis et al., 2006), with the exclusion of 
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pyridoxine. Pyridoxine hydrochloride (PN, Sigma, St Louis, MO, USA) was added to 
the dry ingredient mixture of the test diets after being properly mixed with dextrin to 
provide graded concentrations of 1.5, 3.8, 9.4, 23.4 mg pyridoxine kg-1 diet. The 
experimental diets were manufactured following standard procedures implemented at 
Deakin University as previously described by Brown et al. (2010) and explained in 
detail in Chapter 2 of this thesis. The dry pellets were then transferred to sealed plastic 
bags and stored at -20 °C until used. The four experimental diets/treatments were 
designated from RT-B6-1 to RT-B6-4 in order of their pyridoxine content which ranged 
from 1.5 to 23.4 mg kg-1, respectively. 
 
5.2.2 Experimental design 
Following the acclimation period, 240 juvenile specimens were individually weighed 
and randomly allocated in triplicate groups into 12 tanks (20 fish per tank; 3 tanks per 
treatment). At the commencement of the experiment, an additional sample of 10 fish was 
taken, euthanized in excess anaesthetic and stored at -20 °C until subsequent analysis.  
Fish were fed with one of the four treatments, as described in Chapter 2, for a 60 day 
rearing period. Faeces were collected during the last week of the feeding trial. At the 
termination of the feeding trial, all fish were individually weighed and eight fish from 
each experimental tank (24 fish per treatment) were culled and stored at -20°C for 
further analysis. 
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5.2.3 Chemical analyses 
The samples subjected to chemical analysis included six experimental diets, trout whole 
bodies (4 fish per tank; 12 fish per treatment), trout fillets and livers (4 fish per tank; 12 
fish per treatment) and trout faeces (3 samples per treatment).   
 
Proximate analyses, Fatty acid analysis and Chromic acid analysis and subsequent 
calculations of digestibility for each fatty acid were carried out according to the 
procedures and formulae described in Chapter 2. 
 
5.2.4 Calculation of growth, biometric and feed utilization parameters 
Growth, biometric and feed utilization parameters were determined using the formulae 
described in Chapter 2. 
  
5.2.5 Determination of in vivo β-oxidation, desaturase and elongase activity 
The estimation of the apparent in vivo fatty acid metabolism (fatty acid de novo 
production, β-oxidation, elongation and desaturation) was calculated via the 
implementation of the whole body fatty acid balance method briefly explained in 
Chapter 2 of this thesis and initially proposed and fully described by Turchini et al. 
(2007b) with subsequent developments (Turchini et al., 2008; Turchini and Francis, 
2009).  
 
5.2.6 Determination of pyridoxine (Vitamin B6) 
The analysis for pyridoxine content of the diets, fish whole bodies and faeces was 
implemented on blind samples by an accredited external laboratory (National 
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Measurement Institute, Department of Innovation, Industry, Science and Research, 
Melbourne, VIC, Australia). Briefly, pyridoxine content was determined using reverse 
phase high performance liquid chromatography (HPLC) as described by Bergaentzle et 
al. (1995). Samples were homogenised and extracted in acetate buffer at pH 4.5, prior to 
using acid phophotase and glyoxilic acid to convert various vitamin B6 forms into 
pyridoxal form. The converted extract was then filtered and an aliquot was reacted with 
borohydried to reduce pyridoxal to pyridoxine. Pyridoxine in the sample filtrate was 
determined by reverse phase HPLC on a C18 Nova-Pak column using fluorescence 
detection. Separation was made using a mobile phase of 0.0005M hexane sulphonic acid 
(sodium salt)/0.05M potassium dihydrogen phosphate in 8% acetonitrile / 92% water, 
pH; 2.5. Detection was performed by fluorescence using an excitation wavelength of 
295nm and emission wavelength of 390nm. Results were expressed at to two significant 
figures in units of mg/kg. 
 
5.2.7 Statistical analysis 
Statistical analyses were performed as described in Chapter 2. In addition, all data were 
analysed by linear regression, relative to analytically verified dietary pyridoxine 
concentrations, and where appropriate, further curvilinear trends (Michaelis-Menten) 
were also computed. Regression analyses were computed using GraphPad Prism ver. 
5.02 (GraphPad Software, Inc. La Jolla, CA, USA). 
 
 
 
139 
 
5.3 Results 
5.3.1 Diet composition  
The analysed pyridoxine (vitamin B6) concentrations of the four experimental diets were 
2.4, 4.6, 7.8 and 19.0 mg kg-1 of diet for RT-B6-1, RT-B6-2, RT-B6-3 and RT-B6-4, 
respectively. These values were slightly discrepant with the diet formulation, which 
were 1.5, 3.8, 9.4 and 23.4 mg kg-1, respectively, indicating that some pyridoxine was 
present in the raw materials used for diet formulation (as in RT-B6-1 and RT-B6-2, 
more pyridoxine was measured than what was added), and that some of the pyridoxine 
in the two treatments with highest addition (RT-B6-3 and RT-B6-4) was lost during the 
diet manufacturing process. However, the recorded pyridoxine contents of the four 
experimental diets were adequately suited for the purpose of this study. 
 
The proximate compositions of the four diets were similar across all four treatments and 
the total lipid contents ranged from 196.1 to 201.9 mg kg-1 of dry diet (Table 5.1). Fatty 
acid analysis of different experimental diets reflected the objective of the formulations, 
and their fatty acid compositions were almost identical (Table 5.2). The percentages (on 
total fatty acids) of EPA, DHA and ARA in each experimental diet were minimal, 
equating to 0.3, 0.6 and 0.1 respectively. The concentration of LA and ALA in all diets 
was constant at ~19 and ~21 % of total fatty acids, respectively. MUFA represented the 
most abundant fatty acid class (~49%), followed by PUFA (~41%) and SFA (10%) 
(Table 5.2). 
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5.3.2 Growth performance, feed utilization and biometry  
During the entire feeding trial, all experimental diets were readily accepted by fish and 
mortality was very low and independent of the dietary treatments. Throughout the 60-
day experimental period, fish recorded a weight gain in excess of 4.2-fold their initial 
weight, regardless of the dietary treatment (Table 5.3), with no significant differences 
(ANOVA, P>0.05) amongst treatments in relation to any of the recorded parameters 
relative to performance, feed utilisation and fish biometry. The values recorded for final 
mean weight, SGR and weight gain % ranged from 155.8 to 166.8g, 2.34 to 2.46 and 
306.7 to 338%, respectively. The average feed consumption and FCR values were 
approximately 160 g fish-1and 1.25, respectively. 
 
5.3.3 Proximate composition and pyridoxine content 
The proximate composition of trout whole-bodies and fillets at the commencement and 
termination of the experiment is reported in Table 5.4. No statistically significant 
(ANOVA, P>0.05) differences were recorded for ash, moisture, protein or lipid contents 
in whole bodies or fish fillets among the four dietary treatments. A statistically 
significant linear regression was observed for fillet ash content (P = 0.027). 
 
Pyridoxine (vitamin B6) content in fish whole bodies showed a gradual increase with the 
increasing level of its dietary inclusion, ranging from 1.40±0.50 mg kg-1 (RT-B6-1) to 
1.97±0.18 mg kg1 (RT-B6-4), but no statistically significant differences could be 
observed among the four dietary treatments (ANOVA and regression). Pyridoxine 
content in faeces from all fish groups was below the minimum detection limit (0.2 
mg/kg) of the methodology used. 
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5.3.4 Fillet and whole body fatty acid composition 
The fatty acid composition of total lipids of trout fillets and whole-bodies are reported in 
Table 5.5 and Table 5.6, respectively, and all values are reported as mg of fatty acid per 
g of lipid. Regardless of the dietary treatment, the highest proportion of the SFA class 
was comprised of 16:0 followed by 18:0 in trout fillet and whole body samples. 
Similarly, the MUFA content was mainly represented by 18:1n-9 followed by 18:1n-7 
and 20:1 in both tissues. Of the total PUFA, the amount of n-3 PUFA was almost 
identical to that of n-6 PUFA, in both fillets and whole bodies, with LA and ALA 
accounting for the majority, respectively. Irrespective of the dietary treatment and in 
both tissues, the LA content was much higher (~150 mg g-1) than that of ALA (~97 mg 
g-1). 
 
In fillets (Table 5.5), ANOVA detected statistically significant differences (P<0.05) for 
18:1n-9 (RT-B6-1 higher than RT-B6-3), 20:1 (RT-B6-1 higher than all the other 
treatments) and total MUFA (RT-B6-1 higher than RT-B6-3). Interestingly, a 
statistically significant linear regression (P=0.038) was recorded for docosapentaenoic 
acid (22:5n-3; DPA), with its content increasing from 4.27 to 5.85 mg g-1, when moving 
from RT-B6-1 to RT-B6-4.  Thought not statically significant, similar apparent trends 
were recorded for EPA, DHA and, in general, total n-3 LC-PUFA. 
 
In whole bodies (Table 5.6), the only statistically significant difference (P<0.05) 
recorded by ANOVA was for 20:1, with RT-B6-2 recording a lower content than all 
other treatments. The regression analysis recorded a statistically significant linear 
correlation between dietary pyridoxine content and 22:4n-6 and DPA whole body 
142 
 
content (P= 0.009 and P=0.012, respectively). As reported for the fillet, apparent trends 
(not statistically significant) of increased EPA, DHA and total n-3 LC-PUFA contents 
were also evident in whole bodies of fish fed the four different experimental diets. 
 
In both tissues, the intermediate products of the n-3 and n-6 LC-PUFA bioconversion 
pathways, such as 18:4n-3 and 18:3n-6, showed an increasing trend with the increased 
dietary pyridoxine content from RT-B6-1 to RT-B6-3, then slightly decreasing in RT-
B6-4, though these trends were not significantly described by the regression analysis. 
 
5.3.5 Fatty acid metabolism 
Whilst the whole body fatty acid balance method (described in detail in Chapter 2) 
generated a large amount of data, describing the fate of all individual fatty acids towards 
β-oxidation, bioconversion and deposition, no statistically significant differences were 
detected by ANOVA, and therefore, not all data were reported. 
 
The key results of the whole body fatty acid balance method, grouped by general 
enzymatic activity on the three main fatty acid pathways (SFA and MUFA, n-6 PUFA 
and n-3 PUFA) are depicted in Table 5.7 and values are reported as apparent in vivo 
enzyme activity expressed as nmol of enzyme product produced per g of body weight 
per day (nmol g-1 day-1). Although not significantly different, RT-B6-1 demonstrated a 
slightly higher fatty acid de novo production, lower β-oxidation and higher elongation 
and Δ-9 desaturation of SFA and MUFA compared to the other three treatments. The β-
oxidation of n-6 and n-3 PUFA recorded very similar values (~1700 nmol g-1 day-1) and 
was not affected by dietary treatment. The elongation of n-3 PUFA was proportionally 
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higher than that of n-6 PUFA (~800 nmol g-1 day-1 vs. ~130 nmol g-1 day-1, respectively), 
and was not affected by dietary treatment. Similarly, the apparent in vivo Δ-6 and Δ-5 
desaturase activities acting on n-3 PUFA were higher than that of n-6 PUFA (~700 and 
~280 nmol g-1 day-1 vs. ~800 and ~300 nmol g-1 day-1, respectively), and were not 
affected by dietary treatment. However, regression analysis detected a statistically 
significant (P= 0.048) linear relationship for the apparent in vivo Δ-5 desaturase activity 
on n-6 PUFA, which was double in fish fed the diet with highest pyridoxine content 
(RT-B6-4) compared to fish fed the diet with the lowest pyridoxine content (RT-B6-1). 
 
In Table 5.8, the results of fatty acid bioconversion along the n-6 LC-PUFA and n-3 LC-
PUFA biosynthetic pathways are reported. No statistically significant differences could 
be detected by ANOVA, but the linear regression analysis demonstrated the existence of 
a statistically significant relationship for dietary pyridoxine content and apparent in vivo 
Δ-5 desaturase activity on n-6 PUFA (as above reported), and for the elongation of 
18:3n-6 to 20:3n-6 and 20:4n-6 (ARA) to 22:4n-6. All other individual fatty acid 
bioconversions showed an apparent trend of increased activity with the increase of 
pyridoxine dietary content, but the resultant slopes of these linear equations were not 
statistically different from zero. Therefore, data were plotted against dietary pyridoxine 
content, and further analysed by curvilinear regression (using the Michaelis-Menten 
equation for enzyme kinetics) and interesting trends were observed, likely suggesting the 
possible existence of an effect of pyridoxine on the activity of these enzymes (Figure 5.1 
and Figure 5.2). 
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Table 5.1 Ingredients and proximate composition of the rainbow trout experimental 
diets used for the 2nd feeding trial for 60 days  
  Dietary treatments1 
RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 
Ingredients(g kg-1) 
Fish meal2 90 90 90 90 
Defatted soybean meal2 287 287 287 287 
Wheat Gluten2 4 4 4 4 
Whey Protein3 135 135 135 135 
Lupin Flour4 180 180 180 180 
Wheat Flour5 6 6 6 6 
Gelatin6 28 28 28 28 
CMC7 20 20 20 20 
Mineral mix8 40 40 40 40 
Vitamin mix9 30 30 30 30 
Choline6 5 5 5 5 
Cr2O36 2 2 2 2 
Canola oil5 120 120 120 120 
Linseed10 50 50 50 50 
(mg kg-1) 
Pyridoxine hydrochloride6 (Vitamin B6) 1.50 3.75 9.38 23.44 
Dextrin6  2998.50 2996.25 2990.62 2976.56 
 
Proximate composition (mg g-1) 
Moisture 53.7 55.1 56.5 51.7 
Crude lipid 197.3 201.9 196.1 199.8 
Crude protein 396.6 396.6 396.7 403.0 
Ash 67.8 67.8 68.4 67.2 
NFE11 256.1 278.6 282.3 278.3 
Energy kJ g-1 21.6 22.1 22.0 22.2 
 
1 Diet abbreviations – RT-B6-1: (Vitamin B6; 2.4 mg/kg); RT-B6-2: (Vitamin B6; 4.6 mg/kg), RT-B6-3: 
(Vitamin B6; 7.8 mg/kg),  
RT-B6-4: (Vitamin B6; 19.0 mg/kg), 
2 Ridley Agriproducts, Narangba, Queensland, Australia. 
3 Warrnambool cheese and butter factory, Warrnambool, Victoria, Australia 
4 Irwin Valley, Palmyro,Western Australia, Australia 
5 Black and Gold, Tooronga, Victoria, Australia. 
6. Sigma-Aldrich, Inc. St. Louis, MO, USA 
7 Carboxymethyl cellulose - BDH Laboratory Supplies, Poole, United Kingdom.   
10Sceney Chemical PTY., LTD. Sunshine, VIC., Australia 
11 NFE (Nitrogen Free Extract): Calculated by difference 
12Calculated on the basis of 23.6,39.5 and 17.2 kJ g-1 of protein, fat and carbohydrate, respectively 
8Mineral mix supplemented (in g/kg diet) with Ca(C6H10O6)-5H2O, 348.49; Ca(H2PO4)2-H2O, 136; 
MgSO4-7H2O, 132; K2HPO4, 240; NaH2PO4-H2O, 88; NaCl, 45; AlCl3-6H2O, 0.15; KI,0.15; CuSO4-
5H2O,0.5; MnSO4-H2O,0.7; CoCl2-6H2O,1.0; ZnSO4-7H2O,3.0; NaSeO3,0.01; FeSO4,5.0 
9Pyridoxine free vitamin mix (in g/kg diet) with Ascorbic acid,50; DL-calcium pantothenate,5; choline 
bitartrate,100; inositol,5; menadione,2; niacin,5; riboflavin,3; thiamine hydrochloride,0.5; Dl-alpha-
tocopherol acetate (250IU/g),8; vitamin A acetate (20 000 IU/g),5; biotin,0.05; cholecalciferol (1μg = 
40IU),0.002; folic acid;0.18; vitamin B12,0.002; alpha cellulose, 816.266 
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Table 5.2 Fatty acid composition of experimental diets (mg g lipid -1 and w/w % of 
total fatty acids in parentheses and italics) 
Fatty acids   Dietary treatments1   
mg g-1 lipid RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 
14:0 4.2(0.4) 4.3(0.5) 4.0(0.4) 4.5(0.5) 
16:0 54.8(5.8) 56.4(6.0) 54.5(5.8) 55.0(5.9) 
16:1n-7              3.1(0.3) 3.2(0.3) 3.0(0.3) 3.0(0.3) 
18:0 25.8(2.7) 26.4(2.8) 25.5(2.7) 25.7(2.7) 
18:1n-9              422.1(44.8) 418.3(44.4) 419.9(44.6) 418.9(44.6) 
18:1n-7              28.2(3.0) 28.4(3.0) 28.9(3.1) 28.8(3.1) 
18:2n-6              196.1(20.8) 196.6(20.9) 198.5(21.1) 196.8(21.0) 
18:3n-6              0.1(0.0) 0.1(0.0) 0.1(0.0) 0.1(0.0) 
18:3n-3              180.7(19.2) 181.3(19.3) 181.1(19.3) 181.0(19.3) 
18:4n-3              0.1(0.0) 0.1(0.0) 0.1(0.0) 0.1(0.0) 
20:0                 4.0(0.4) 4.2(0.4) 4.0(0.4) 4.2(0.5) 
20:12 6.8(0.7) 7.5(0.8) 6.9(0.7) 7.0(0.7) 
20:2n-6              0.7(0.1) 0.6(0.1) 0.6(0.1) 0.5(0.1) 
20:3n-6              0.2(0.0) 0.2(0.0) 0.2(0.0) 0.1(0.0) 
20:4n-6              0.7(0.1) 0.6(0.1) 0.6(0.1) 0.6(0.1) 
20:3n-3              0.0(0.0) 0.0(0.0) 0.0(0.0) 0.0(0.0) 
20:4n-3              0.0(0.0) 0.0(0.0) 0.0(0.0) 0.0(0.0) 
20:5n-3              2.7(0.3) 2.7(0.3) 2.9(0.3) 2.8(0.3) 
22:0                 2.8(0.3) 2.9(0.3) 2.7(0.3) 2.9(0.3) 
22:13 1.2(0.1) 0.5(0.0) 0.5(0.1) 0.7(0.1) 
22:2n-6              0.1(0.0) 0.1(0.0) 0.1(0.0) 0.1(0.0) 
22:4n-6              0.2(0.0) 0.3(0.1) 0.1(0.0) 0.2(0.0) 
22:5n-3              2.0(0.2) 1.6(0.2) 1.2(0.1) 1.5(0.2) 
22:6n-3              5.6(0.6) 5.5(0.6) 5.3(0.6) 5.3(0.6) 
Total 942.1(100.0) 942.0(100.0) 940.9(100.0) 940.0(100.0) 
SFA 91.5(9.7) 94.3(10.0) 90.7(9.6) 92.3(9.8) 
MUFA 461.3(49.0) 457.8(48.6) 459.2(48.8) 458.5(48.8) 
PUFA 389.3(41.3) 389.8(41.4) 391.0(41.5) 389.3(41.4) 
n-6 PUFA 198.1(21.0) 198.5(21.1) 200.3(21.3) 198.6(21.1) 
n-6 LC-PUFA 1.9(0.1) 1.8(0.2) 1.7(0.2) 1.6(0.1) 
n-3 PUFA 191.2(20.3) 191.3(20.3) 190.7(20.3) 190.7(20.3) 
n-3 LC-PUFA 10.3(1.1) 9.9(1.0) 9.4(1.0) 9.6(1.0) 
1 See Table 5.1 for diet abbreviations. 
2 Sum of 20:1 isomers. 
3 Sum of 22:1 isomers. 
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Table 5.3 Growth, feed utilization and biometry data of rainbow trout at the end of the 
60-day feeding trial fed with vitamin B6 supplemented semi-purified diets.  
 
  Dietary treatments1 Regression 
  RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
Initial mean wt. (g) 38.61±0.25 38.30±0.52 38.02±0.24 38.51±0.50 ns 
Mean final wt. (g) 161.12±4.45 155.79±3.22 166.82±4.60 156.70±4.34 ns 
Weight Gain2 (%) 317.45±13.41 306.72±5.48 338.60±9.41 307.29±15.33 ns 
SGR3 (% day-1) 2.38±0.05 2.34±0.02 2.46±0.04 2.34±0.06 ns 
Feed consumption (g/fish) 159.68±2.62 163.97±6.47 167.48±0.63 166.05±5.92 ns 
FCR4 1.24±0.03 1.32±0.02 1.23±0.05 1.33±0.01 ns 
PER5 (% day-1) 1.93±0.04 1.81±0.03 1.94±0.07 1.77±0.02 ns 
FDR6(% day-1) 4.16±0.12 4.12±0.05 4.13±0.06 4.07±0.06 ns 
DP 7(%) 83.75±0.63 82.04±0.96 84.06±0.45 84.15±0.24 ns 
HSI8(%) 1.47±0.07 1.46±0.06 1.26±0.06 1.51±0.04 ns 
FY9 (%) 50.99±1.32 49.57±0.66 52.75±1.56 52.44±0.73 ns 
 
Data represent mean ± SEM (n=3, N=12) 
Values in the same row with different superscripts are significantly different (P < 0.05)   
1 See Table 5.1 for diet abbreviations 
2 Weight Gain%: = (final weight−initial weight)×(initial weight)−1×100. 
3 SGR; Specific Growth Rate = [Ln(final weight) − Ln(initial weight)] × (number of days)−1 ×100. 
4 FCR; Feed conversion ratio = (dry feed fed) × (wet weight gain)−1. 
5 PER; Protein Efficiency Ratio = (final weight - initial weight) x (mass of protein consumed)-1. 
6 FDR; Fat deposition rate = [Ln(final lipid)−Ln(initial lipid)]×(number of days)−1. 
7 DP%;Dress-out percentage = (CW x BW -1) x 100; where CW is carcass gutted weight (g) and BW is  
body weight (g). 
8 HSI%; Hepatosomatic index percent = (LW x BW -1) x 100; where LW is liver weight (g). 
9 FY%; Fillet yield percentage = (FW x BW -1) x 100; where FW is fillet weight (g). 
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Table 5.4 Proximate composition (mg g-1) of fillets, whole bodies and vitamin B6 
concentration in whole bodies of rainbow trout fed vitamin B6 supplemented experimental 
diet over a 60 day period.  
                  Dietary Treatments1  Regression 
  RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
  
Fillet (%) 
Protein 17.66±0.35 17.72±0.20 17.47±0.21 17.53±0.17 ns 
Moisture 69.70±1.17 70.66±0.34 72.16±0.77 71.33±0.69 ns 
Lipid 11.47±0.83 10.45±0.29 9.22±0.76 10.00±0.53 ns 
Ash 1.17±0.01 1.17±0.02 1.15±0.01 1.14±0.01 0.027 
Whole body (%) 
Protein 15.33±0.23 15.77±0.10 16.11±0.16 15.23±0.43 ns 
Moisture 66.52±0.38 66.31±0.42 66.97±0.28 67.19±0.46 ns 
Lipid 16.34±0.43 16.25±0.36 15.20±0.43 15.83±0.29 ns 
Ash 1.81±0.09 1.67±0.05 1.72±0.07 1.75±0.05 ns 
Vitamin B6 (mg kg-1) 1.40±0.50 1.50±0.30 1.70±0.30 1.97±0.18 ns 
        
Data represent mean ± SEM (n=3, N=12) 
Values in the same row with different superscripts are significantly different (P < 0.05)   
1 See Table 5.1 for diet abbreviations 
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Table 5.5 Fatty acid composition (mg g-1 of lipid) of rainbow trout fillets under different 
treatments at the end of the 60-day feeding trial. 
    Dietary Treatments1   Regression 
 Fatty acids RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
8.43±0.18 8.18±0.15 8.27±0.38 8.77±0.52 ns 
16:0 95.86±1.94 93.70±1.69 92.38±3.02 99.28±2.44 ns 
16:1n-7              11.30±0.77 11.04±1.10 10.23±0.66 12.45±0.68 ns 
18:0 33.93±0.21 33.56±0.40 34.20±0.93 34.05±0.74 ns 
18:1n-9              396.79±2.60b 388.56±2.23ab 382.46±4.67a 388.80±2.04ab ns 
18:1n-7              26.31±0.08 25.96±0.08 26.12±0.65 26.63±0.78 ns 
18:2n-6              151.40±2.49 152.62±1.71 151.06±2.58 148.52±0.63 ns 
18:3n-6              3.30±0.19 3.49±0.29 3.65±0.10 3.60±0.09 ns 
18:3n-3              97.44±2.88 98.38±3.56 96.28±3.41 94.35±1.40 ns 
18:4n-3              10.99±0.62 11.94±1.10 12.41±0.23 12.33±0.40 ns 
20:0 2.32±0.04 2.26±0.06 2.27±0.03 2.29±0.01 ns 
20:12 13.62±0.27b 12.35±0.16a 12.60±0.14a 12.85±0.27a ns 
20:2n-6              5.76±1.20 6.46±0.25 6.47±0.14 5.22±1.06 ns 
20:3n-6              0.65±0.19 0.55±0.07 0.57±0.02 0.78±0.22 ns 
20:4n-6              3.08±0.11 3.17±0.11 3.57±0.37 3.31±0.20 ns 
20:3n-3              3.98±0.25 3.80±0.34 3.86±0.10 3.61±0.05 ns 
20:4n-3              4.08±0.03 3.98±0.16 4.36±0.26 4.28±0.13 ns 
20:5n-3              7.22±0.09 7.45±0.40 8.32±0.75 8.21±0.43 ns 
22:0 1.68±0.04 1.68±0.04 1.66±0.03 1.67±0.02 ns 
22:13 1.83±0.13 1.51±0.10 1.46±0.15 1.46±0.08 ns 
22:2n-6              0.63±0.04 0.64±0.04 0.69±0.02 0.58±0.01 ns 
22:4n-6              0.54±0.02 0.54±0.02 0.60±0.05 0.61±0.07 ns 
22:5n-3              4.27±0.06 4.34±0.71 5.63±0.62 5.85±0.32 0.038 
22:6n-3              35.90±2.33 36.67±0.70 41.61±4.19 39.64±3.28 ns 
Total 921.31±8.72 912.84±1.23 910.69±1.63 919.13±5.83 ns 
SFA 142.23±2.29 139.38±1.66 138.77±4.34 146.05±3.46 ns 
MUFA 449.85±2.23b 439.42±2.73ab 432.87±4.49a 442.19±2.15ab ns 
PUFA  329.23±7.66 334.04±3.18 339.05±2.28 330.88±2.15 ns 
n-6 PUFA  165.36±2.82 167.47±1.43 166.60±1.92 162.61±1.14 ns 
n-6 LC-PUFA  10.66±1.19 11.36±0.15 11.89±0.57 10.49±0.85 ns 
n-3 PUFA 163.87±4.84 166.58±1.79 172.45±2.61 168.27±2.72 ns 
n-3 LC-PUFA 55.44±2.57 56.25±0.83 63.77±5.15 61.60±4.04 ns 
Data represent means ± standard error (n=3; N=12) 
Values in the same row with different superscripts are significantly different (P < 0.05; ANOVA and 
Student–Newman–Keuls post hoc test). P value of regression analysis is (relative to dietary content of 
pyridoxine) also reported at 5% level. ; ns = not significant   
1 See Table 5.1 for diet abbreviations 
2 Sum of 20:1 isomers. 
3 Sum of 22:1 isomers. 
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Table 5.6 Fatty acid composition (mg g-1 of lipid) of rainbow trout whole-bodies fed the 
four experimental diets containing different pyridoxine contents at the end of the 60-day 
feeding trial. 
  Dietary treatments1 Regression 
Fatty acids RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
14:0 8.33±0.30 8.42±0.40 8.35±0.10 8.80±0.16 ns 
16:0 87.36±3.11 83.90±1.40 83.37±1.58 87.36±0.97 ns 
16:1n-7              11.16±0.99 10.83±0.87 10.57±0.72 10.90±0.60 ns 
18:0 32.92±0.51 32.93±0.89 32.10±0.76 34.41±0.69 ns 
18:1n-9              399.05±5.42 383.79±6.79 385.78±2.94 386.61±3.18 ns 
18:1n-7              26.36±0.89 25.45±0.96 24.73±0.39 24.50±0.23 ns 
18:2n-6              153.50±1.09 151.05±3.14 151.76±1.95 150.61±1.77 ns 
18:3n-6              3.28±0.30 3.63±0.11 3.59±0.40 3.31±0.07 ns 
18:3n-3              101.11±1.46 96.84±2.33 98.54±2.21 96.52±1.09 ns 
18:4n-3              11.44±0.81 13.49±0.14 12.64±1.27 11.62±0.36 ns 
20:0 2.43±0.04 2.41±0.02 2.41±0.02 2.50±0.08 ns 
20:12 13.56±0.13b 12.75±0.21a 13.37±0.15b 13.52±0.19b ns 
20:2n-6              6.77±0.17 6.43±0.24 7.07±0.21 6.91±0.25 ns 
20:3n-6              0.49±0.06 0.57±0.03 0.51±0.07 0.48±0.02 ns 
20:4n-6              3.08±0.23 3.26±0.11 3.32±0.07 3.49±0.25 ns 
20:3n-3              4.38±0.19 3.80±0.16 4.48±0.51 4.46±0.18 ns 
20:4n-3              4.33±0.07 4.53±0.08 4.55±0.28 4.49±0.11 ns 
20:5n-3              7.93±0.32 8.68±0.92 8.14±0.19 8.68±0.39 ns 
22:0 1.83±0.07 1.91±0.07 1.89±0.02 1.95±0.11 ns 
22:13 1.73±0.05 1.72±0.13 1.55±0.21 1.65±0.19 ns 
22:2n-6              0.78±0.03 0.81±0.16 0.64±0.14 0.71±0.18 ns 
22:4n-6              0.32±0.21 0.44±0.07 0.49±0.17 1.01±0.24 0.009 
22:5n-3              5.47±0.63 5.99±0.80 7.42±0.29 8.12±0.67 0.012 
22:6n-3              33.30±1.56 36.39±2.55 37.52±0.53 37.71±0.93 ns 
Total 920.89±8.45 900.00±8.24 904.81±4.97 910.32±5.31 ns 
SFA 132.87±3.76 129.56±1.98 128.13±2.20 135.01±1.29 ns 
MUFA 451.85±6.40 434.54±6.27 436.00±3.23 437.18±2.95 ns 
PUFA  336.17±1.68 335.90±2.37 340.68±3.63 338.13±2.76 ns 
n-6 PUFA  168.22±0.64 166.18±3.13 167.38±1.80 166.53±1.88 ns 
n-6 LC-PUFA  11.43±0.33 11.50±0.08 12.03±0.27 12.60±0.82 ns 
n-3 PUFA 167.96±2.29 169.72±1.42 173.30±1.84 171.61±1.20 ns 
n-3 LC-PUFA 55.41±2.48 59.39±3.79 62.11±0.90 63.46±1.61 ns 
Data represent means ± standard error (n=3; N=12). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test). P value of regression analysis 
(relative to dietary content of pyridoxine) is also reported at 5% level; ns = not significant  
1See Table 5.1 for diet abbreviations. 2 Sum of 20:1 isomers. 3 Sum of 22:1 isomers. 
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Table 5.7 Overall fatty acid metabolism (as total apparent in vivo enzyme activity, nmol g-
1 day-1) in rainbow trout fed the four experimental diets containing different pyridoxine 
contents, deduced by the whole body fatty acid balance method.  
Dietary treatments1 Regression 
RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
SFA & MUFA 
De novo production 228.2±122.0 26.6±26.6 34.9±32.0 16.6±8.8 ns 
Elongation 279.6±123.5 66.9±27.2 83.7±40.8 67.4±3.6 ns 
β-oxidation 2,507.2±480.6 3,444.4±264.5 3,485.8±386.1 3,484.0±138.8 ns 
Δ-9 desaturation 45.2±23.4 23.3±17.0 25.4±12.9 22.5±7.3 ns 
n-6 PUFA  
Elongation 125.4±9.1 122.4±7.0 125.4±1.3 144.7±16.1 ns 
β-oxidation 1,356.0±131.2 1,708.2±62.1 1,690.4±110.9 1,728.1±40.6 ns 
Δ-6 desaturation 76.1±12.8 82.7±1.3 81.1±9.5 87.2±5.3 ns 
Δ-5 desaturation 23.3±5.4 24.4±1.5 26.5±0.8 35.8±6.2 0.026 
n-3 PUFA  
Elongation 776.0±72.7 889.9±129.4 928.8±44.9 964.8±51.2 ns 
β-oxidation 1,482.9±98.6 1,758.6±107.5 1,662.4±110.4 1,761.7±25.7 ns 
Δ-6 desaturation 659.6±68.3 768.9±88.2 757.3±56.9 768.1±33.8 ns 
Δ-5 desaturation 221.5±29.5 268.6±56.0 281.3±23.1 297.6±19.2 ns 
 
Data represent means ± standard error (n=3; N=12) 
Values in the same row with different superscripts are significantly different (P < 0.05; ANOVA and 
Student–Newman–Keuls post hoc test). P value of regression analysis (relative to dietary content of 
pyridoxine) is also reported; ns = not significant 
1See Table 5.1 for diet abbreviations 
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Table 5.8  Apparent in vivo activity (nmol g-1 day-1) of key enzymes in the LC-PUFA 
biosynthetic pathways in rainbow trout fed the four experimental diets containing 
different pyridoxine content deduced by the whole body fatty acid balance method. 
Dietary Treatments1 Regression 
RT-B6-1 RT-B6-2 RT-B6-3 RT-B6-4 P value 
n-6 LC-PUFA biosynthesis 
Δ-6 desaturase (18:2n-6 to 18:3n-6) 76.1±12.8 82.7±1.3 81.1±9.5 87.2±5.3 ns 
Elongase (18:3n-6 to 20:3n-6) 26.7±6.4 28.9±1.7 30.1±2.0 39.6±5.9 0.037 
Δ-5 desaturase (20:3n-6 to 20:4n-6) 23.3±5.4 24.4±1.5 26.5±0.8 35.8±6.2 0.026 
Elongase (20:4n-6 to 22:4n-6) 2.2±2.2 1.3±1.0 3.7±1.8 9.7±3.0 0.008 
 
n-3 LC-PUFA biosynthesis 
Δ-6 desaturase (18:3n-3 to 18:4n-3) 444.5±50.8 522.7±56.2 511.4±46.4 515.7±18.2 ns 
Elongase (18:4n-3 to 20:4n-3) 276.0±32.0 325.1±56.5 335.0±21.6 351.9±21.0 ns 
Δ-5 desaturase (20:4n-3 to 20:5n-3) 221.5±29.5 268.6±56.0 281.3±23.1 297.6±19.2 ns 
Elongase (20:5n-3 to 22:5n-3) 222.3±24.3 264.7±42.5 288.0±17.3 298.7±12.5 ns 
E+Δ-6+CS2 (22:5n-3 to 22:6n-3) 215.1±17.6 246.2±32.7 246.0±10.6 252.5±15.6 ns 
 
Data represent means ± standard error (n=3; N=12). 
Values in the same row with different superscripts are significantly different (P < 0.05; 
ANOVA and Student–Newman–Keuls post  
hoc test). P value of regression analysis (relative to dietary content of pyridoxine) is also 
reported; ns = not significant.   
1 See Table 5.1 for diet abbreviations 
2 E+Δ-6+CS = Elongase (22:5n-3 to 24:5n-3) + Δ-6 desaturase (24:5n-3 to 24:6n-3) + 
Chain shortening (24:6n-3 to 22:6n-3) 
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Figure 5.1 Apparent in vivo desaturase activity (nmol g-1 day-1) in rainbow trout fed the four experimental diets containing different 
pyridoxine contents, deduced by the whole body fatty acid balance method. A) Δ-6 desaturase activity acting on: 18:2n-6, regression 
equation: Y = 87.54X × (0.3560+X)-1, normality of residuals P>0.1; 18:3n-3, regression equation: Y = 540.2X × (0.4247+X)-1, 
normality of residuals P>0.1; and 24:5n-3 regression equation: Y = 261.9X × (0.4659+X)-1, normality of residuals P>0. B) Δ-5 
desaturase activity acting on: 20:3n-6, regression equation: Y = 0.7712X +20.98, R2 = 0.40, P = 0.0263; 20:4n-3, regression 
equation: Y = 3.570X +237.1, R2 = 0.16, P >0.05. 
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Figure 5.2 Apparent in vivo elongase activity (nmol g-1 day-1) in rainbow trout fed the four experimental diets containing different 
pyridoxine contents, deduced by the whole body fatty acid balance method. A) Elongase acting on n-3 PUFA: 18:4n-3, regression 
equation: Y = 368.8X × (0.7560+X)-1, normality of residuals P=0.095; 20:5n-3, regression equation: Y = 319.2X × (0.9978+X)-1, 
normality of residuals P>0.1; and 22:5n-3 regression equation: Y = 261.9X × (0.4659+X)-1, normality of residuals P>0. B) Elognase 
acting on n-6 PUFA: 18:3n-6, regression equation: Y = 0.7697X +24.82, R2 = 0.37, P = 0.0366; 20:4n-6, regression equation: Y = 
0.4970X +0.0213, R2 = 0.52, P =0.0085. 
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5.4. Discussion 
In the present study, no pyridoxine-deficient treatment was present, and different dietary 
pyridoxine contents, varying from 2.4 to 19.0 mg kg-1, did not affect overall growth 
performance, feed efficiency and fish survival during the 60 day feeding trial in rainbow 
trout fed a vegetable oil based diet. This is in agreement with the results of a previous 
investigation on the same species in which fish oil based diets with varying amounts of 
pyridoxine supplementation were fed (Maranesi et al., 2005), and in Atlantic salmon fed 
vegetable oil (soybean oil) and fish oil based diets supplemented with pyridoxine ( 
Albrektsen et al., 1993; Albrektsen et al., 1994; Albrektsen et al., 1995). Similarly, the 
key fish biometrical parameters, such as hepatosomatic index, dress-out percentage or 
fillet yield were not affected by the dietary pyridoxine content. This observation is in 
agreement with results (HSI values) previously reported for Atlantic salmon (Albrektsen 
et al., 1993). In contrast, a previous study by the same authors (Albrektsen et al., 1994) 
demonstrated that Atlantic salmon fed with pyridoxine-supplemented diets had 
significantly higher liver weights and HSI values compared to those fed diets containing 
lower levels of pyridoxine. 
 
The retention and deposition of pyridoxine into the whole-bodies of trout was directly 
proportional to its dietary content, though the reported values were not significantly 
different from each other (P>0.05). Similarly, other studies have reported significantly 
elevated levels of pyridoxine in the muscle tissue of rainbow trout (Maranesi et al., 
2005) and Atlantic salmon (Albrektsen et al., 1994) when fed with increasing 
concentrations of this vitamin. In the latter study, the dietary pyridoxine supplementation 
ranged from 0 to 10 mg kg-1, but the non-supplemented basal diet contained 1.6 mg kg-1 
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of pyridoxine, which was roughly similar to the minimum dietary requirement for 
Atlantic salmon (2-3 mg kg-1), previously determined by the same authors (Albrektsen et 
al., 1993). Another investigation carried out by the same authors on the same species, 
showed reduced levels of tissue pyridoxine in Atlantic salmon fed a non-supplemented 
diet (Albrektsen et al., 1995). In line with the above studies, the present study on 
rainbow trout was comprised of four pyridoxine supplemented treatments, ranging from 
2.4 (RT-B6-1) to 19.0 (RT-B6-4) mg kg1, where the minimum level of dietary 
pyridoxine (RT-B6-1) was similar to the defined minimum dietary requirement (2 mg 
kg1) for rainbow trout (Woodward, 1990). Though not the objective of the present study 
and in consideration also that fish is not particularly rich in pyridoxine (Fineli, 2010), it 
was shown that the overall nutritional quality of cultured fish, and specifically its 
vitamin B6 content, can be partially improved by appropriate dietary pyridoxine 
fortification. 
 
The proximate composition analysis of trout tissues was unaffected by dietary 
pyridoxine content, and specifically, it was shown that the total lipid content in whole 
bodies and fillets of trout was not influenced by the dietary pyridoxine level. In contrast, 
dietary pyridoxine content has been previously demonstrated to have a significant 
impact on the total lipid content of Atlantic salmon fillets, resulting in higher 
concentrations in fish groups fed with higher vitamin levels (Albrektsen et al., 1994). 
However, and in accordance with the present study, no significant differences were 
observed in relation to whole body total lipid contents in Atlantic salmon fed different 
amount of pyridoxine (Albrektsen et al., 1994). 
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The results of the fatty acid analysis of trout fillets and whole bodies did not show 
significant differences for the individual fatty acids, with the exception of some MUFA, 
i.e. 18:1n-9 and 20:1, which were generally present in higher concentrations in the RT-
B6-1 treatment which contained the lowest dietary pyridoxine content. The results of the 
in vivo fatty acid metabolism did not reveal any statistically significant modification to 
the overall non essential fatty acid metabolism. However, it was interesting to note that 
the fish fed the RT-B6-1 diet demonstrated a higher (not significant, P>0.05) de novo 
production of SFA, lower β-oxidation of SFA and MUFA and higher Δ-9 desaturation 
activity, compared to the other three groups, suggesting the existence of a direct 
relationship between pyridoxine availability and SFA and MUFA metabolism. This 
observation has not been made previously, and in consideration of the known roles of 
pyridoxine in reducing plasma cholesterol and low-density lipoprotein (Brasttstrom et 
al., 1990) and the multitude of roles of pyridoxine (as PLP) in mitochondria activity 
(Depeint et al., 2006), the roles of pyridoxine in SFA and MUFA metabolism clearly 
warrant further investigation. 
 
A significant linear trend was observed for DPA content in fillet and whole body 
samples. Although  DPA is not commonly considered as one of the main human health 
promoting n-3 LC-PUFA, as the vast majority of studies have primarily focused on EPA 
and DHA, this fatty acid has recently been recognised to play a series of important 
metabolic functions and exhibit health promoting properties (Kaur et al., 2011). In the 
present study, all animals were fed with almost identical amounts of 22:5n-3, as was the 
case for all other LC-PUFA, and thus it is possible that this trend towards increased 
22:5n-3 accumulation in synchrony with the increase in dietary pyridoxine 
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concentrations could be attributable to potential positive effects of pyridoxine on the 
elongation of EPA, or a negative effect on the further bioconversion or β-oxidation of 
DPA. Similarly, the 22:4n-6 content in trout whole body samples demonstrated a 
significant linear trend, suggesting that dietary pyridoxine may also positively affect the 
elongation of ARA or reduce the further bioconversion or β-oxidation of this fatty acid. 
Other key LC-PUFA, such as EPA, DHA and ARA in trout fillet and whole body 
showed apparent increasing trends (thought not statistically significant P>0.05) with the 
increasing dietary availability of pyridoxine. Accordingly, a previous study conducted 
on the same species (but with fish oil-based diets) demonstrated a significantly higher 
content of LC-PUFA in fillets, DHA in particular, in experimental groups supplemented 
with pyridoxine in comparison to the deficient group (Maranesi et al., 2005). In 
agreement with the results of present study, previous investigations conducted using rats 
reported higher levels of ARA in pyridoxine supplemented groups compared to the non-
supplemented group (Cunnane et al., 1984; Bordoni et al., 1998; Bertrandt et al., 2004a). 
Similarly, the results of the previous study on Atlantic salmon (Albrektsen et al., 1994) 
reported significantly higher levels of DHA and total n-3 PUFA in hepatic phospholipids 
of Atlantic salmon fed pyridoxine supplemented diets. 
 
The results of the whole body fatty acid balance method, employed to determine the 
fatty acid metabolism in rainbow trout during the present investigation, revealed a series 
of interesting trends of fatty acid enzyme activity relative to dietary pyridoxine 
supplementation. The activity of Δ-6 desaturase on its three substrates (LA, ALA and 
24:5n-3) was increased by the dietary pyridoxine content, peaking at the inclusion level 
of 4.6 mg kg-1. On the other hand, Δ-5 desaturase activity on 20:3n-6 and 20:4n-3 (to 
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produce ARA and EPA, respectively) showed a direct linear relationship with dietary 
pyridoxine content. Similar trends were also recorded for elongase activity on the 
various substrates, with the most evident effect on the elongation of 18:3n-6 and 20:4n-6 
which was properly described by a linear relationship (P<0.05), clearly suggesting that 
pyridoxine has a direct positive effect on this enzymatic activity. Accordingly, in a study 
carried out on rats by Bertrandt et al. (2004a), it was suggested that dietary 
supplementation with pyridoxine might stimulate pathways of PUFA synthesis. 
Similarly, Tsuge et al. (2000) clearly showed that the activity of Δ-6 desaturase was 
significantly lower (~64%) in rats fed with a pyridoxine-deficient diet compared to the 
pair-fed control group. A direct effect of pyridoxine status on fatty acid elongation in 
microsomes and mitochondria in rat brains has been shown (Chauhan and 
Dakshinamurti, 1979).  Accordingly, impaired fatty acid desaturation and elongation 
was apparent in rats receiving pyridoxine deficient diets (Cunnane et al., 1984). 
However, in Atlantic salmon (Albrektsen et al., 1994), it was reported that the 
desaturation and elongation of [1-14C] 18:3n-3 in liver following intra-peritoneal 
injection was not affected by dietary pyridoxine level. The discrepancy between this 
study and the results of present study are likely attributable to the differing pyridoxine 
administration methods and the vastly different experimental durations. 
 
In conclusion, whilst the actual mechanism by which pyridoxine affects the activity of 
enzymes involved in the LC-PUFA biosynthetic pathway are not yet fully elucidated, the 
present study further confirms that dietary pyridoxine level modulates and positively 
stimulates LC-PUFA biosynthesis despite the effects observed are likely of very limited 
biological significance.   
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Over fortification with pyridoxine, above the minimum dietary requirement, has no 
significant impact on growth performance of rainbow trout, but can be responsible for 
improved LC-PUFA biosynthesis. Therefore, it is possible to suggest that dietary 
pyridoxine levels higher than the minimum dietary requirement should be included in 
aquafeed formulations, especially when fish oil is replaced with alternative oils, in order 
to maximise the LC-PUFA biosynthetic capability of cultured fish. However, it is also 
important to underline that the actual modification of the final fatty acid make-up of fish 
tissues in response to pyridoxine fortification is trivial. Thus, whilst the results of the 
present study could contribute towards expanding the knowledge of fatty acid 
metabolism in fish, and tentatively improve the efficiency of n-3 LC-PUFA utilisation in 
aquaculture, the problem of substituting fish oil in aquafeed formulations and the 
resultant detrimental modification of the nutritional qualities of culture products are still 
far from being solved. 
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CHAPTER 6 
Effects of dietary iron supplementation on growth performance, fatty acid 
composition and fatty acid metabolism in rainbow trout (Oncorhynchus mykiss) fed 
vegetable oil based diets 
A peer reviewed publication has resulted from this chapter. 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of 
dietary iron supplementation on growth performance, fatty acid composition and fatty 
acid metabolism in rainbow trout (Oncorhynchus mykiss) fed vegetable oil based diets. 
Aquaculture 342-343, 80-88.  
 
6.1 Introduction 
Previous studies conducted using animal models have reported that several nutritional 
factors affect de novo fatty acid biosynthesis (Kirschman and Coniglio, 1961; Bautista 
and Cruz, 1988; Sul and Wang, 1998; Krajcovicova-Kudlackova et al., 2004; Nakamura 
and Nara, 2004; Rao et al., 1984). Among these factors, specific metals play an 
important structural and functional role in a number of proteins which function in 
enzyme catalysing fatty acid bioconversions (Broadwater et al., 1998; Cunnane, 1988a; 
Cunnane, 1988b; Fox et al., 1994; Taugbøl et al., 2009; Guillou et al., 2010). Of these, 
iron has been recognised as one of the key regulatory factors in lipid metabolism in 
animals and is known to be heavily involved in LC-PUFA biosynthesis (Cunnane and 
McAdoo, 1987; Fox et al., 1994; Stangle and Kirchgessner, 1998Krajcovicova-
Kudlackova et al., 2004). 
 
Iron is present in the active di-iron centres in each terminal protein of the Δ-6 and Δ-5 
desaturase enzyme complex (Okayasu et al., 1981; Wallis et al., 2002; Krajcovicova-
Kudlackova et al., 2004; Shanklin et al., 2009). Moreover, iron is known to function as a 
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structural component of the Δ-9 desaturase (stearoyl CoA desaturase) enzyme complex 
(Fox et al., 1993; Fox et al., 1994; Fox et al., 2004) that consists of cytochrome b5, 
cytochrome b5 reductase and terminal desaturase containing non-heme iron protein 
(Wallis et al., 2002). In their action, desaturase enzymes perform dehydrogenation 
reactions that result in the introduction of double bonds into the fatty acid carbon chain 
initiated by the energy-demanding abstraction of hydrogen from a methylene group 
(Broadwater et al., 1998; Buist, 2004; Fox et al., 2004). To achieve this, desaturase 
enzymes recruit and activate molecular oxygen with the use of an active-site di-iron 
cluster (Fox et al., 1993). 
 
Previous clinical and experimental studies on rats & humans have shown that iron 
deficiency has an adverse effect on the metabolism of PUFA (Cunnane and McAdoo, 
1987; Krajcovicova-Kudlackova et al., 2004). For example, vegetarian test subjects with 
low iron serum levels demonstrated a significantly reduced formation of n-3 LC-PUFA 
in comparison to test subjects with normal iron serum levels (Krajcovicova-Kudlackova 
et al., 2004).  The same study then goes on to suggest that iron plays an important role in 
the synthesis of LC-PUFA, specifically through its involvement in the Δ-6 and Δ-5 
desaturation steps. Consistently, it has been suggested that iron deficiency affects the 
synthesis and/or the activity of the Δ-6 desaturase enzyme because of its presence in the 
enzyme complex (Okayasu et al., 1981; Stangle and Kirchgessner, 1998). In rats, iron 
deficiency has been shown to depress serum phospholipid levels and resultantly 
significantly affect fatty acid composition, indicating impaired desaturation of saturated 
fatty acids (SFA) by the Δ-9 desaturase (to produce monounsaturated fatty acids, 
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MUFA) and impaired desaturation of PUFA by the Δ-6 and Δ-5 desaturase enzymes 
(Stangle and Kirchgessner, 1998). 
 
Despite the numerous functional roles played by iron in living organisms, and its direct 
involvement in LC-PUFA biosynthesis, so far, to the best of authors’ knowledge, no 
clear scientific evidence is available on the effects of dietary iron on lipid metabolism in 
fish. In consideration of the escalating fish oil crisis and the major constraints associated 
with fish oil replacement in aquaculture feed and the dilution of n-3 LC-PUFA in final 
products, this topic is of particular importance. Hence, the objective of this study was to 
determine the potential role of iron on the bioconversion of n-3 C18 PUFA (18:3n-3) to 
n-3 LC-PUFA (20:5n-3 and 22:6n-3) when fish are fed a fish oil free diet. In this 
context, the present feeding experiment was designed to explore the effects of graded 
dietary iron concentration in 100% vegetable oil based diets on the n-3 LC-PUFA 
biosynthetic pathway in rainbow trout (Oncorhynchus mykiss). 
 
6.2 Materials and methods 
Animals and husbandry methodologies used for this experimentation were described in 
Chapter 2. 
 
6.2.1 Experimental diets 
Six iso-proteic, iso-lipidic experimental diets, varying only in the iron concentration 
were formulated to contain ~20% of lipid and ~40% of protein.  Fish meal, whey 
protein, lupin flour, wheat gluten, gelatine and soybean meal were used as dietary 
protein sources and a blend of canola (rapeseed) and linseed oils was utilised as the 
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dietary lipid source to formulate the vegetable oil based basal diets (Table 6.1). Ferrous 
sulphate (FeSO4.7H2O) was added to the well-homogenised dry ingredient mixture of 
the diet after being dissolved in de-ionised water to provide graded concentrations of 0, 
20, 40, 80, 160 and 320 mg of ferrous sulphate per kg diet. Diets were manufactured as 
previously described in detail (Brown et al., 2010) and the dry pellets were then stored in 
sealed plastic bags at -20 0C until used. The six experimental diets were designated from 
RT-FE-1 through RT-FE-6 based on their iron concentration (Table 6.1). 
 
6.2.2 Experimental design 
Upon acclimation, 360 juvenile specimens were individually weighed (initial mean 
weight of 50.50±0.36 g) and randomly allocated into triplicate groups amongst the 18 
tanks (20 fish per tank; 3 tanks per treatment, n=3, N= 18). At the commencement of the 
feeding trial, an additional sample of 10 fish was taken and euthanized in excess 
anaesthetic for subsequent analysis.  Fish were fed with one of the six formulated diets 
twice daily to apparent satiation at 0900 h and 1600 h for a 58-day rearing period. Feed 
consumption was recorded weekly and mortalities were recorded throughout the 
experimental period.  Faeces were collected for the estimation of digestibility parameters 
during the last week of the feeding trial using collection vessels mounted on the tank 
outflow line as previously described by Francis et al. (2007c) Briefly, tanks and 
collection vessels were evacuated of any uneaten feed following the afternoon feed in 
preparation for faeces collection the following morning. Prior to the morning feed the 
faeces collection vessels were individually emptied and faecal matter immediately 
frozen at −20 °C, subsequently freeze dried and stored at −20 °C until analysed. At the 
termination of the feeding trial, all fish were individually weighed and 12 fish from each 
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experimental tank (36 fish per treatment) were culled in excess anaesthetic and stored at 
-20°C for further analysis. All implemented procedures during the experimentation were 
approved by the Deakin University Animal Welfare Committee. 
 
6.2.3 Chemical analysis 
The samples subjected to chemical analysis included the six experimental diets, trout 
whole bodies (4 fish per tank; 12 fish per treatment), fillets and livers (8 fish per tank; 24 
fish per treatment).   
 
Proximate analysis, Fatty acid analysis and Chromic acid analysis and subsequent 
calculations of digestibility for each individual fatty acid were carried out according to 
the procedures and formulae mentioned in General Materials and Method (Chapter 2). 
 
6.2.4 Calculation of growth, biometric and feed utilization parameters 
Growth, biometric and feed utilization parameters were determined using the formulae 
described in Chapter 2. 
 
6.2.5 Determination of in vivo β-oxidation, desaturase and elongase activity 
The estimation of the apparent in vivo fatty acid metabolism (fatty acid de novo 
production, β-oxidation, elongation and desaturation) was calculated via the 
implementation of the whole body fatty acid balance method briefly explained in 
Chapter 2 of this thesis and initially proposed and fully described by Turchini et al. 
(2007b) with subsequent developments (Turchini et al., 2008; Turchini and Francis, 
2009).  
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6.2.6 Determination of iron 
Determination of iron in experimental diets, trout whole bodies and livers was 
implemented on blind samples by an accredited external laboratory (National 
Measurement Institute, Department of Innovation, Industry, Science and Research, 
Melbourne, VIC, Australia) and was carried out by inductively coupled plasma-mass 
spectrometry (ICP-MS) and inductively coupled-atomic emission spectrometry (ICP-
AES). Briefly, samples were homogenised and a sub-sample (0.2-0.5g) was digested 
with re-distilled nitric acid on a DigiPrep block for one hour until vigorous reaction was 
complete. Samples were then transferred to a Milestone microwave to be further 
digested. After making up to an appropriate volume with Milli-Q (high purity) water, the 
digest was analysed for trace elements using ICP-MS and / or ICP-AES. Limit of 
reporting (LOR) by the method was 0.2-1.0 Fe mg/kg sample. 
 
6.2.7 Statistical analysis 
Statistical analyses were performed as described in Chapter 2. In addition, all data were 
analysed amongst treatments by (i) linear regression (relative to analytically verified 
dietary iron concentrations at significant levels of 0.05) 
 
6.3 Results 
6.3.1 Experimental diets composition  
The proximate composition of the six experimental diets were close to identical and the 
diets were therefore considered iso-proteic (~400 mg/kg), iso-lipidic (~200 mg kg-1) and 
iso-energetic (~22 MJ kg-1) (Table 6.1). The analysed iron concentrations of the six 
experimental diets were 56.5, 65.5, 73.0, 82.5, 92 and 115 mg kg-1 of diet for RT-FE-1, 
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RT-FE-2, RT-FE-3, RT-FE-4, RT-FE-5 and RT-FE-6, respectively. Considering that the 
iron content of ferrous sulphate (FeSO4.7H2O) is roughly 20.1% of total mass, the 
dietary iron concentrations were close to expected values. However, these values clearly 
demonstrate that the raw materials used for diet formulation contained some iron. 
 
The fatty acid composition of the experimental diets were almost identical (Table 6.2) 
and comprised of 9% of saturated fatty acids (SFA), 49% of monounsaturated fatty acids 
(MUFA) and 42% of polyunsaturated fatty acids (PUFA) as a percentage of total fatty 
acids. The SFA content was mainly represented by 16:0 followed by 18:0, while the 
MUFA content was dominated by 18:1n-9. The PUFA fraction of the experimental diets 
was dominated by 18:2n-6 followed by 18:3n-3, representing 21% and 19% of total fatty 
acids, respectively. The dietary LC-PUFA content was very limited and was constant 
across the six dietary treatments. 
 
6.3.2 Growth performances and biometry 
All experimental diets were well accepted by the fish and mortality was negligible 
throughout the 58-day feeding trial. No significant differences were noted by ANOVA 
or linear regression analysis (P>0.05) in final mean weight, % gain or SGR amongst the 
six dietary treatments. Similarly, in relation to feed utilisation parameters, no significant 
differences were observed in FCR, PER or FDR. With regard to biometric parameters, 
no significant differences were noted in %DP or %FY. However, HSI was significantly 
lower (ANOVA, P<0.05) in fish fed the RT-FE-4 diets in comparison to fish fed the RT-
FE-2 and RT-FE-6 diets (Table 6.3). 
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6.3.3 Chemical composition 
The proximate composition of trout fillets and whole-bodies at the termination of the 
experimental trial did not show any statistically significant differences amongst 
treatments in relation to moisture, protein or ash content (data not reported). 
Independently from the dietary iron concentrations, during the course of the experiment, 
there was a large increase in lipid content in fish fillet and whole body samples. 
Statistically significant differences were recorded in total lipid levels in trout fillets 
(Table 6.4), showing an inversely correlated linear relationship (P<0.05) with the 
increasing supplementation of dietary iron. The livers of fish fed the RT-FE-4 and RT-
FE-5 diets demonstrated significantly higher (P<0.05) levels of total lipid compared to 
those fed the RT-FE-1 and RT-FE-2 diets. However, no statistically significant linear 
regression relative to dietary iron content was observed (Table 6.4). 
 
During the feeding trial, the hepatic and whole body iron concentrations of trout showed 
a drastic reduction compared to those reported in the initial fish samples taken at the 
commencement of the feeding experiment (Table 6.4). The final iron concentrations in 
liver and trout whole bodies clearly reflected the dietary iron concentrations. Therefore, 
the iron concentrations in both liver and whole body samples increased with the 
increasing iron levels in corresponding diets. The iron concentrations in trout livers 
ranged from 250.0±5.8 mg kg-1 (RT-FE-1) to 273.3±17.6 mg kg-1 (RT-FE-6). However, 
there was no significant difference between the dietary treatments in reference to these 
levels, although there was a noticeable increasing trend with elevated dietary iron 
supplementation. The whole body iron concentration ranged from 30.0±2.1 mg kg-1 
(RT-FE-1) to 48.0±0.6 mg kg-1 (RT-FE-6) and though no significant differences were 
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detected by ANOVA , the linear regression analysis clearly showed the existence of a 
statistically significant (P<0.05) relationship (Table 6.4). 
 
6.3.4 Fatty acid composition of trout tissues 
The fatty acid composition of the livers and fillets of fish fed the six iron supplemented 
diets are reported in Tables 5 and 6, respectively.  Regardless of the dietary treatment, 
the highest proportion of SFA was comprised of 16:0 followed by 18:0 and 14:0, in both 
trout livers and fillets, whilst the MUFA content in both tissues was generally dominated 
by 18:1n-9, followed by 18:1n-7. The n-3 PUFA content in trout livers was more than 2-
fold higher in comparison to n-6 PUFA. However, in trout fillets, the amount of n-3 
PUFA was almost identical to that of n-6 PUFA. 
 
In the liver, the only fatty acids recording statistically significant differences were 18:3n-
6, 18:4n-3 (in both cases significantly higher in RT-FE-4, RT-FE-5 and RT-FE-6 
compared to RT-FE-1, RT-FE-2 and RT-FE-3) and 20:4n-3 (significantly higher in RT-
FE-4, RT-FE-5 and RT-FE-6 compared to RT-FE-1 and RT-FE-2). These three fatty 
acids also recorded a statistically significant linear relationship with the dietary iron 
content, clearly indicating that the higher the dietary iron content, the higher the fatty 
acid concentration in liver samples (Table 6.5). Liver concentrations of 18:0 and 20:4n-
6, though non-significant when ANOVA was applied, demonstrated a significant linear 
regression relative to dietary iron content, with fatty acid concentrations reducing as the 
dietary iron concentration increased. 
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In the fillet, ANOVA detected statistically significant differences for 18:0, 18:3n-3, 
20:4n-6, 20:4n-3, SFA, n-3 PUFA and n-3 LC-PUFA. On the other hand, linear 
regression analysis recorded several other noteworthy statistically significant trends 
(Table 6.6). In particular, SFA, specifically 14:0, 16:0 and 18:0 decreased with the 
increase in dietary iron, whilst n-3 PUFA and n-3 LC-PUFA, particularly 20:3n-3, 
20:4n-3, 20:5n-3 and 22:6n-3, all demonstrated an increasing concentration with the 
increase of dietary iron content. Similarly, 20:4n-6 was higher in RT-FE-4, RT-FE-5 and 
RT-FE-6 (the diets containing higher concentrations of iron) compared to the other 
treatments. The fatty acid composition of trout whole body samples followed general 
similar trends as those reported for trout fillets, and data are therefore not reported. 
 
6.3.5 In vivo fatty acid metabolism  
The main results of the assessment of the in vivo fatty acid metabolism in rainbow trout 
fed diets containing different concentrations of iron and deduced by the whole body fatty 
acid balance method are reported in Tables 6.7 and 6.8. No statistically significant 
differences (P>0.05) were detected  by ANOVA in any of the estimated apparent in vivo 
enzyme activities. Similarly, regression analysis was unable to detect any statistically 
significant trends. This lack of significance was likely given by the relatively large 
variability recorded. However, several apparent trends were noted with apparent in vivo 
Δ-9 desaturase activity, elongase activity on n-3 PUFA, and both Δ-6 and Δ-5 desaturase 
activity on n-3 PUFA, all recording an R2 value over 0.7 (Table 6.7).  Similarly, the 
apparent in vivo bioconversion of 18:3n-3 to 18:4n-3 (Δ-6 desaturase), 24:5n-3 to 24:6n-
3 (Δ-6 desaturase) and 20:4n-3 to 20:5n-3 (Δ-5 desaturase), also recorded R2 values over 
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0.7, as was the case for some elongase activity for the bioconversion of 18:3n-3 to 
20:3n-3, 18:4n-3 to 20:4n-3 and 22:5n-3 to 24:5n-3 (Table 6.8). 
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Table 6.1 Formulation and proximate composition of the rainbow trout experimental diets 
for the 3rd feeding trial for 58 days 
 Dietary treatments1 
Formulation RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 
(g k-1) 
Fish meal2 90 90 90 90 90 90 
Defatted soybean meal2 287 287 287 287 287 287 
Wheat gluten2 4 4 4 4 4 4 
Whey protein3 135 135 135 135 135 135 
Lupin flour4 180 180 180 180 180 180 
Wheat flour5 6 6 6 6 6 6 
Gelatin6 28 28 28 28 28 28 
CMC7 20 20 20 20 20 20 
Mineral mix8 40 40 40 40 40 40 
Vitamin mix9 30 30 30 30 30 30 
Choline6 5 5 5 5 5 5 
Cr2O36 2 2 2 2 2 2 
Canola oil5 120 120 120 120 120 120 
Linseed10 50 50 50 50 50 50 
(mg kg-1) 
alpha –cellulose10 1000 980 960 920 840 680 
Fe (Ferrous sulphate)6 0 20 40 80 160 320 
Proximate composition (mg g-1) 
Moisture 53.9 53.2 51.8 51.1 46.3 48.7 
Crude lipid 198.4 206.1 192.4 190.0 200.4 196.6 
Crude protein 403.1 405.9 406.3 404.0 403.2 401.6 
Ash 68.5 68.0 65.8 67.8 66.9 67.4 
NFE11 276.0 266.8 283.7 287.1 283.2 285.6 
Energy12 22.1 22.3 22.1 22.0 22.3 22.2 
1 Diet abbreviations- RT-FE-1: (56.5mg Fe/kg); RT-FE-2: (65.5 mg FE/kg), RT-FE-3: (73.0mg FE/kg), RT-
FE-4: (82.5 mg Fe/kg), RT-FE-5: (92.0 mg Fe/kg); RT-FE-6 (115 mg Fe/kg) 
2 Ridley Agriproducts, Narangba, Queensland, Australia. 
3 Warrnambool cheese and butter factory, Warrnambool, Victoria, Australia 
4 Irwin Valley, Palmyro,Western Australia, Australia 
5Black and Gold, Tooronga, Victoria, Australia. 
6 Sigma-Aldrich, Inc. St. Louis, MO, USA 
7Carboxymethyl cellulose (CMC) - BDH Laboratory Supplies, Poole, United Kingdom. 
8Iron free mineral mix supplemented (in g/kg diet) with Ca(C6H10O6)-5H2O, 348.49; Ca(H2PO4)2 -H2O, 136;  
MgSO4-7H2O, 132; K2HPO4, 240; NaH2PO4-H2O, 88; NaCl, 45; AlCl3-6H2O, 0.15; KI,0.15; CuSO4-5H2O,0.5;  
MnSO4-H2O,0.7; CoCl2-6H2O,1.0; ZnSO4-7H2O,3.0; NaSeO3,0.01; alpha cellulose,5.0. 
9Vitamin mix (in g/kg diet) with Ascorbic acid (vit C),50; DL-calcium pantothenate,5; choline bitartrate,100; 
inositol,5; menadione,2; niacin (vit B3),5; riboflavin,3; thiamine hydrochloride,0.5; Dl-alpha- tocopherol 
acetate (250IU/g),8; vitamin A acetate (20 000 IU/g),5; biotin,0.05; cholecalciferol (1ug=40IU),0.002; folic 
acid;0.18; vitamin B12,0.002; Pyridoxine,1.0; alpha cellulose,815.266. 
10 Sceneys refined, Scenery Chemical PTY., LTD. Sunshine, VIC., Austraria 
11 NFE (Nitrogen Free Extract): Calculated by difference. 
12Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat and carbohydrate, respectively 
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Table 6.2 Fatty acid composition of experimental diets in mg g lipid-1 (% of total fatty 
acids w/w, in parentheses) 
  Dietary treatments1 
  RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 
14:0                 3.63(0.38) 3.72(0.39) 3.84(0.40) 3.82(0.39) 3.46(0.36) 3.98(0.41) 
16:0                 52.72(5.49) 53.45(5.54) 54.58(5.65) 54.86(5.64) 52.68(5.45) 53.57(5.55) 
16:1n-7              2.86(0.30) 2.87(0.30) 2.90(0.30) 3.25(0.33) 2.88(0.30) 2.93(0.30) 
18:0                 24.80(2.58) 25.47(2.64) 25.58(2.65) 25.93(2.67) 25.25(2.61) 25.69(2.66) 
18:1n-9              429.89(44.77) 430.30(44.56) 428.24(44.35) 431.17(44.35) 430.06(44.50) 429.57(44.52) 
18:1n-7              28.65(2.98) 29.59(3.06) 28.76(2.98) 29.83(3.07) 29.53(3.06) 29.33(3.04) 
18:2n-6              203.34(21.17) 205.04(21.23) 206.13(21.35) 206.79(21.27) 205.76(21.29) 204.30(21.17) 
18:3n-6              nd2 nd nd nd nd nd 
18:3n-3              186.62(19.43) 187.64(19.43) 187.86(19.45) 187.61(19.30) 188.26(19.48) 187.76(19.46) 
18:4n-3              0.68(0.07) 0.32(0.03) 0.42(0.04) 0.17(0.02) 0.32(0.03) 0.32(0.03) 
20:0                 4.07(0.42) 4.21(0.44) 4.19(0.43) 4.18(0.43) 4.37(0.45) 4.10(0.43) 
20:1 6.75(0.70) 7.34(0.76) 6.75(0.70) 7.28(0.75) 6.82(0.71) 7.07(0.73) 
20:2n-6              0.65(0.07) 0.62(0.06) 0.51(0.05) 0.78(0.08) 0.91(0.09) 0.69(0.07) 
20:3n-6              0.00(0.00) 0.00(0.00) 0.00(0.00) 0.00(0.00) 0.00(0.00) 0.00(0.00) 
20:4n-6              0.59(0.06) 0.62(0.06) 0.62(0.06) 0.71(0.07) 0.59(0.06) 0.64(0.07) 
20:3n-3              0.16(0.02) 0.15(0.02) 0.14(0.01) 0.13(0.01) 0.16(0.02) 0.13(0.01) 
20:4n-3              0.21(0.02) 0.16(0.02) 0.16(0.02) 0.18(0.02) 0.17(0.02) 0.18(0.02) 
20:5n-3              2.79(0.29) 2.87(0.30) 3.09(0.32) 3.41(0.35) 2.84(0.29) 2.68(0.28) 
22:0                 2.88(0.30) 2.90(0.30) 3.08(0.32) 2.99(0.31) 2.91(0.30) 2.92(0.30) 
22:1 0.78(0.08) 0.79(0.08) 0.83(0.09) 0.53(0.05) 0.71(0.07) 0.96(0.10) 
22:2n-6              nd nd nd nd nd nd 
22:4n-6              0.22(0.02) 0.20(0.02) 0.23(0.02) 0.18(0.02) 0.24(0.02) 0.21(0.02) 
22:5n-3              1.97(0.20) 1.31(0.14) 1.73(0.18) 1.72(0.18) 2.55(0.26) 1.80(0.19) 
22:6n-3              6.06(0.63) 6.02(0.62) 6.01(0.62) 6.70(0.69) 5.91(0.61) 6.05(0.63) 
Total Fatty Acids 960.32(100) 965.61(100) 965.66(100) 972.21(100) 966.38(100) 964.90(100.) 
SFA 88.11(9.17) 89.76(9.30) 91.27(9.45) 91.77(9.44) 88.67(9.18) 90.26(9.35) 
MUFA 468.94(48.83) 470.89(48.77) 467.48(48.41) 472.07(48.56) 470.00(48.63) 469.87(48.70) 
PUFA 403.28(41.99) 404.95(41.94) 406.91(42.14) 408.37(42.00) 407.71(42.19) 404.77(41.95) 
n-6 PUFA 204.80(21.33) 206.49(21.38) 207.49(21.49) 208.45(21.44) 207.49(21.47) 205.84(21.33) 
n-6 LC-PUFA 1.45(0.15) 1.45(0.15) 1.36(0.14) 1.66(0.17) 1.73(0.18) 1.54(0.16) 
n-3 PUFA 198.48(20.67) 198.46(20.55) 199.42(20.65) 199.92(20.56) 200.22(20.72) 198.93(20.62) 
n-3 LC-PUFA 11.19(1.17) 10.50(1.09) 11.14(1.15) 12.13(1.25) 11.63(1.20) 10.84(1.12) 
 
1 See Table 6.1 for diet abbreviations. 
2nd=not detected 
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Table 6.3 Mean (± SEM) of growth, feed utilization and other body parameters of rainbow trout 
reared for 58 days on the vegetable oil experimental diets with graded levels of iron 
Dietary treatments1 Regression 
  RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 P value 
Initial mean weight (g) 50.72±0.17 50.55±0.55 50.50±0.36 50.40±1.05 50.42±0.52 50.50±0.25 ns2 
Mean final weight (g) 185.63±3.34 190.57±2.62 190.25±4.02 195.00±6.40 196.27±7.65 192.89±6.32 ns 
Weight gain (%)3 266.01±6.10 277.11±7.13 276.77±8.33 287.06±12.25 289.07±11.30 281.87±10.79 ns 
SGR4(% day-1) 2.40±0.03 2.46±0.03 2.46±0.04 2.50±0.06 2.51±0.05 2.48±0.05 ns 
Feed consumption  
(g fish-1) 167.39±1.18 177.02±3.72 171.56±1.36 181.92±2.76 177.62±4.39 177.50±5.38 ns 
FCR5 1.17±0.02 1.20±0.01 1.17±0.03 1.20±0.07 1.16±0.03 1.19±0.02 ns 
PER6(% day-1) 2.00±0.04 1.96±0.02 2.02±0.05 1.98±0.11 2.03±0.05 1.99±0.03 ns 
FDR7(% day-1) 5.25±0.09 5.32±0.14 5.35±0.02 5.43±0.06 5.49±0.20 5.37±0.03 ns 
DP8 (%) 84.33±0.49 83.38±0.67 84.70±0.16 84.46±0.75 83.44±0.47 84.05±0.67 ns 
FY9(%) 51.09±1.49 50.41±1.81 49.25±1.62 50.08±1.93 49.14±1.10 50.99±1.50 ns 
HSI10(%) 1.50±0.05ab 1.65±0.02b 1.51±0.07ab 1.38±0.04a 1.52±0.04ab 1.66±0.04b ns 
Data represent mean ± SEM (n=3, N=18). Values in the same row with different superscripts are significantly different (P 
< 0.05; ANOVA and Student–Newman–Keuls post hoc test).  
1 See Table 6.1, for diet abbreviations. 
2ns = not significant (P >0.05)    
3 Weight Gain% = (final weight−initial weight)×(initial weight)−1×100. 
4 SGR; Specific Growth Rate = [Ln(final weight) − Ln(initial weight)] × (number of days)−1 ×100. 
5 FCR; Feed Conversion Ratio = (dry feed fed) × (wet weight gain)−1. 
6 PER; Protein Efficiency Ratio = (final weight - initial weight) x (mass of protein consumed)-1. 
7 FDR; Fat Deposition Rate = [Ln(final lipid)−Ln(initial lipid)]×(number of days)−1. 
8 DP; Dress-out percentage = (CW x BW -1) x 100; where CW is carcass gutted weight (g) and BW is body weight (g). 
9 FY; Fillet yield percentage = (FW x BW -1) x 100; where FW is fillet weight (g). 
10 HSI; Hepatosomatic index = (LW x BW -1) x 100; where LW is liver weight (g). 
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Table 6.4 Lipid and iron concentration of trout tissues (mean ± SE) at the end of the 58-day 
rearing period on vegetable oil based experimental diets with varying concentrations of 
iron2 
  Dietary treatments
1 Regression 
  Initial RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 P value 
Lipid (%)         
Whole body 3.62 16.53±0.64 16.65±0.57 16.73±0.45 17.04±0.44 17.54±1.04 16.76±0.22 ns2 
Liver 3.6 4.06±0.09a 3.99±0.09a 4.33±0.12ab 4.52±0.08b 4.48±0.08b 4.14±0.13ab ns 
Fillet 1.6 9.90±0.23a 11.27±0.28b 9.95±0.36a 9.72±0.29a 9.68±0.16a 9.35±0.35a 0.003 
         
Iron (mg kg-1)         
Whole body 58 30.00±2.08 30.33±0.33 34.33±2.19 40.50±3.75 47.00±11.06 48.00±0.58 0.005 
Liver 590 250.00±5.77 256.67±8.82 260.00±5.77 260.00±11.55 270.00±20.82 273.33±17.64 ns 
Data represent means ± standard error (n=3; N=18). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test).  
1 See Table 6.1 for diet abbreviations  
2 ns = not significant (P >0.05)    
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Table 6.5 Fatty acid composition of rainbow trout livers (mg g of lipid-1) at the end of 
the 58-day feeding trial using vegetable oil based experimental diets supplemented with 
iron 
  Dietary treatments1 Regression 
 RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 P value 
14:0                 4.67±0.15 4.66±0.16 4.77±0.19 4.61±0.28 5.06±0.48 4.60±0.11 ns2 
16:0                 98.16±3.82 96.01±5.11 94.50±2.27 90.94±4.01 88.99±5.17 93.63±1.02 ns 
16:1n-7              5.47±0.18 5.60±0.33 6.86±1.60 5.78±0.29 5.97±0.53 5.73±0.81 ns 
18:0                 49.96±2.38 50.03±2.45 49.11±2.14 50.37±0.55 47.05±3.71 43.39±1.05 0.037 
18:1n-9              185.55±9.97 186.64±5.21 186.33±15.10 191.38±7.75 203.55±0.54 190.47±9.70 ns 
18:1n-7              15.26±0.54 15.13±0.33 15.30±1.04 15.78±0.33 16.33±0.25 15.44±0.61 ns 
18:2n-6              73.60±2.73 71.07±0.48 71.06±1.61 71.95±1.13 78.25±3.46 76.35±3.32 ns 
18:3n-6              1.90±0.21 1.72±0.04 1.87±0.23 1.65±0.35 2.16±0.08 2.28±0.12 0 
18:3n-3              34.94±2.15 32.39±0.71 32.04±0.32 32.69±1.42 38.78±3.69 36.51±1.88 ns 
18:4n-3              5.10±0.34a 5.38±0.19a 5.68±0.42a 6.92±0.32b 6.79±0.12b 7.02±0.17b 0 
20:0                 2.02±0.32 2.05±0.15 1.77±0.18 1.79±0.06 1.86±0.12 1.95±0.08 ns 
20:1 12.11±1.67 13.90±1.18 13.24±1.53 14.70±0.73 14.92±1.47 13.28±0.78 ns 
20:2n-6              10.28±0.86 11.10±0.43 10.48±0.28 11.57±0.20 11.83±0.70 11.06±0.24 ns 
20:4n-6              30.78±0.86 31.80±1.77 30.97±1.62 29.20±1.66 27.46±2.23 27.84±0.44 0.05 
20:3n-3              4.32±0.38 5.03±0.10 4.37±0.21 5.03±0.20 5.04±0.23 4.88±0.11 ns 
20:4n-3              5.00±0.34a 5.18±0.19a 5.38±0.42ab 6.52±0.32b 6.29±0.12b 6.42±0.17b 0.001 
20:5n-3              21.94±0.53 21.60±0.94 22.78±1.65 23.20±1.04 23.58±0.64 22.84±0.14 ns 
22:0                 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.32±0.32 0.14±0.14 ns 
22:1 0.56±0.33 0.93±0.18 0.89±0.15 0.20±0.20 0.99±0.28 0.60±0.32 ns 
22:2n-6              nd3 0.40±0.20 nd nd nd nd ns 
22:4n-6              1.94±0.23 1.93±0.05 2.04±0.24 2.00±0.10 1.55±0.13 1.68±0.08 ns 
22:5n-3              10.45±1.32 10.89±1.09 9.09±1.28 11.99±0.74 10.86±0.52 11.42±1.63 ns 
22:6n-3              190.02±2.95 188.66±8.60 178.97±10.11 181.06±12.74 165.52±5.83 174.63±2.20 ns 
Total 764.05±12.68 762.09±12.92 747.50±14.42 759.32±14.03 763.16±17.18 752.15±15.50 ns 
SFA 154.81±1.75 152.75±7.65 150.16±3.97 147.71±4.64 143.29±8.26 143.71±1.42 ns 
MUFA 218.96±12.34 222.20±6.83 222.61±18.86 227.84±8.96 241.77±2.10 225.51±11.76 ns 
PUFA 390.28±1.23 387.14±12.01 374.73±13.09 383.77±13.30 378.10±9.41 382.93±5.06 ns 
n-6 -PUFA 118.51±1.89 118.02±2.09 116.42±2.76 116.37±1.34 121.24±3.01 119.21±3.44 ns 
n-6 LC-PUFA 43.00±1.57 45.23±1.77 43.49±1.96 42.77±1.58 40.84±2.50 40.58±0.38 ns 
n-3 PUFA 271.77±2.13 269.13±9.95 258.30±12.24 267.40±12.56 256.86±6.59 263.72±1.68 ns 
n-3 LC-PUFA 231.73±4.01 231.36±9.15 220.58±12.11 227.79±13.67 211.29±6.29 220.19±1.24 ns 
Data represent means ± standard error (n=3; N=18). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test).  
1 See Table 6.1 for diet abbreviations 
2 ns = not significant (P >0.05)    
3nd= not detected 
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Table 6.6 Fatty acid composition of rainbow trout fillets (mg g of lipid-1) at the end of 
the 58-day feeding trial using vegetable oil based experimental diets supplemented with 
iron. 
Dietary treatments1 Regressio
n
RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 P value 
14:0                8.49±0.05 8.22±0.06 8.44±0.15 8.16±0.12 7.92±0.17 7.88±0.25 0.006 
16:0                98.47±0.60 95.89±0.33 98.46±1.33 95.87±1.11 91.92±2.23 92.22±3.06 0.008 
16:1n-7           10.52±0.26 10.56±0.34 11.20±0.80 10.06±0.42 9.97±0.47 9.45±1.14 ns2 
18:0                36.03±0.58c 34.56±0.27bc 35.24±0.45bc 35.29±0.41bc 33.60±0.22ab 32.72±0.63a 0.000 
18:1n-9           392.92±2.54 401.06±4.12 391.57±2.39 391.61±2.40 396.10±5.60 393.43±4.17 ns 
18:1n-7           26.66±0.16 27.00±0.18 26.52±0.13 26.50±0.34 27.92±0.23 26.72±0.20 ns 
18:2n-6           153.08±1.13 154.83±1.15 153.55±0.87 152.96±2.24 156.99±0.73 155.89±0.60 ns 
18:3n-6           4.11±0.21 3.80±0.12 4.14±0.23 4.30±0.60 4.18±0.35 4.24±0.10 ns 
18:3n-3           98.02±1.01a 102.12±0.95a
b
97.73±0.68a 99.17±1.68ab 103.12±1.32
b
102.29±0.32a
b
0.014 
18:4n-3           14.37±0.73 12.98±0.56 14.54±0.89 15.65±2.35 14.90±1.21 15.73±0.45 ns 
20:0                2.35±0.04 2.35±0.03 2.33±0.03 2.29±0.02 2.38±0.03 2.40±0.04 ns 
20:1 12.03±0.20 12.73±0.18 12.34±0.05 12.68±0.66 13.26±0.31 12.80±0.23 ns 
20:2n-6           5.89±0.20 6.65±0.17 5.26±1.01 6.42±0.56 6.94±0.19 6.71±0.11 ns 
20:4n-6           2.39±0.16a 2.32±0.09a 2.86±0.08b 3.06±0.04b 2.96±0.21b 2.96±0.03b 0.001 
20:3n-3           3.46±0.18 4.00±0.09 3.66±0.10 3.81±0.42 4.38±0.22 4.25±0.07 0.016 
20:4n-3           4.02±0.07a 4.11±0.08a 4.05±0.05a 4.14±0.15a 4.58±0.06b 4.71±0.12b 0.000 
20:5n-3           7.40±0.04 7.42±0.07 7.68±0.41 7.95±0.21 8.11±0.21 8.14±0.11 0.007 
22:0                1.67±0.05 1.71±0.01 1.73±0.05 1.75±0.03 1.79±0.02 1.81±0.02 0.007 
22:1 1.31±0.04 1.34±0.02 1.44±0.14 1.31±0.05 1.38±0.03 1.35±0.02 ns 
22:2n-6           0.62±0.01 0.65±0.01 0.69±0.05 0.69±0.06 0.69±0.03 0.68±0.02 ns 
22:4n-6           0.52±0.01 0.56±0.03 0.60±0.05 0.55±0.04 0.60±0.08 0.62±0.07 ns 
22:5n-3           4.04±0.16 4.11±0.16 4.58±0.41 4.73±0.19 4.90±0.18 4.06±0.07 ns 
22:6n-3           38.62±1.25 36.02±0.67 39.87±1.09 41.83±1.52 41.58±1.72 41.71±0.78 0.010 
Total 926.99±4.22 934.99±4.61 928.46±0.34 930.79±4.13 940.18±8.33 932.76±7.20 ns 
SFA 147.01±0.19
b
142.73±0.43a
b
146.20±1.61a
b
143.36±1.10a
b
137.60±2.59a 137.03±3.82a 0.002 
MUFA 443.43±2.43 452.69±4.33 443.07±2.71 442.17±1.60 448.63±6.03 443.74±5.76 ns 
PUFA 336.54±2.04 339.57±1.88 339.20±4.33 345.25±4.19 353.95±0.32 351.99±2.23 0.000 
n-6 PUFA 166.62±1.12 168.81±1.04 167.10±2.12 167.98±2.36 172.36±0.66 171.09±0.66 0.002 
n-6 LC-
PUFA
9.42±0.21 10.18±0.22 9.41±1.05 10.71±0.64 11.19±0.13 10.96±0.11 0.023 
n-3 PUFA 169.92±1.02a 170.76±1.08a 172.10±2.55a
b
177.27±2.20b 181.59±0.98
b
180.90±1.60b 0.000 
n-3 LC-
PUFA
57.54±1.23ab 55.66±0.95a 59.84±1.80ab 62.46±2.10b 63.56±1.69b 62.88±0.86b 0.002 
 
Data represent means ± standard error (n=3; N=18). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test).  
1 See Table 6.1 for diet abbreviations 
2ns = not significant (P >0.05)   
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Table 6.8 Apparent in vivo activity (nmol g fish-1 day-1) of key enzymes in the LC-
PUFA biosynthetic pathways in rainbow trout fed the six experimental diets containing 
different iron contents, deduced by the whole body fatty acid balance method. 
  Dietary Treatments1 Regression 
 RT-FE-1 RT-FE-2 RT-FE-3 RT-FE-4 RT-FE-5 RT-FE-6 P value 
Δ-6 DESATURASE         
Δ-6 (18:2n-6 to 18:3n-6) 101.8±7.3 123.1±15.5 107.2±4.1 119.2±4.8 133.6±29.3 115.2±3.7 ns2 
Δ-6 (18:3n-3 to 18:4n-3) 648.1±58.0 700.4±65.0 673.3±18.8 712.6±10.8 741.2±16.1 742.6±34.8 ns 
Δ-6 (24:5n-3 to 24:6n-3) 331.6±34.0 342.8±32.1 322.3±20.5 339.4±11.3 358.0±9.5 370.1±18.2 ns 
 
Δ-5 DESATURASE         
Δ-5 (20:3n-6 to 20:4n-6) 38.6±2.7 50.2±6.6 39.8±0.7 44.8±0.7 53.5±14.5 44.5±1.1 ns 
Δ-5 (20:4n-3 to 20:5n-3) 382.4±40.4 400.1±36.9 381.1±18.6 405.1±17.6 423.1±11.9 445.5±31.7 ns 
 
ELOGNASES        
Elov-5 (18:2n-6 to 20:2n-6 ) 120.8±8.1 119.6±13.0 125.1±14.5 124.1±1.6 118.6±13.6 122.4±10.0 ns 
Elov-5 (18:3n-6 to 20:3n-6) 38.6±2.7 50.2±6.6 39.8±0.7 44.8±0.7 53.5±14.5 44.5±1.1 ns 
Elov-5 (18:3n-3 to 20:3n-3) 70.7±4.3 69.5±6.1 71.4±6.9 69.6±1.0 74.8±5.7 77.1±4.3 ns 
Elov-5 (18:4n-3 to 20:4n-3) 445.9±42.6 467.6±40.5 447.2±24.4 471.3±12.7 494.6±13.2 516.9±32.4 ns 
Elov-5 or Elov-2 (20:2n-6 to 22:2n-6 ) 12.4±1.4 10.2±2.2 12.1±4.5 15.5±1.3 12.0±3.2 12.3±2.0 ns 
Elov-5 or Elov-2 (20:4n-6 to 22:4n-6 ) 1.0±0.1 8.9±3.7 1.2±0.7 2.7±1.9 6.4±4.0 2.7±1.0 ns 
Elov-5 or Elov-2 (20:5n-3 to 22:5n-3) 333.9±34.2 350.5±35.3 340.1±17.9 364.4±16.6 368.0±7.2 382.0±21.3 ns 
Elov-2 (22:5n-3 to 24:5n-3) 331.6±34.0 342.8±32.1 322.3±20.5 339.4±11.3 358.0±9.5 370.1±18.2 ns 
 
Data represent means ± standard error (n=3; N=18). Values in the same row with different superscripts are 
significantly different (P < 0.05; ANOVA and Student–Newman–Keuls post hoc test).  
1 See Table 6.1 for diet abbreviations 
2ns = not significant (P >0.05)     
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6.4 Discussion 
In the present study, the six experimental diets comprising varying concentrations of 
iron resulted in an average growth increase of 2.7-fold regardless of the dietary 
treatment over the 58 day experimental period. Survival, growth performance and feed 
utilisation parameters were not affected by the dietary treatments, suggesting that the 
diet containing no iron supplementation (RT-FE-1) contained enough iron (56.6 mg kg-
1) within the raw materials to satisfy the minimum dietary iron requirement of rainbow 
trout. Iron requirements for rainbow trout are not known, but for Atlantic salmon (Salmo 
salar), these are reported as 30-60 mg kg-1 (NRC, 2011). In the present study, initial fish 
contained a higher concentration of iron (in whole body and liver samples) than fish at 
the end of the feeding trial. A similar trend was previously reported in juvenile Atlantic 
salmon (Andersen et al., 1996). The authors of this earlier study suggested that these 
higher concentrations could have been the result of reduced iron absorption stemming 
from an adaptation to a high intake of dietary iron, resulting high body iron stores. In a 
previous study conducted to investigate iron metabolism in rainbow trout 
(Carriquiriborde et al., 2004), it was revealed that this species manifest a completely 
different physiological responses to low and high dietary iron intakes. The 
gastrointestinal barrier of rainbow trout did not seem to prevent iron accumulation in the 
tissues and fish demonstrated increased iron binding to blood transferrin together with 
an elevated hepatic ferrireductase activity to facilitate rapid iron storage in the liver. On 
the other hand, in order to maintain tissue iron accumulation at relatively normal levels, 
an up-regulation of intestinal ferrireductase activity was recorded in the iron-deficient 
treatment. Though the present study was not specifically focused towards establishing 
iron requirements in rainbow trout, nor in vivo iron metabolism, the preliminary results 
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reported here suggest that rainbow trout may possess relatively high iron requirements, 
as even in the highest iron treatment (RT-FE-6, 115 mg Fe kg-1), fish whole body and 
liver samples had a reduced final iron content in relation to the original initial fish 
samples. 
 
The major focus of the current study was to explore the effects of dietary iron on fatty 
acid metabolism, particularly n-3 LC-PUFA biosynthesis, in rainbow trout. Iron is 
known to be a structural component of the end proteins of the three (Δ-9, Δ-6 and Δ-5) 
desaturase enzyme complexes (Wallis et al., 2002; Krajcovicova-Kudlackova et al., 
2004b). The Δ-9 desaturase (also known as steroyl CoA desaturase) enzyme catalyses 
the conversion of 18:0 into 18:1n-9, and 16:0 into 16:1n-7. The Δ-6 desaturase enzyme 
catalyses the conversion of 18:2n-6 into 18:3n-6, 18:3n-3 into 18:4n-3 and 24:5n-3 into 
24:6n-3, and has been suggested to be the rate limiting step in LC-PUFA biosynthesis 
(Brenner, 1977); whilst the Δ-5 desaturase enzyme catalyses the conversion of 20:3n-6 
into 20:4n-6 and 20:4n-3 into 20:5n-3 (Tocher, 2003; Tocher et al., 2003a). 
 
In line with the main hypothesis of this study, which implied that an increased dietary 
availability of iron would result in increased fatty acid desaturase activity, the results of 
the present study have provided preliminary evidence of such phenomenon. In fact, 
increased concentrations of desaturated fatty acids were recorded in both the liver and 
the fillet samples of fish fed higher concentrations of dietary iron. This trend was not 
particularly evident for Δ-9 desaturated fatty acids such as 18:1n-9 and 16:1n-7, but was 
evident and statistically significant (linear regression; P<0.05), for Δ-6 desaturated fatty 
acids, such as 18:3n-6, 18:4n-3 and DHA, and also Δ-5 desaturated fatty acids, such as 
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20:4n-6 and EPA. The results of the in vivo assessment of fatty acid metabolism, 
measured with the whole body fatty acid balance method, partially backed up these 
findings, though the relatively large variability recorded in the apparent in vivo enzyme 
activity, was responsible for a lack of any statistically significant results. 
 
Relatively few scientific reports have focused on the interactions between dietary iron 
availability and fatty acid desaturase activity. However, in line with the results of the 
present study, the few studies carried out on this topic in humans demonstrated 
significantly reduced levels of Δ-6 and Δ-5 desaturated fatty acids in subjects with low 
serum iron concentrations (Krajcovicova-Kudlackova et al., 2004). Additionally, Rao et 
al (1983) observed a reduction of hepatic Δ-9 desaturase activity in rats fed low iron 
diets. 
 
In the present study, a trend towards apparent increased fatty acid elongase activities 
(both ELOVL-5 and 2) were also noted, but in consideration that iron has not been 
reported to play any specific role in fatty acid elongation, it could be that these trends 
were simply the result of increased specific elongase substrate availability, as the result 
of increased desaturase activity. However, it is evident that further focused research 
trials are needed to better understand this metabolic response. 
 
The whole body fatty acid balance method has been previously used to deduce the in 
vivo fatty acid metabolism in a variety of fish species, including rainbow trout 
(Thanuthong et al., 2011a; 2011b; Turchini and Francis, 2009). These studies have 
revealed that rainbow trout is quite efficient in bioconverting C18 PUFA into LC-PUFA 
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when fish are fed with diets comprising vegetable oils which contain higher amounts of 
C18 PUFA and negligible amounts of LC-PUFA. Interestingly, a recent study by 
Thanuthong et al (2011b) clearly demonstrated that LC-PUFA biosynthesis in rainbow 
trout is substrate limited. In the present study, average dietary concentrations (~20% of 
dietary fatty acids) of the two key substrates for Δ-6 desaturase (18:2n-6 and 18:3n-3) 
were provided, and thus it is possible to speculate that the potential effects of increased 
dietary iron concentration could be further emphasised when diets are formulated with 
higher C18 PUFA concentrations. Additionally, it is also important to note that in the 
present study, to avoid risks of lipid peroxidation, conservative iron fortification levels 
were implemented, but higher dietary iron levels could potentially be used, particularly 
if antioxidant agents were included in diet formulations. 
 
The overall results obtained by the whole body fatty acid balance method in the present 
study are highly consistent with previous studies implemented on the same species 
(Turchini and Francis, 2009; Thanuthong et al., 2011a; Thanuthong et al., 2011b) and 
this clearly highlights one of the main advantages of this method in comparison to in 
vitro methods where results obtained in different experiments are difficult to compare 
(Brown, 2005). However, in the present study, the lack of any statistically significant 
trends generated by the whole body fatty acid balance method, in comparison to the 
apparent trends generated by the tissue fatty acid compositional analyses, could indicate 
a limit of this method. In fact, the results obtained using this method in its current 
application were highly variable within the same treatment, and thus to increase the 
analytical power of this methodology the use of increased replicate numbers is 
suggested. 
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In conclusion, this study provided a series of preliminary evidence that increased dietary 
iron concentration may have a positive effect on LC-PUFA biosynthesis in fish. 
Although dietary fatty acid compositions were almost identical across the treatments, the 
fillets of rainbow trout fed the diets with the higher iron levels contained statistically 
significantly higher concentrations of n-3 LC-PUFA compared to fish fed diets 
containing lower dietary iron levels. However, it is also important to underline that this 
increased n-3 LC-PUFA content in fish fillets, though statistically significant, can be 
considered somewhat trivial from an overall human nutritional and aquacultural 
practical viewpoint, as the maximal difference recorded (between RT-FE-2 and RT-FE-
5) was an increase of 14% of n-3 LC-PUFA (from 55.6 to 63.6 mg g-1) and a 
concentration significantly lower than values generally recorded in fish fed a fish oil 
based diet (normally >180 mg g-1). 
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CHAPTER 7 
General discussion 
To address the escalating issue of global FO shortages, the aquaculture industry has 
focused on increasing the utilization of readily available AO for aquafeed production. 
Nevertheless, the fatty acid composition of the resultant edible fish portion has been 
reported to mirror the dietary fatty acid composition (Bell et al., 2002; Bell et al., 2003b; 
Bell et al., 2004; Turchini et al., 2009). Therefore any reduction in dietary n-3 LC-PUFA 
content, ultimately results in decreased n-3 LC-PUFA content of the flesh of cultured 
fish. It is important to highlight that the renowned health benefits of fish consumption 
are derived majorly by their content of n-3 LC-PUFA (Valfre et al., 2003). Thus, over 
the last two decades, an understanding of fish lipid and fatty acid metabolism, and 
specifically, the capabilities of cultured fish to bioconvert dietary ALA (which can be 
found in readily available AO) into n-3 LC-PUFA has attracted significant research 
focus (Turchini et al., 2009; Torstensen and Tocher, 2010), and produced promising 
results (Crampton et al., 2010; Turchini et al., 2011a) 
 
On the other hand, n-6 PUFA, in particular LA, are reported to be consumed in excess in 
western societies and, the resultant imbalanced n-3/n-6 PUFA ratio is known to have 
detrimental impacts on human health (Wijendran and Hayes, 2004). Unfortunately, the 
majority of readily available AO used to replace FO contain large amounts of LA, which 
is also known to be abundantly deposited and preferentially retained into fish tissues 
(Francis et al., 2009; Turchini et al., 2009). Therefore, it is obvious that a balanced ratio 
of n-3/n-6 PUFA in aquafeed is of paramount importance in determining the final 
nutritional quality of aquaculture products. 
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The extent of the ability of fish to bioconvert C18 PUFA into LC-PUFA is known to vary 
between species, to be modulated by the diet, particularly the dietary fatty acid 
composition, and reported to be dormant or inhibited as the result of the adaptation of 
fish species to an environment particularity rich in LC-PUFA (Sargent et al., 2002; 
Tocher, 2003; Turchini et al., 2009). In addition to this relatively inefficient 
bioconversion capability, it is important also to highlight two major issues: 
1) Both ALA and LA are known to compete for the same desaturase and elongase 
enzymes which are actively involved in the LC-PUFA biosynthetic pathway and 
therefore, the conversion of ALA to n-3 LC-PUFA can be profoundly affected by 
the total dietary supply of LA (Sargent et al., 2002; Tocher, 2003; Torstensen 
and Tocher, 2010).  
2) The activity of the aforementioned enzymes involved in the LC-PUFA 
bioconversion pathway are known to be regulated by several other nutritional 
factors such as micronutrients acting as co-factors/activators and/or as structural 
components of the particular enzymes (Kirschman and Coniglio, 1961; Rao et 
al., 1984; Bautista and Cruz, 1988; Sul and Wang, 1998; Krajcovicova-
Kudlackova et al., 2004; Nakamura and Nara, 2004) 
 
The present PhD study employed two freshwater farmed fish species, Murray cod (an 
iconic Australian native fish) and rainbow trout (a popular salmonid cultured worldwide) 
which are naturally inhabiting in temperate warm and coldwaters, respectively and of 
great economic importance to both Australian and global aquaculture, contributing 
significantly to the country’s gross national production (Ingram et al., 2005). 
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The series of experiments carried out in this PhD study investigated i) the effects of the 
ratio of dietary ALA/LA (interactions between 18:3n-3 and 18:2n-6) mainly found in 
AO which are also acting as the basic precursors to LC-PUFA biosynthesis in Murray 
cod and ii) the role of two key micronutrients (pyridoxine and iron) which are speculated 
to have regulatory effects on the desaturase and elongase enzymatic activities of the LC-
PUFA bioconversion pathway in rainbow trout. The major outcomes generated during 
first feeding trial (Part a & Part b) were the effects of ALA/LA ratio on growth 
performance, feed efficiency, tissue fatty acid composition and fatty acid restoration and 
retention efficiency following a FO finishing period and the influence of dietary 
ALA/LA ratio on lipid and fatty acid metabolism in Murray cod (Chapter 3 and Chapter 
4). The last two  experiments (Chapter 5 and Chapter 6) which were carried out using 
rainbow trout, investigated the effects of two supplemental dietary micronutrients; 
pyridoxine (Vitamin B6) and iron, respectively on the lipid and fatty acid metabolism in 
rainbow trout including their impacts on growth performance, feed efficiency and tissue 
fatty acid composition of the final edible product.  
 
7.1 Survival and Growth performance 
Throughout the series of experimentation, mortalities of both Murray cod and rainbow 
trout were minimal with high survival rates and did not seem to be influenced by any 
dietary treatment. Further, replacing dietary FO completely with AO did not show any 
significant impact on the growth performance of both experimented species in all the 
feeding experiments conducted under the present PhD study. Importantly all 
experimental diets contained some fish meal as protein source in their formulation and 
thus some dietary n-3 LC-PUFA were present originating from the residual oil contained 
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in fish meal. Findings of previous nutritional studies evaluating the effects of replacing 
dietary FO with LO and SFO in rainbow trout (Turchini and Francis, 2009b; 
Thanuthong et al., 2011a; Thanuthong et al., 2011b) and in different life stages of 
Atlantic salmon (Bell and Dick, 1991; Bell et al., 1992; Bell et al., 1993; Thompson et 
al., 1996; Tocher et al., 1997; Rosenlund et al., 2001; Rollin et al., 2003; Torstensen et 
al., 2005) are also in agreement with this PhD study, where no growth impairment was 
detected. Chapter 3 of this PhD thesis describes the effects of varying dietary ALA/LA 
ratio at constant C18 PUFA in Murray cod juveniles during grow-out phase using 100% 
FO free diets. The observation made with Murray cod in relation to growth performance 
was consistent with the results obtained from a similar type of feeding experiment 
recently conducted with rainbow trout by Thanuthong et al.(2011b) and with Eurasian 
perch (Perca fluviatilis) by Blanchard, et al.(2008) using AO-based experimental diets. 
This observation in Murray cod is partially in contrast to previous findings on the same 
species where significant impairment of growth was recorded following 100% dietary 
fish oil replacement (Francis et al., 2006; Francis et al., 2007a; Francis et al., 2007b;  
Francis et al., 2009). However, the above studies were all conducted using semi-purified 
diets with a very limited fish meal content (10% of protein source) compared to the 
present study which employed a more practical diet with a relatively high content of 
fishmeal (50% of the protein source). This clearly suggests that n-3 LC-PUFA, and in 
particular EPA and DHA, play a direct and important role in the overall growth 
performance of Murray cod and when diets are void of sufficient minimal amount of n-3 
LC-PUFA growth impairment can be observed in this carnivorous, top order predator, 
freshwater species. 
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In an attempt to evaluate the effects of two potential micronutrients (pyridoxine and 
iron) on growth performance and fatty acid metabolism, Chapter 5 and Chapter 6 of this 
PhD thesis described two separate feeding experiments conducted using the same AO-
based experimental diets (ie with constant fatty acid composition) supplemented with 
varying concentrations of pyridoxine (pyridoxine hydrochloride) and iron (ferrous 
sulfate), respectively. Neither experiment demonstrated any significant modification of 
growth performance of rainbow trout with varying dietary concentrations of pyridoxine 
or iron. These results are in agreement with the previous studies on Atlantic salmon 
(Albrektsen et al., 1994) and rainbow trout (Maranesi et al., 2005), on dietary pyridoxine 
supplementation and in rainbow trout (Carriquiriborde et al., 2004) on dietary iron 
supplementation. The results of present studies suggest that the dietary levels of 
pyridoxine (Chapter 5) and iron (Chapter 6) in all the experimental diets used in the two 
experiments, even in the lowest supplemented treatments, were adequate enough to meet 
their minimum requirements for rainbow trout for its normal health and optimal growth 
performance. 
 
7.2 Feed intake and efficiency  
The feed utilization indices, in particular FCR, reported in this study for both Murray 
cod and rainbow trout ranged from 1.1-1.3 for both control (FO) and AO-based 
experimental diets indicated that all the diets were efficiently utilized by both species 
regardless of dietary lipid source (FO or AO), ALA/LA ratio, pyridoxine or iron 
contents in AO-based formulated diets confirming that both species possess a good 
capability of converting food energy into biomass at a high rate. 
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The FCR values recorded for Murray cod fed AO-based diets containing varying 
ALA/LA ratio during the present study were more or less similar to those recorded in a 
similar study (1.0-1.1) recently conducted with rainbow trout (Thanuthong et al., 
2011b). The FCR values recorded in rainbow trout fed graded levels of pyridoxine or 
iron in the present study were similar, suggesting that fortification with either of these 
two micronutrients had little/no effect on feed utilisation efficiency. 
 
In achieving a maximum profit from fish culture, feed palatability is considered one of 
the key non-nutritional factors in formulating diets with a view to obtaining an optimal 
growth, maximum feed utilization efficiency and minimum wastage of feed at a 
minimum feed cost (Francis, 2007). The only measurable parameter to estimate feed 
palatability in fish is the amount of feed intake/mean feed consumption (Jobling, 2001) 
as it is not possible to determine taste or flavour perception in fish (Lamb, 2001). In 
general, fish meal and fish oil are the most acceptable ingredients commonly available in 
formulated diets (Geurdena, 2005) and natural diets of carnivorous fish such as Murray 
cod and rainbow trout are not normally containing high amount of plant derived food 
items, which may be characterized by lower palatability for these carnivorous species. 
The practical diets formulated for this PhD study containing AO (eg. sunflower oil, 
linseed oil and beef tallow or a mixed blend of them) and the FO control/reference diet 
used in the grow-out experiment (Chapter 3 and Chapter 4) were all well accepted by 
Murray cod with no significant differences. Therefore, it is reasonable to speculate that 
the fish meal inclusion at the rate of 50% of the protein source in the practical diets for 
Murray cod used in the present PhD study compared to that in the previous study 
(Francis et al., 2007a) which only contained 10% fishmeal of the protein source have 
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had significant impacts on the improved feed palatability and hence to the non-
compromised growth of Murray cod. 
 
Despite the absence of a FO control diet for the two experiments with rainbow trout to 
evaluate the effects of dietary pyridoxine (Chapter 5) and iron supplementation (Chapter 
6) over fatty acid metabolism, observing the overall reported feed intake values, it is 
possible to assume that the VO-based semi-purified diets fed to rainbow trout have had 
good palatability, even if included only minimal levels of fish meal (12%). This 
suggestion is further supported by the recent study with rainbow trout (Thanuthong et 
al., 2011b) which did not show any significant differences in feed intake whether 
rainbow trout were fed either FO (control) or VO-based diet. However, it should be 
mentioned that the above study also employed a FO-based diet (control) and VO-based 
test diets with higher fish meal inclusion (24 %), compared to present trials.  
 
7.3 Fatty acids metabolism 
The whole body fatty acid balance method is an easily implemented method useful for 
the assessment of in vivo fatty acid metabolism in animals and it has been increasingly 
used by many researchers and on different species such as Murray cod (Turchini et al., 
2006b; Francis et al., 2009; Senadheera et al., 2011 (Chapter 4)), rainbow trout (Turchini 
and Francis, 2009; Thanuthong et al., 2011a; Thanuthong et al., 2011b; Senadheera et 
al., 2012a (Chapter 5), 2012b (Chapter 6)), tilapia (Teoh et al., 2011), Atlantic salmon 
(Codabaccus et al., 2011) and baramundi (Alhazzaa et al., 2011). One of the main 
advantages of this method in comparison to in vitro methods where results obtained in 
different experiments are difficult to compare (Brown, 2005) is that the values recorded 
191 
 
for the various enzymatic activities are highly consistent, and comparisons between 
different trails can be made.  For example, comparing the main results of the two trials 
implemented on rainbow trout in this PhD study, the total n-3 PUFA elongase activity 
recorded in fish varied from 776.0±72.7 to 1,346.0±75.9 nmol per g of fish per day on 
RT-B6-1 and RT-Fe-6 treatments respectively and the total n-3 PUFA Δ-6 destaurase 
activity and Δ-5 destaurase activities varied from 659.6±68.3 (RT-B6-1) to 1112.7±52.8 
(RT-FE-6) and 221.5±29.5 (RT-B6-1) to 445.5±31.7 (RT-FE-6) nmol g of fish-1 day-1 
respectively. 
 
Numerous studies suggest that dietary fatty acids can remarkably affect overall lipid 
metabolism in fish (Bell et al., 1997; Francis et al., 2007b; Turchini and Francis, 2009: 
Torstensen and Tocher, 2010). Also, it has been pointed out that some other nutritional 
and non-nutritional factors other than dietary fatty acids might have significant impacts 
on fatty acid bioconversion (or de novo LC-PUFA biosynthesis) in vertebrates including 
fish. However, little information is available on the direct effects of the dietary ALA/LA 
ratio on overall fatty acid metabolism and the effects of micronutrients such as 
pyridoxine and iron on LC-PUFA bioconversion of freshwater fish. 
 
The findings of present PhD study further support the fact that both Murray cod and 
rainbow trout posses the capability of producing LC-PUFA via the n-3 and n-6 
biosynthetic pathways at the expense of complete replacement of FO by VO such as 
sunflower, linseed, and/or canola oil or terrestrial animal fats such as beef tallow.  As 
previously reported, it further confirms that coldwater/freshwater species, rainbow trout 
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is much more efficient in utilizing dietary C18 PUFA (ALA and LA) for the biosynthesis 
of LC-PUFA compared to the warmwater/ freshwater counterpart, Murray cod. 
 
In the present PhD study, the average n-3 PUFA elongase, Δ-6 and Δ-5 desaturase 
activities recorded in rainbow trout on zero iron supplemented diet (RT-FE-1) with 1:1 
ALA:LA ratio were 1,182±0.1, 979.7±91.6 and 382.4±40.4 nmol per g of fish per day 
respectively while the n-3 PUFA elongase and Δ-6 desaturase activities in Murray cod 
on the AO-based diet (MC-1.0) having same ALA/LA ratio (1:1)  were 111.0±12.2  and 
103.4±8.2 nmol g-1 of fish day-1 respectively with no apparent in vivo Δ-5 desaturase 
activity. 
 
Moreover, a similar study to Murray cod fed different ALA/LA ratios but, recently 
conducted on rainbow trout (Thanuthong et al., 2011b) further supports the above 
statement showing that rainbow trout possess remarkably higher fatty acid desaturase 
and elongase activities compared to those reported for Murray cod during the present 
investigation. This can be considered very useful information for both aquafeed 
developers and fish nutritionists to more cautiously consider the effects of dietary FO 
substitution when dealing with different species.  
 
7.3.1 Fatty acid neogenesis/de novo production 
Chapter 4 of this PhD thesis indicates that the total apparent in vivo fatty acid neogenesis 
or de novo production was minimal and only detectable in Murray cod fed the diet 
containing the higher amount of LA. In fact, an apparent de novo production of SFA and 
MUFA was recorded. These results suggest that high LA in diets stimulate specifically 
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the enzymes involved in lipid neogenesis, thus resulting in increased energetic 
expenditures. Similar types of observations were made previously in fish fed diets rich 
in C18 PUFA and with relatively low levels of dietary SFA and MUFA (Turchini et al., 
2006a : Turchini and Francis, 2009).  
 
The results of the Chapter 5 which investigated dietary pyridoxine supplementation in 
rainbow trout, revealed an apparent increasing trend of neogenesis of SFA and MUFA at 
the expense of decreasing dietary pyridoxine contents, suggesting the existence of a 
direct relationship between pyridoxine availability and SFA and MUFA metabolism.  
 
Nevertheless, the final feeding trial of this PhD study conducted to investigate the 
effects of dietary iron supplementation in rainbow trout showed neither significant 
differences nor any apparent relationship of fatty acid neogenesis in trout with varying 
dietary amounts of iron. 
 
7.3.2 Fatty acid E-oxidation 
Generally, it is recognized that β-oxidation of specific fatty acids is proportional to their 
dietary availability. The results of Chapter 4 clearly show that n-6 PUFA and n-3 PUFA 
were β-oxidized to a greater extent in treatments with high LA and high ALA, 
respectively.  However, observing the results of β-oxidation, expressed as a percentage 
of net intake (Table 4.4), β-oxidation of LA in Murray cod seemed to occur 
independently from dietary availability at a constant level (~36 % of net intake) while 
ALA was proportionally oxidized at a higher rate, if provided in surplus, as would 
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normally be expected (Stubhaug et al., 2007). Additionally, ALA was found to be β-
oxidized to a greater extent than LA regardless of the dietary level, as previously 
recorded for Murray cod (Francis et al., 2007b; Turchini et al., 2006b) displaying a 
preferential order of β-oxidization of ALA over LA. Therefore, the present PhD study 
further validates the hypothesis that n-6 fatty acids play a different role in the general 
fatty acid metabolism of Murray cod compared to other cultured species as previously 
suggested (De Silva et al., 2004; Francis et al., 2009; Turchini et al., 2006b). 
Furthermore, as previously mentioned in Chapter 4, the β-oxidation of SFA and MUFA 
showed a decreasing trend with elevated dietary LA contents or lower ALA/LA ratios in 
Murray cod showing an apparent trend towards saving SFA and MUFA at higher dietary 
LA contents. 
 
Currently available information on fatty acid β-oxidation in fish suggests the existence 
of a substrate preference for SFA and MUFA over PUFA (Kiessling and Kiessling, 
1993: Henderson, 1996). A previous study on Atlantic salmon fed a diet with low n-3 
LC-PUFA showed that these fatty acids were selectively retained in fish tissues 
(Stubhaug et al., 2007) suggesting a switch in fatty acid substrate used for β-oxidation 
when dietary levels are low. On the contrary, the present PhD study observed that in 
Murray cod there is a higher level of β-oxidation and lower retention levels of EPA and 
DHA in fish fed the five experimental diets containing low n-3 LC-PUFA, compared to 
those fed the FO-based diet.  This result may be attributed to differences in the overall 
fatty acid metabolism of the two different species having habitat differences, Atlantic 
salmon being a coldwater anadromous species, and Murray cod being a strictly 
freshwater warmwater species.  Additionally, the present PhD study shows that EPA 
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was highly oxidized compared to DHA in both Murray cod and rainbow trout on all the 
dietary treatments. This finding is in agreement with previous observations made for 
rainbow trout (Turchini and Francis, 2009), and likely relative to the fact that DHA is 
less easily oxidized as it requires an additional step to remove the Δ-4 double bond, prior 
to β-oxidization for energy production (Sargent et al., 2002). 
 
Rainbow trout in the feeding experiment carried out using pyridoxine supplemented VO-
based experimental diets (Chapter 5) demonstrated a decreasing trend in β-oxidation of 
SFA and PUFA at low dietary pyridoxine levels indicating that low dietary pyridoxine 
contents are decreasing the overall general β-oxidation of SFA and MUFA. However, 
given the experimental design used, it would be difficult to speculate on such 
phenomenon, and further, more focused and specifically designed experimentations are 
needed to tentatively clarify this interesting effect of dietary pyridoxine content. 
 
7.3.3 Fatty acid elongation  
In general, the elongase activity recorded in the present PhD study was manifestly 
substrate dependant, as previously reported for the same two species studied 
(Thanuthong et al., 2011b; Turchini and Francis, 2009).  
 
In Murray cod, the relatively high elongase activity acting on n-3 LC-PUFA was 
recorded in fish receiving the MC-FO treatment and was attributable to an elongation of 
EPA to 22:5n-3,  and then up to DHA, which could also be considered substrate 
dependent/limited. These results are in agreement with similar observations made for 
rainbow trout fed on a FO-based experimental diet (Turchini and Francis, 2009). The 
196 
 
varying dietary ALA/LA ratios recorded no differences in total elongase activity, but the 
elongation of n-3 fatty acids occurred at much higher efficiency values than those of n-6 
fatty acids. This was in agreement with the results of the similar type of experiment in 
rainbow trout with varying ALA/LA conducted recently using fish oil free diets 
(Thanuthong et al., 2011b). 
 
In rainbow trout fed FO-free diets containing increasing amounts of dietary pyridoxine 
(Chapter 5), despite the identical dietary contents of 22:5n-3 and 22:4n-6 as other LC-
PUFA, an increased 22:5n-3 and 22:4n-6 accumulation in synchrony with the increase in 
dietary pyridoxine concentrations could be noted. This observation might be attributable 
to potential positive effects of pyridoxine on the elongation of EPA and ARA or a 
negative effect on the further bioconversion or β-oxidation of the above mentioned fatty 
acids. Further, increased activity of elongase activity on various substrates, specifically 
on 18:3n-6 and 20:4n-6 could be noted during the present feeding experiment and it 
could be properly described by a linear relationship (P<0.05), clearly suggesting one or 
both of the following: pyridoxine has a direct positive effect on elongase activity or 
pyridoxine has an indirect positive effect on elongase activity, as the result of increased 
substrate availability resulting from increased desaturase activity of the fatty acid that 
proceed in the metabolic pathway. However, a previous study on Atlantic salmon 
reported that desaturation and elongation of [1-14C] 18:3n-3 (ALA) in liver following 
intra-peritoneal injection was not affected by dietary pyridoxine level (Albrektsen et al., 
1994); thus the second suggested hypothesis (eg: an indirect effect of pyridoxine) seems 
to be more likely.  
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In rainbow trout fed FO-free diets containing increasing amounts of dietary iron 
(Chapter 6), increased fatty acid elongase activities (both ELOVL-5 and ELOVL-2) 
were also apparent, but in consideration that iron has not been reported to play any 
specific role in fatty acid elongation, it could be that these trends were, as suggested for 
the experiment on pyridoxine, simply the result of increased specific elongase substrate 
availability, as the result of increased desaturase activity. However, it is obvious that 
further focused research trials are needed to better understand and elucidate this 
metabolic response. 
 
7.3.4 Fatty acid desaturation 
Δ-6 desaturase is often considered as the rate-limiting enzyme in the LC-PUFA 
biosynthetic pathway (Brenner, 1981; Hastings et al., 2001) which converts LA and 
ALA to 18:3n-6 and 18:4n-3, respectively (Turchini and Francis, 2009). Following Δ-6 
desaturation and subsequent elongation, the Δ-5 desaturase enzyme further desaturates 
the 20:3n-6 to ARA and 20:4n-3 to EPA (Sargent et al., 2002; Nakamura and Nara, 
2004). The production of DHA requires the combination of a further two elongation 
steps, a Δ-6 desaturation and finally, a β-oxidation (a chain-shortening reaction) step 
(Sprecher et al., 1995). 
 
More than the existence of a specific limiting step (ie the first Δ-6 desaturase), the 
results of present study clearly indicate that the LC-PUFA biosynthetic pathway in 
Murray cod is substrate limited, as fish receiving higher dietary levels of ALA recorded 
significantly higher apparent in vivo production of enzyme products such as 18:4n-3, 
20:4n-3, EPA, DPA and DHA. In addition, the highest Δ-6 desaturase activity on 24:5n-
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3 and consequently the highest in vivo production of DHA was observed in fish fed the 
control (FO-based) diet, which was characterised by high EPA levels to produce DPA 
and then DHA providing further evidence of substrate limitation. These observations 
were highly consistent with that reported for rainbow trout fed similar type of diets 
(Thanuthong et al., 2011a), which provided strong evidence that in fish, the absence of 
dietary enzyme products (LC-PUFA) stimulated the enzyme transcription rates, but the 
actual enzyme activity was primarily affected by substrate availability, and not products 
presence/absence.  
 
In the present study on Murray cod, the specific kinetics of Δ-6 desaturase activity 
acting on the two possible substrates (LA or ALA) was quite different. The apparent in 
vivo Δ-6 desaturase activity acting on LA (μmol g of fish-1 day-1) showed an increasing 
trend in relation to the substrate availability (LA net intake), as previously reported 
(Francis et al., 2009). However, when this activity was expressed as a percentage of net 
intake, thus indicating the efficiency of this enzyme, the Δ-6 desaturase activity acting 
on LA initially increased, then peaked at average substrate level and subsequently 
remained constant, indicating that any further increase of substrate availability is 
inefficient in terms of n-6 LC PUFA production. On the other hand, the apparent in vivo 
Δ-6 desaturase activity on ALA was observed to increase with the increased substrate 
availability (ALA net intake), but reached its maximum at an average substrate level. 
The trend of relative Δ-6 desaturase activity (as a percentage of net intake) on ALA 
appears similar to previous findings (Francis et al., 2009), suggesting that the amount of 
ALA desaturated is proportionally reduced by an increasing dietary substrate level. 
Interestingly, the maximum relative Δ-6 desaturase activity acting on ALA peaked at the 
199 
 
substrate level of 3.2186 (μmol g fish-1 day-1) ALA equivalent to the MC-1.6 treatment 
suggesting that any additional amount of ALA is not only wasteful, but also 
counterproductive in terms of n-3 LC-PUFA bioconversion. A similar trend was noted 
for both absolute (μ mol g-1 fish day-1) and relative (as a percentage of net intake) in vivo 
total apparent desaturase activity in relation to the dietary ALA/LA ratio, peaking at an 
ALA/LA ratio of 1.54, suggesting that this could be considered the optimal dietary 
ALA/LA ratio for Murray cod. 
 
In the study relative to rainbow trout fed graded amount of dietary pyridoxine (Chapter 
5), the activity of Δ-6 desaturase on its three substrates (LA, ALA and 24:5n-3) was 
increased by the dietary pyridoxine content, peaking at the inclusion level of 4.6 mg kg-
1. On the other hand, Δ-5 desaturase activity on 20:3n-6 and 20:4n-3 (to produce ARA 
and EPA, respectively) showed a direct linear relationship with dietary pyridoxine 
content. Consistent with these results, Tsuge et al. (2000) clearly showed that the 
activity of Δ-6 desaturase was significantly lower (~64%) in rats fed with a pyridoxine 
deficient diet compared to the pair-fed control group, However, in Atlantic salmon 
(Albrektsen et al., 1994), it was reported that the desaturation and elongation of [1-14C] 
18:3n-3 (ALA) in liver following intra-peritoneal injection was not affected by dietary 
pyridoxine level. The discrepancy between this study and the results of present study are 
likely attributable to the differing pyridoxine administration methods and the vastly 
different experimental durations. 
 
In line with the main hypothesis of the study relative to rainbow trout fed graded amount 
of dietary iron (Chapter 6), which implied that an increased dietary availability of iron 
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would result in increased fatty acid desaturase activity, the results obtained provided 
evidence of such phenomenon. In fact, statistically significant increased concentrations 
of desaturated fatty acids were recorded in both the liver and the fillet samples of fish 
fed higher concentrations of dietary iron. This trend was not particularly evident for Δ-9 
desaturated fatty acids such as 18:1n-9 and 16:1n-7. However, a statistically 
significantly relationship (linear  regression) relative to dietary iron concentrations were 
obtained for Δ-6 desaturated fatty acids, such as 18:3n-6, 18:4n-3 and DHA, and also Δ-
5 desaturated fatty acids, such as ARA and EPA. However, in this study the results of 
the in vivo assessment of fatty acid metabolism, measured by the whole body fatty acid 
balance method, did not show any statistically significant difference or trend. This was 
mainly attributable the relatively large variability recorded in the apparent in vivo 
enzyme activity, was responsible for a lack of any statistically significant results.  
 
Nevertheless, in consistent with the results obtained by the tissue fatty acid analysis in 
the present study, the few studies carried out on this topic in humans demonstrated 
significantly reduced levels of Δ-6 and Δ-5 desaturated fatty acids in subjects with low 
serum iron concentrations (Krajcovicova-Kudlackova et al., 2004). Additionally, Rao et 
al. (1983) observed a reduction of hepatic Δ-9 desaturase activity in rats fed low iron 
diets. No prior studies could be found regarding dietary iron supplementation and fatty 
acid metabolism in fish, and thus it is believed that this innovative study and its 
preliminary but promising results are quite significant and warrant further investigation 
to better understand this complicated metabolic phenomenon. 
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7.4 Restoration and retention efficiency of n-3 LC-PUFA during finishing period 
Implementation of a finishing period using a FO-based finishing (or wash-out) diet 
during the final part of the production cycle is one of the potential strategies which has 
drawn keen attention of fish nutritionists in restoring the original FO-like fatty acid 
profile in fillets of fish previously fed a FO-deprived diet (Bell et al., 2003a; Benedito-
Palos et al., 2009; Turchini et al., 2009).  
 
In the first feeding experiment of this PhD study, five groups of Murray cod were fed 
with FO-free experimental diets containing different ALA/LA ratios for 74-day grow-
out period. The hypothesis underlined this study was that the high ALA/LA ratio or high 
ALA content in the diet would allow fish to produce more n-3 LC-PUFA (eg. EPA and 
DHA) in their tissues as ALA and LA are the dominant PUFA in AO-based diets and 
also the main dietary precursors/substrates which compete for the same desaturase and 
elongase enzymes in de novo LC-PUFA biosynthetic pathway of freshwater fish 
(Sargent et al., 2002). As expected, such a phenomenon could be observed and the 
deposition levels of EPA and DHA in cod fillet (mg FA per 100 g fillet) at the end of 74-
day grow-out period tend to show increasing trends with the elevated ALA/LA ratio 
supporting the hypothesis. In addition, this study showed that the high percentage of 
dietary C18 PUFA (51%) mainly LA and ALA, in AO-based diets had greatly influenced 
the higher retention rates of these fatty acids in cod fillets resulting in a highly modified 
fatty acid make up during the grow-out period. However, subsequent to a 42-day 
finishing period, the fillet contents of EPA and DHA increased significantly restoring 
the FO-like fatty acid profile in Murray cod. The levels of ALA and LA were reduced on 
average across the alternative oil treatments by 50% and 40%, respectively. This 
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observation further confirmed the fact that LA is not only preferentially deposited into 
fish fillets, but also preferentially retained even during a finishing/wash-out period, as 
previously suggested (Turchini et al., 2009). However, the levels of n-3 LC-PUFA were 
still lower than Murray cod continuously fed to the FO-based diet. Therefore, the present 
PhD study suggests that employing a finishing period greater than 42 days would be 
worthwhile in achieving complete restoration of FO-like fatty acid profile. The present 
study also suggests that high LA diets adversely and negatively impact on the restoration 
efficiency of health beneficial fatty acids during the finishing phase. This was further 
supported by the significantly elevated coefficient of distance values obtained for fish 
groups previously fed on high LA diets. Additionally, the calculated percentage 
deposition/retention values of the sum of EPA+DHA which ranged from 7.8 – 11.0%, 
during the finishing period of the present study indicate that Murray cod are relatively 
inefficient in depositing EPA and DHA in the fillet. In fact,  roughly 90% of dietary 
EPA and DHA was catabolised or deposited in the non-edible portions of the fish, such 
as head, pervisceral or subcutaneous fat, liver and other organs even the fish are fed with 
a FO-based diet. However, fish groups previously receiving AO-based diets containing 
higher ALA/LA (MC-1.6 and MC-2.9) appeared to have higher percentage 
deposition/retention values for EPA and DHA, than other treatments (MC-0.3 and MC-
1.0) revealing that fish previously fed high LA diets were actually depositing less EPA 
and DHA. Therefore, the present study suggests that a high level of LA in the diet may 
affect adversely to the overall efficiency of the finishing strategy in Murray cod. 
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7.5 Nutritional characteristics of table products: Murray cod and Rainbow trout 
The renowned health benefits of fish consumption are derived majorly by their content 
of n-3 LC-PUFA and by its favorable n-3/n-6 PUFA content that can help in rebalancing 
the excessive n-6 PUFA intake of common western societies (Simopoulos, 1999; Valfre 
et al., 2003). Despite the environmental and economic issues which are currently forcing 
the aquafeed industry in modifying the fatty acid composition of aquafeed, cultured 
products are expected to fulfill such expectations. 
 
The results obtained in Chapter 3 demonstrate a clear trend towards increased content of 
EPA and DHA with the increasing dietary supply of ALA in Murray cod. On the other 
hand, when dietary LA was abundant, it was preferentially deposited, and retained even 
during the finishing period, and greatly impacting on the final n-3/n-6 PUFA ratio of fish 
fillet. The results of the feeding experiment described in Chapter 3 of this thesis with 
Murray cod clearly indicate that replacing fish oil in aquafeed with an appropriate 
alternative vegetable oil which contain more ALA and limited LA is imperative, from a 
human nutritional view point, when attempting to produce cultured fish rich in health 
promoting n-3 LC-PUFA and higher n-3/n-6 PUFA ratio. Similar and highly consistent 
observations were made also for rainbow trout fed varying ALA/LA ratio (Thanuthong 
et al., 2011d; in press, DOI: 10.1016/j.aquaculture.2012.02.020) 
 
The last two feeding experiments representing Chapter 5 and Chapter 6 with dietary 
pyridoxine and iron supplementation respectively using rainbow trout fed 100% VO-
based diets demonstrate a positive correlation between dietary pyridoxine 
supplementation or iron supplementation and fillet LC-PUFA content in rainbow trout. 
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The results relative to the study of pyridoxine are consistent with previous investigations 
in Atlantic salmon (Albrektsen et al., 1994) and in rainbow trout (Maranesi et al., 2005), 
where pyridoxine supplemented diets demonstrated significantly higher deposition 
levels of n-3 LC-PUFA in fish fillets. Similarly the present study also suggested that 
dietary iron can play a similar positive role, but no other previous study is currently 
available in the literature which investigated the effects of dietary iron supplementation 
on fatty acid metabolism in fish.  
 
Overall, the results of the present PhD study suggest the importance of balancing the 
dietary ALA/LA ratios optimizing the level of substrate (ALA) to enhance the de novo 
biosynthesis of n-3 LC-PUFA and minimize LA deposition, and thereby improving the 
fillet content of these health beneficial fatty acids. Subsequently, the observations made 
in the present study also highlighted the importance of ensuring appropriate dietary 
levels of specific micronutrients (in this case, pyridoxine and iron) when dietary FO is 
replaced, to increase the final n-3 LC-PUFA content in the edible product. 
 
Nevertheless, it is also important to underline that in all instances the increased n-3 LC-
PUFA content in fish fillets, as a result of optimal ALA/LA ratio, or micronutrient 
fortification, though very interesting from a metabolic point of view, can be considered 
somewhat trivial from an overall human nutritional and aquacultural practical viewpoint, 
as the maximal difference recorded in fillet n-3 LC-PUFA content of fish fed FO-
deprived/replaced diets was minimal if compared to that generally recorded in fish fed a 
FO-based diet. 
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7.6 Future research direction 
Based on the results obtained during this PhD project, it seems at this point possible to 
suggest future research directions towards improving the efficiency of FO replacement 
in aquafeed.  
1) Alternative oils rich in LA should be used very cautiously and further 
investigations into the potential of ALA rich oils in aquatic animal nutrition 
should be pursued. From an agronomic research point of view, the development 
of new selected cultivars of oilseed crops richer in ALA (or other n-3 PUFA, 
such as stearidonic acid) and with low LA content would be also extremely 
beneficial for their potential utilization in aquafeed formulation.  
2) The capability of different species of bioconverting C18 PUFA to LC-PUFA is 
remarkably variable. Therefore more comparative studies should be attempted to 
individuate which species could cope better with fish oil replacement, and at the 
same time, still providing some LC-PUFA in their fillets to consumers. Along 
these lines, it is also possible to imagine that within the same cultured species, 
there will be some variability in the LC-PUFA biosynthesis capability of 
different sub-populations, and therefore a selection specifically focused towards 
maximizing this metabolic capability could ultimately result in great benefit for 
the overall aquaculture industry.  
3) The vast majority of studies implemented to determine vitamin and mineral 
requirements of fish have been based on FO-based diet, and most commonly 
using growth performance as the reference point. In light of the results presented 
in this PhD project, it seems therefore possible to suggest that all the main 
vitamin and mineral requirements of cultured fish should be re-assessed using 
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FO-deprived diet (or at least diet containing relatively little FO as the currently 
used commercial aquafeed), and also considering other reference points (rather 
than only growth), such as overall tissue fatty acid composition or better, in vivo 
LC-PUFA biosynthesis.   
4) Vitamin B6 and iron have been shown to partially being able to modulate overall 
in vivo LC-PUFA biosynthesis in cultured fish. However, in the present study a 
blend of vegetable oils was used (with average ALA content), and it is therefore 
possible to imagine that even more pronounced effects could be observed if fish 
would be fed with a diet containing abundant ALA (ie linseed/flaxseed oil or 
chia oil alone). 
5) Eventually, other micronutrients which could play a modulatory role or acting as 
co-factors for the enzymes involved in the LC-PUFA biosynthesis pathway 
should be studied, individually and in conjunction, to test the maximal capability 
of fish to produce LC-PUFA, and thus ultimately being able to reduce the FO 
content of aquafeed.  
 
7.7 Closing remarks 
The present study highlights that an increased ratio of ALA/LA in diets or complete 
replacement of FO by AO does not impair growth performance or tissue lipid content of 
juvenile Murray cod. However, dietary ALA/LA ratio significantly impacts on final fatty 
acid make-up and nutritional quality of fish fillets. It is suggested that high dietary LA 
contents have significant negative impacts on the efficiency of a finishing strategy, and 
in general, that alternative oils rich in LA should be used cautiously when replacing fish 
oil. Additionally, the results indicate that dietary ALA was more actively β-oxidized and 
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bioconverted, whilst LA appears to be more efficiently deposited. The in vivo apparent 
Δ-6 desaturase activity on n-3 and n-6 PUFA exhibits an increasing and decreasing 
trend, respectively, in conjunction with the increasing dietary ALA/LA ratio, clearly 
indicating that this enzymatic activity is substrate dependant. However, the maximum Δ-
6 desaturase activity acting on ALA peaked at the substrate level of 3.2186 (μmol g fish-
1 day-1), suggesting that additional inclusion of ALA is not only wasteful, but 
counterproductive in terms of n-3 LC-PUFA production. Despite a constant total supply 
of ALA+LA, the recorded total in vivo apparent Δ-6 desaturase activity on both 
substrates (ALA and LA) increased in synchrony with the ALA/LA ratio, peaking at 
1.54 with a 3.2-fold greater Δ-6 desaturase affinity towards ALA over LA in Murray 
cod.  
 
Despite the fact that the actual mechanism by which pyridoxine affects the activity of 
enzymes involved in the LC-PUFA biosynthetic pathway are not yet fully elucidated, the 
present study further confirms that dietary pyridoxine level directly modulates and 
positively stimulates LC-PUFA biosynthesis in rainbow trout. Over fortification with 
pyridoxine, above the minimum dietary requirement, has no significant impact on 
growth performance of trout, but can be responsible for improved LC-PUFA 
biosynthesis. Therefore, it is possible to suggest that dietary pyridoxine levels higher 
than the minimum dietary requirement should be included in aquafeed formulations, 
especially when FO is replaced with AO, in order to maximise the LC-PUFA 
biosynthetic capability of cultured fish.  
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In contrast to the roles of pyridoxine, the role of iron in fatty acid metabolism is clearer, 
as iron is measurably present in the fatty acid desaturase enzymes, and clearly an 
insufficient supply of this element can jeopardise the integrity of the entire fatty acid 
bioconversion pathway. In this study, it demonstrates that irrespective of the identical 
dietary fatty acid compositions across the treatments, the fillets of rainbow trout fed the 
diets with the higher iron levels contain significantly higher concentrations of n-3 LC-
PUFA compared to fish fed diets containing lower dietary iron levels.  
 
Therefore, the findings of this PhD study provide a series of significant evidence, some 
of which should still be considered as only preliminary, that dietary pyridoxine and iron 
supplementation can have positive effects on the overall LC-PUFA biosynthesis in 
rainbow trout. 
 
It is also important to underline that despite it being that the amount of n-3 LC-PUFA 
content of fillet of cultured fish fed FO-deprived diet can be partially modulated, the 
actual final n-3 LC-PUFA content of fish fed FO-based diet is remarkable higher, and 
thus, the complete and successful replacement of FO in aquafeed without compromising 
fillet n-3 LC-PUFA concentrations has yet to be achieved. 
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APPENDICES 
Appendix I 
Senadheera, S.P.S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2010. Effects of dietary alpha-
linolenic acid (18:3n-3)/linoleic acid (18:2n-6) ratio on growth performance, fillet fatty acid profile and 
finishing efficiency in Murray cod. Aquaculture. 309, 222-230. 
Abstract 
The objective of the present study was to evaluate the effect of different dietary α-linolenic 
acid (ALA, 18:3n-3) to linoleic acid (LA, 18:2n-6) ratios, while employing 100% fish oil 
deprived diets, on growth performance and flesh fatty acid composition of Murray cod, and 
subsequent finishing (wash-out) efficiency. The ALA/LA ratios of the five experimental 
diets were gradually increased from 0.3 to 2.9, with a constant total content of ALA+LA of 
51%. Fish oil was used for the sixth diet (control), which was also used during the finishing 
period. It was shown that an increased dietary ALA/LA ratio does not impair growth 
performance or the tissue lipid concentration of Murray cod. However, the dietary ALA/LA 
ratio significantly impacts on the final fatty acid make-up and nutritional quality of the fish 
fillet. In particular, the fillets of fish fed with higher ALA/LA ratios (hence receiving more 
dietary ALA) recorded significantly higher concentrations of EPA and DHA 
(eicosapentaenoic acid, 20:5n-3, and docosahexaenoic acid, 22:6n-3, respectively). High 
dietary LA content, however, was shown to have significant negative impacts on the 
efficiency of a finishing strategy. Interestingly, it was observed that, on average, only 10% of 
the total EPA and DHA provided during the finishing period via the fish oil-based diet was 
retained and deposited into the fish fillet. Additionally, the deposition of EPA and DHA 
during the finishing period was shown to be affected by previous feeding history, with fish 
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previously fed high LA diets depositing significantly lower amounts of these fatty acids in 
comparison to fish previously fed a diet rich in ALA. 
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Appendix II 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of Dietary alpha-Linolenic 
Acid (18:3n-3)/Linoleic Acid (18:2n-6) Ratio on Fatty Acid Metabolism in Murray Cod (Maccullochella 
peelii peelii). Journal of Agricultural and Food Chemistry. 59, 1020-1030. 
Abstract 
Global shortages in fish oil are forcing the aquaculture feed industry to use alternative 
oil sources - the use of which negatively affects the final fatty acid makeup of cultured 
fish. Thus, the modulation of fatty acid metabolism in cultured fish is the core of an 
intensive global research effort. The present study aimed to evaluate the effects of 
varying dietary α-linolenic acid (ALA, 18:3n-3) / linoleic acid (LA, 18:2n-6) ratios in 
cultured fish. A feeding trial was implemented on the freshwater finfish Murray cod, in 
which fish were fed either a fish oil-based control diet or one of five fish oil-deprived 
experimental diets formulated to contain an ALA/LA ratio ranging from 0.3 to 2.9, but 
with a constant total C18 PUFA (ALA+LA) content. The whole body fatty acid balance 
method was used to evaluate fish in vivo fatty acid metabolism. The results indicate that 
dietary ALA was more actively β-oxidized and bioconverted, whilst LA appears to be 
more efficiently deposited. LA was β-oxidized at a constant level (~36 % of net intake) 
independent of dietary availability, while ALA was oxidized proportionally to dietary 
supply. The in vivo apparent Δ-6 desaturase activity on n-3 and n-6 PUFA exhibited an 
increasing and decreasing trend, respectively, in conjunction with the increasing dietary 
ALA/LA ratio, clearly indicating that this enzymatic activity is substrate dependant. 
However, the maximum Δ-6 desaturase activity acting on ALA peaked at the substrate 
level of 3.2186 (μmol g fish-1 day-1), suggesting that additional inclusion of ALA is not 
only wasteful, but counterproductive in terms of n-3 LC-PUFA production. Despite a 
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constant total supply of ALA+LA, the recorded total in vivo apparent Δ-6 desaturase 
activity on both substrates (ALA and LA) increased in synchrony with the ALA/LA 
ratio, peaking at 1.54, and a 3.2-fold greater Δ-6 desaturase affinity towards ALA over 
LA was recorded. 
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Appendix III 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of dietary vitamin B6 
supplementation on fillet fatty acid composition and fatty acid metabolism of rainbow trout fed vegetable 
oil based diets, Journal of Agricultural & Food Chemistry 60, 2343-2353. 
Abstract 
Fish oil replacement in aquaculture results in major modifications to the fatty acid make-
up of cultured fish. Therefore, the in vivo fatty acid biosynthesis has been a topic of 
considerable research interest. Evidence suggests that pyridoxine (Vitamin B6) plays a 
role in fatty acid metabolism, and in particular, the biosynthesis of LC-PUFA has been 
demonstrated in mammals. However, there is little information on the effects of dietary 
pyridoxine availability in fish fed fish oil deprived diets.  Here, we demonstrate a 
relationship between dietary pyridoxine supplementation and fatty acid metabolism in 
rainbow trout.  In particular, dietary pyridoxine level was shown to modulate and 
positively stimulate the activity of the elongase, Δ-6 and Δ-5 desaturase enzymes. This 
activity was insufficient to compensate for a diet lacking in LC-PUFA but does highlight 
potential strategies to maximise this activity in cultured fish, especially when fish oil is 
replaced with alternative oils. 
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Appendix IV 
Senadheera, S.D., Turchini, G.M., Thanuthong, T., Francis, D.S., 2011. Effects of dietary iron 
supplementation on growth performance, fatty acid composition and fatty acid metabolism in rainbow 
trout (Oncorhynchus mykiss) fed vegetable oil based diets. Aquaculture 342-343, 80-88. 
Abstract 
The complete and successful replacement of fish oil in aquafeed has yet to be achieved, 
and the failure to meet this milestone is largely attributed to the unsolved issues 
surrounding omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA). As means 
of overcoming this issue, the potential of in vivo biosynthesis of n-3 LC-PUFA in 
cultured fish has been widely investigated and may permit the future economical and 
sustainable development of aquaculture. Two of the key enzymes involved in this 
process include the fatty acid Δ-6 and Δ-5 desaturases, where, in the terminal protein of 
each complex, iron is present in the active di-iron centres.  To the best of authors’ 
knowledge, no investigations have thus far been attempted to elucidate the potential 
roles of dietary iron on the fatty acid metabolism of cultured fish. In this study, graded 
inclusions of dietary iron were tested in vegetable oil based diets in rainbow trout. A 
series of strong, but preliminary evidence, suggests that dietary iron concentrations can 
have a positive effect on the overall LC-PUFA biosynthesis in fish and are herein 
reported. In particular, dietary iron level was shown to affect the final n-3 LC-PUFA 
content of fish tissues and also to modulate the activity of fatty acid desaturase enzymes. 
This activity was insufficient to compensate for a diet lacking in LC-PUFA but does 
highlight potential strategies to maximise this activity in cultured fish fed fish oil free 
diets.  
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